telmisartan has been researched along with Hypertension in 611 studies
*Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (1.96) | 18.2507 |
| 2000's | 284 (46.48) | 29.6817 |
| 2010's | 282 (46.15) | 24.3611 |
| 2020's | 33 (5.40) | 2.80 |
| Authors | Studies |
|---|---|
| Markham, A; McClellan, KJ | 1 |
| Schieffer, B; Schmidt, B | 1 |
| Bao, X; Chen, Z; Da, Y; Li, F; Ren, H; Wang, L; Wu, D; Yan, Y; Zhu, W | 1 |
| Ammazzalorso, A; Amoia, P; Amoroso, R; Maccallini, C | 1 |
| Guion-Firmin, J; Montastruc, JL; Tessier, S | 1 |
| Agrawal, S; Anand, J; Bachani, D; Doshi, M; Gaikwad, VB; Halder, SK; Kinholkar, B; Kumar, DA; Kumbhar, A; Mathur, R; Mehta, S; Sarkar, G; Sharma, A | 1 |
| Desai, N; Jadhav, U; Kumar, GP; Muppalla, BS; Parthasaradhi, SV; Ram, CVS; Ray, S; Sawhney, JPS; Unni, G | 1 |
| Bai, L; Chen, Y; Gao, J; Guo, X; Lai, B; Shang, F; Wang, C; Wen, E | 1 |
| Jat, R; Mistry, RP; Shah, C | 1 |
| Agbaraolorunpo, F; Anigbogu, CN; Ogunnowo, SA; Oloyo, AK; Sofola, O | 1 |
| Allada, R; Ann, EYC; Ganesan, T; Ghosal, S; Kwok, J; Muthudoss, P; Omar, MF; See, HH; Shahnawaz, SS; Voguri, RS | 1 |
| Kang, TS; Kim, BK; Kim, JY; Lee, CJ; Lee, SH; Park, S; Sung, JH | 1 |
| Anhua, Z; Dandan, S; Honglei, Y; Jing, W; Junming, T; Min, L; Na, F; Sheng, D; Wenjun, Z; Xiju, H; Yan, J; Yun, H; Yun, W | 1 |
| Ahn, JC; Cho, EJ; Han, SH; Kang, SM; Kim, KH; Kim, KI; Kim, SY; Kim, W; Kim, YJ; Park, CG; Park, SJ; Park, SM; Shin, J; Shin, JH; Sohn, IS; Sung, JH; Sung, KC | 1 |
| Cazabon, D; Hering, D; Krishna, A; Moran, AE; Pathni, AK; Sahoo, SK; Sharma, B | 1 |
| Campbell, N; Cheng, F; Cummings, J; Gao, S; Hou, Y; Leverenz, JB; Pieper, AA; Tu, W; Zhang, P | 1 |
| Bernatchez, P; Donen, G; Tehrani, AY; Zhao, R | 1 |
| Aich, J; Devarajan, S; Kumar, U | 1 |
| Chen, S; Dong, P; Liu, H; Zhao, D | 1 |
| Duarte, M; Ignacio, FC; Nicolosi, L; Pelorosso, FG; Rothlin, RP; Salgado, MV; Vetulli, H | 1 |
| Liang, H; Tang, T; Xie, M | 1 |
| Ahn, Y; Cha, KS; Chang, K; Cho, EJ; Choi, DJ; Choi, SY; Doh, JH; Hong, SJ; Hong, SP; Hwang, JY; Hyon, MS; Ihm, SH; Kang, WC; Kim, HS; Kim, MH; Kim, SH; Kim, WS; Kim, YH; Kwon, K; Lee, JH; Lee, N; Lim, SW; Rhee, MY; Shin, J; Son, JW; Yoo, BS | 1 |
| Gosteva, EV; Latisheva, MN; Nikitin, AV; Starodubtseva, IA; Vasilieva, LV | 1 |
| Lee, TH; Li, YR; Lin, YS; Liu, CH; Sung, PS; Wei, YC | 1 |
| Acín, T; Alzueta, N; Echeverría, A; Fontela, C; Garjón, J; Montenegro, L; Sanz, L | 1 |
| Chen, H; Li, M; Liu, L; Tian, G; Zhu, D | 1 |
| Bazylevych, AY; Bochar, OM; Bochar, VT; Faynyk, AF; Kuzminov, YB; Sklyarova, HY | 1 |
| Billot, L; de Silva, A; Guggilla, R; Jan, S; Maulik, PK; Mysore, J; Naik, N; Patel, A; Prabhakaran, D; Rodgers, A; Salam, A; Selak, V; Stepien, S; Thom, S; Wang, N; Webster, R | 1 |
| Ahn, JC; Chae, IH; Cho, EJ; Cho, JM; Cho, Y; Choi, SY; Han, KH; Hong, SJ; Hong, SP; Hwang, J; Hyon, MS; Jin, X; Kim, H; Kim, HS; Kim, JH; Kim, MH; Kim, PJ; Kim, WS; Kwon, K; Lee, H; Lee, HC; Lee, JH; Lee, K; Lee, SH; Park, CG; Rhee, MY; Seo, JS; Shin, JH; Sung, JH; Sung, KC; Yoo, BS | 1 |
| Hong, GR; Jo, SH; Kim, SW; Park, CG; Park, SJ | 1 |
| Aguirre, MV; Ferrer, EG; Lima, AM; Martínez, VR; Stergiopulos, N; Todaro, JS; Williams, PA | 1 |
| Ameen, O; Motawea, SM; Naguib, YM; Rizk, MS; Samaka, RM | 1 |
| Basiak, M; Krysiak, R; Okopień, B; Szkróbka, W | 1 |
| Feng, J; Gan, Y; Jiang, H; Ma, H | 1 |
| Li, ZX; Song, XR; Wang, FZ; Zhang, Z | 1 |
| Chen, TH; Huang, CC; Huang, WK; Lee, TH; Lee, TW; Li, YR; Liu, CH; Sung, PS; Wei, YC | 1 |
| Ali Syed, M; Amjad Beg, M; Athar, F; Dohare, R; Sharma, K; Singh, P | 1 |
| Choi, J; Ihm, SH; Kim, JY; Kwon, SU; Lee, HY; Park, SH; Park, SW; Sung, KC; Yoon, CH | 1 |
| Böhm, M; Lonn, EM; Mahfoud, F; Mancia, G; Mann, JFE; Redon, J; Schmieder, RE; Schumacher, H; Sliwa, K; Teo, KK; Weber, MA; Williams, B; Yusuf, S | 1 |
| Li, X; Sun, L; Sun, N; Wang, H; Wu, Y; Xi, Y; Yan, LL; Zhang, J; Zhang, P | 1 |
| Gao, P; Li, Q; Lin, S; Liu, D; Lu, Z; Wang, B; Wei, X; Xia, W; Xiong, S; Zhao, Z; Zhu, Z | 1 |
| Ding, Y; Dou, F; Li, Y; Liu, T; Liu, W; Mu, F; Shang, P; Sun, L; Wen, A; Zhang, T; Zhang, Y; Zhu, Z | 1 |
| Chen, H; Du, R; Han, H; Hu, L; Li, J; Li, W; Ma, L; Tian, L; Zhou, Q | 1 |
| Chatterjee, B; Pal, TK; Sengupta, P | 1 |
| Califf, RM | 1 |
| Choi, JH; Kang, HY; Kim, Y; Park, SW | 1 |
| Bae, JH; Baek, SH; Cho, J; Choi, YJ; Doh, JH; Han, JK; Han, KH; Hong, KS; Hyon, MS; Ihm, SH; Jeong, JO; Kim, H; Kim, HS; Kim, MH; Kim, SH; Kim, SJ; Lee, BK; Oh, GC; Rhee, MY; Rhew, JY; Shin, ES; Sung, JH; Yoo, BS | 1 |
| Böhm, M; Lonn, E; Mahfoud, F; Mancia, G; Mann, JFE; Redon, J; Schmieder, R; Schumacher, H; Sliwa, K; Teo, KK; Weber, M; Williams, B; Yusuf, S | 1 |
| Cho, HJ; Choi, DJ; Han, KR; Jo, SH; Kim, EJ; Kim, SJ; Park, JJ; Park, SJ; Shin, J; Shin, JH; Song, JM | 1 |
| Kang, SS; Kim, HJ; Kwon, YJ; Suh, GH | 1 |
| Amarasekara, S; Amarasena, N; Billot, L; de Silva, AP; de Silva, HA; Fernando, M; Guggilla, R; Jan, S; Jayawardena, J; Maulik, PK; Mendis, S; Munasinghe, J; Naik, N; Patel, A; Prabhakaran, D; Rajapakse, S; Ranasinghe, G; Rodgers, A; Salam, A; Selak, V; Senaratne, V; Stepien, S; Thom, S; Tisserra, N; Webster, R; Wijekoon, S; Wijeyasingam, S | 1 |
| Behuliak, M; Jirsa, M; Kuda, O; Mlejnek, P; Pravenec, M; Šilhavý, J; Šimáková, M; Sticová, E; Vaněčková, I | 1 |
| Gilowski, W; Krysiak, R; Marek, B; Okopień, B | 1 |
| Albrecht, B; Elliott, J; Glaus, TM; Herberich, E; Zimmering, T | 1 |
| Chernatska, O; Demikhova, N | 1 |
| Ahn, Y; Chang, K; Cho, JM; Hong, SJ; Hyon, MS; Jeong, HS; Kang, WC; Kim, HS; Lee, JH; Pyun, WB | 1 |
| Budak, F; Guclu, M; Kiyici, S; Sigirli, D; Tuncel, E | 1 |
| Brown, SA; Bryson, L; Coleman, AE; Traas, AM; Zimmering, T; Zimmerman, A | 1 |
| Ahn, JC; Cha, DH; Cho, SK; Jeon, DW; Kim, KH; Kim, SY; Kim, TS; Kim, WS; Kim, YJ; Lee, HC; Oh, YS; Park, DG; Park, SH; Rha, SW; Rhee, MY; Sung, KC; Yoo, BS; Yoo, KD; Yoon, MH; Yoon, YW | 1 |
| Böhm, M; Lonn, EM; Mahfoud, F; Mancia, G; Mann, JFE; Marx, N; Redon, J; Schmieder, RE; Schumacher, H; Sliwa, K; Teo, KK; Weber, MA; Williams, B; Yusuf, S | 1 |
| Arimitsu, M; Kamei, N; Koike, Y; Naruse, M; Sakamoto, R; Yambe, Y | 1 |
| Guo, CX; Huang, J; Huang, L; Liu, SK; Pei, Q; Tan, HY; Yang, GP; Yang, L; Zuo, XC | 1 |
| Hayashi, N; Hirotani, A; Kamide, K; Katsuya, T; Kawai, T; Kitano, S; Nagano, M; Ohishi, M; Rakugi, H; Yamamoto, K | 1 |
| Kazdová, L; Kurtz, TW; Landa, V; Mlejnek, P; Pravenec, M; Silhavy, J; Simáková, M; Zídek, V | 1 |
| Chen, S; Chen, W; Du, H; Fan, J; Lan, X; Ling, Z; Liu, Z; Su, L; Woo, K; Xiao, P; Xu, Y; Yin, Y; Zhou, B | 1 |
| Biswas, E; Choudhury, H; Ghosh, B; Gorain, B; Halder, D; Pal, TK; Sarkar, AK; Sarkar, P | 1 |
| Agarwal, M; Chugh, PK; Gupta, M; Tekur, U | 1 |
| Achenbach, S; Cicha, I; Garlichs, CD; Klinghammer, L; Lewczuk, P; Raaz-Schrauder, D; Urschel, K | 1 |
| Liu, Y; Xu, L | 1 |
| Mancia, G | 1 |
| Baschiera, F; Brunel, P; Düsing, R; Lacy, PS; Williams, B | 1 |
| Billecke, SS; Marcovitz, PA | 1 |
| Sessa, WC; Siragusa, M | 1 |
| Fan, YM; Gao, DF; Li, YQ; Qin, XJ; Wu, JJ; Zhang, Y | 1 |
| Guthrie, RM; Kjeldsen, SE; Neldam, S; Schumacher, H | 1 |
| Kjeldsen, S; Mancia, G; Mattheus, M; Schmieder, R; Unger, T | 1 |
| Slíva, J; Vítovec, J | 1 |
| Barykina, IN; Chumachok, EV; Ledyaeva, AA; Mazina, G; Nedogoda, SV; Salasyuk, AS; Tsoma, VV | 1 |
| Hamada, T; Haruaki, N; Hirota, Y; Hisatome, I; Kato, M; Kosaka, H; Kotake, H; Kuwabara, M; Miyazaki, S; Mizuta, E; Nakamura, H; Ogino, K; Ohtahara, A; Omodani, H; Taniguchi, S; Watanabe, A; Watanabe, M; Yamamoto, K | 1 |
| Chen, BX; Du, FH; Gong, HT; Guo, CX; Li, Q; Ma, XL; Xu, XY | 1 |
| Goto, SN; Mizuno, Y; Niwa, M; Takagi, H; Umemoto, T | 2 |
| Ferro, A; Wierzbicki, AS | 1 |
| Dahlöf, B; Neldam, S; Oigman, W; Schumacher, H | 1 |
| Bilo, G; Parati, G; Redon, J | 2 |
| Gosse, P; Schumacher, H | 1 |
| Li, L; Liu, LM; Tan, LL; Zhao, HL | 1 |
| Ito, T; Kawahara, K; Kikuchi, K; Maruyama, I; Miura, N; Morimoto-Yamashita, Y; Murai, Y; Tanaka, E; Tancharoen, S | 1 |
| Ruilope, LM; Segura, J | 1 |
| Guan, G; Ma, A; Shao, L; Tian, G; Wang, J; Wang, Y; Zhang, Y | 1 |
| Hirooka, Y; Kishi, T; Sunagawa, K | 3 |
| Akasaka, H; Miura, T; Saitoh, S; Shimamoto, K; Yoshida, H | 1 |
| Chen, JF; Huang, JX; Peng, GC; Sai, SQ; Wang, YF; Xiao, Y; Yang, Y; Ye, YL | 1 |
| Asai, S; Kanou, N; Nakayama, T; Nishida, Y; Susa, N; Takahashi, Y | 1 |
| Ise, T; Iwase, T; Kusunose, K; Niki, T; Oeduka, H; Sata, M; Soeki, T; Taketani, Y; Wakatsuki, T; Yamada, H; Yamaguchi, K | 1 |
| Clase, C; Dagenais, GR; de Zeeuw, D; Gao, P; Heerspink, HJ; Lonn, E; Mann, JF; Sleight, P; Teo, KT; Yusuf, S | 1 |
| Huang, ZJ; Li, XH; Li, Y; Liu, JJ; Tang, XH; Yuan, H | 1 |
| Birgit, V; Gao, PJ; Jeong, MH; Liu, SW; Mattheus, M; Zhu, DL | 1 |
| Antonio, DP; Antonio, PR; Carlos, EN; Francisco, GU; Gabriel, CT; Isabel, MN; Luís, DD; Manuel, GP; Manuel, ST; Marta, PS; Rafael, MS; Sonia, GV | 1 |
| Beige, J; Huber, M; Kreutz, R; Kurzidim, A; Martus, P; Treutler, T | 1 |
| Kobara, M; Nakata, T; Ohigashi, M; Toba, H; Wang, J | 1 |
| DiNicolantonio, JJ; Elisaf, MS; Liberopoulos, EN; Rizos, CV; Tellis, K; Tselepis, AD | 1 |
| Parati, G; Schumacher, H | 1 |
| Haririan, A; Karadsheh, FF; Reddivari, V; Salzberg, DJ; Weir, MR | 1 |
| Gao, P; Holtbruegge, W; Huang, C; Zhu, D | 1 |
| Kinoshita, S; Nakamoto, H; Nishida, E; Ryuzaki, M; Sone, M | 1 |
| Guggilla, R; Jan, S; Kallakuri, S; Maulik, PK; Naik, N; Patel, A; Prabhakaran, D; Rodgers, A; Salam, A; Selak, V; Singh, K; Thom, S; Webster, R | 1 |
| Barkhausen, J; Hübel, N; Mildner, M; Müller-Fielitz, H; Raasch, W; Vogt, FM | 1 |
| Bays, H; Schumacher, H; Zhu, D | 1 |
| Diao, Y; Liu, Z; Lu, F; Qi, Z; Song, H; Wei, F; Ye, L; Zhang, H; Zhao, Y | 1 |
| Caffrey, JL; Chang, CH; Lai, MS; Lin, JW; Wu, LC | 1 |
| Daikuhara, H; Fukunaga, K; Ohshima, T | 1 |
| Böhm, M; Foulquier, S; Schmieder, R; Schumacher, H; Sleight, P; Teo, K; Unger, T; Yusuf, S | 1 |
| Chen, Y; Hao, K; Liu, X; Zhao, X | 1 |
| Pan, G; Zhao, J; Zhou, X | 1 |
| Abe, K; Deguchi, K; Fukui, Y; Hishikawa, N; Kurata, T; Lukic, V; Sato, K; Yamashita, T | 2 |
| Frohlich, ED; Susic, D | 1 |
| Cheng, L; Gou, F; Yuan, Q; Zhang, G; Zhang, Q; Zhang, Y | 1 |
| Bath, PM; Cotton, D; Dahlof, B; Estol, CJ; Gorelick, PB; Martin, RH; Weber, MA | 1 |
| Chwallek, F; Pimenta, E; Wang, JG | 1 |
| Dolan, E; Ley, L; Parati, G; Schumacher, H | 1 |
| Kaul, U; Mansoor, A; Sabbah, ZA | 1 |
| Chalmers, J | 1 |
| Benisty, J; Dial, S; Kezouh, A; Nessim, SJ; Suissa, S | 1 |
| Kjeldsen, SE; Neldam, S; Neutel, JM; Schumacher, H | 1 |
| Hasegawa, Y; Katayama, T; Kim-Mitsuyama, S; Koibuchi, N; Ma, M; Nakagawa, T; Ogawa, H; Sueta, D; Toyama, K; Uekawa, K | 1 |
| Izumikawa, Y; Kato, H; Kojima, K; Kubo, E; Nagura, M; Nosaka, H; Shima, T; Shimada, M; Shiraishi, T; Tanemoto, M; Tomioka, S; Uchida, S; Ueda, S; Yano, H | 1 |
| Takagi, H; Umemoto, T | 2 |
| Chen, L; Hong, H; Lin, X; Shi, X; Wu, Y; Zou, G | 1 |
| Liu, Z; Lu, F; Peng, J; Tang, M; Wang, Z; Zhang, H; Zhang, W; Zhao, Y; Zhong, M | 1 |
| Dika, Z; Fodor, L; Ivković, V; Jelaković, B; Laganović, M; Perkov, D; Premužić, V; Vrkić, TZ; Zivko, M | 1 |
| Baek, SH; Choi, SH; Jung, MD; Lim, SC; Yoo, SM | 1 |
| Ellison, DH; Ingelfinger, JR | 1 |
| Abebe, KZ; Braun, WE; Brosnahan, G; Chapman, AB; Czarnecki, PG; Flessner, MF; Grantham, JJ; Harris, PC; Hogan, MC; Miskulin, DC; Moore, CG; Perrone, RD; Rahbari-Oskoui, FF; Schrier, RW; Steinman, TI; Torres, VE; Winklhofer, FT | 1 |
| Abebe, KZ; Bae, KT; Braun, WE; Brosnahan, G; Chapman, AB; Czarnecki, PG; Flessner, MF; Grantham, JJ; Harris, PC; Hogan, MC; Miskulin, DC; Moore, CG; Perrone, RD; Rahbari-Oskoui, FF; Schrier, RW; Steinman, TI; Torres, VE; Winklhofer, FT | 1 |
| Basile, JN; Gradman, AH | 1 |
| Balam-Salazar, LB; Cardona-Muñoz, EG; Curiel-Beltrán, JA; de Jesús Romero-Prado, MM; Miramontes-Espino, MV; Rios-Arellano, A | 1 |
| Barvaliya, MJ; Naik, VN; Shah, AC; Tripathi, CR | 1 |
| Angeloni, E; Lombardo, P; Pirelli, M; Refice, S; Vitaterna, A | 1 |
| El Hassar, C; Malti, N; Merzouk, H; Merzouk, SA; Meziane, A; Narce, M | 1 |
| Abe, K; Deguchi, K; Hishikawa, N; Kono, S; Kurata, T; Omote, Y; Sato, K; Yamashita, T | 1 |
| Anderson, C; Böhm, M; Custodis, F; Diener, HC; Fagard, R; Laufs, U; Leong, D; Lonn, E; Mancia, G; O'Donnell, M; Redon, J; Schmieder, R; Schumacher, H; Sleight, P; Sliwa, K; Teo, K; Unger, T; Yusuf, S | 1 |
| Abe, K; Deguchi, K; Hishikawa, N; Kono, S; Kurata, T; Liu, W; Yamashita, T; Zhai, Y | 1 |
| Bochar, OM | 1 |
| Baqar, S; Chen, AX; Ekinci, EI; Jerums, G; Lambert, E; MacIsaac, RJ; O'Callaghan, C; Somarajah, G; Thomas, G | 1 |
| Inoue, H; Inui, T; Mizoguchi, M; Nakatsuji, M; Sakamoto, A; Wada, K; Yamaguchi, K | 1 |
| D'Angelo, A; Dario Ragonesi, P; Derosa, G; Franzetti, I; Maffioli, P; Querci, F | 1 |
| Abd-Elgalil, AA; Bakheit, AH; Haque, A; Mustafa, B; Wani, TA | 1 |
| De Bernardo, G; Marchetto, L; Sordino, D; Trevisanuto, D | 1 |
| Chen, JH; Chen, LL; Chen, XH; Fu, FY; Tang, MR; Wang, WW; Zhang, FL | 1 |
| Jinnouchi, H; Kataoka, K; Kim-Mitsuyama, S; Matsui, K; Node, K; Ogawa, H; Sekigami, T; Soejima, H; Yamamoto, E; Yamamuro, M; Yasuda, O | 1 |
| Chen, Y; Hao, K; Yu, D | 1 |
| Giménez-García, R | 1 |
| Fujimoto, M; Kimura, M; Ma, Y; Shimada, Y; Watari, H | 1 |
| Lamie, NT; Mohamed, HM | 1 |
| Chen, XP; Li, HL; Wen, ZP; Yang, GP; Zhang, W; Zhang, ZL | 1 |
| Hirata, K; Ishida, T; Kondo, K; Mori, K; Toh, R; Yasuda, T | 1 |
| Aoki, H; Hoshide, S; Kario, K; Matsumoto, Y; Mizuno, H; Noshiro, T; Okazaki, O; Uchiyama, K; Yoshida, T | 1 |
| Asayama, K; Haga, T; Hosaka, M; Imai, Y; Inoue, R; Kikuya, M; Mano, N; Metoki, H; Murakami, T; Obara, T; Ohkubo, T; Satoh, M | 1 |
| Brunner, HR; Foster, C; Huo, Y; Michel, MC | 1 |
| Agostoni, P; Anza-Ramìrez, C; Bilo, G; Caravita, S; Faini, A; Lang, M; Macarlupu, JL; Parati, G; Salvioni, E; Villafuerte, FC | 1 |
| Guo, J; Huo, CJ; Kang, YM; Li, HB; Li, X; Liu, JJ; Shi, XL; Su, Q; Yuan, ZY; Zhu, GQ | 1 |
| Blumenthal-Katzir, T; Grigoriadis, N; Hollander, K; Lagoudakic, R; Rosenthal, T; Touloumi, O; Younis, FM | 1 |
| Higaki, J; Ikeda, H; Komuro, I; Kuroki, D; Nishimura, S; Ogihara, T; Shiki, K; Taniguchi, A; Ugai, H | 1 |
| Chen, CH; Cheng, HM; Hoshide, S; Huang, QF; Kario, K; Park, CG; Park, S; Wang, JG | 1 |
| Bal, UA; Baysal, SS; Müderrisoğlu, H; Okyay, K; Öztuna, D; Pirat, B; Uluçam, MZ | 1 |
| Birocale, AM; Bissoli, NS; de Oliveira, JM; Medeiros, AR; Nonaka, KO; Pereira, RM; Ruffoni, LD; Takayama, L | 1 |
| Ahn, TH; Cho, EJ; Doh, JH; Ha, JW; Han, GR; Hyeon, MS; Im, SJ; Im, SW; Jae, JG; Kim, CH; Kim, HS; Kim, W; Lee, MM; Park, CG; Pyeon, WB; Ryu, JG; Tak, SJ; Yang, JY | 1 |
| Bilo, G; Caravita, S; Faini, A; Lang, M; Parati, G | 1 |
| Higaki, J; Ikeda, H; Komuro, I; Kuroki, D; Lee, G; Nishimura, S; Ogihara, T; Shiki, K; Taniguchi, A | 1 |
| He, SL; Huang, SS; Yuan, QY; Zhang, QB; Zhang, YM | 1 |
| Morishita, R; Taniyama, Y | 1 |
| Abdulzahra, MS; Al-Aubaidy, HA; Al-Huseini, LM; Hadi, NR | 1 |
| Chan, WP; Mackey, VT; Sun, DK | 1 |
| Kim, B; Kim, HW; Kim, WJ; Lee, DY; Lee, SY; Moon, KH; Park, HS; Park, SK | 1 |
| Liu, Y; Sun, L; Sun, N; Wang, H; Zhang, J; Zhang, P | 1 |
| Weber, MA | 3 |
| Hedner, T; Kjeldsen, SE; Narkiewicz, K; Oparil, S | 2 |
| Grassi, G; Mancia, G; Quarti-Trevano, F | 1 |
| Burnier, M; Hess, O; Lüscher, T; Waeber, B | 1 |
| Hitsumoto, T; Iizuka, T; Shirai, K; Takahashi, M | 1 |
| Bae, YI; Lee, JB; Lee, SC; Park, GT; Yun, SJ | 1 |
| Ano, N; Atsuda, K; Inoue, G; Irie, J; Kitaoka, A; Shiono, K; Toda, K; Yamada, S | 1 |
| Fujimoto, Y; Hinoi, T; Kajiwara, S; Matsuo, S; Ono, T; Shichijo, T; Tomohiro, Y; Yamamoto, S | 1 |
| Abramczyk, P; Bidiuk, J; Dobosiewicz, A; Gaciong, Z; Lewandowski, J; Sinski, M | 1 |
| Arita, M; Furuta, M; Sanke, T; Shimajiri, Y; Yamana, A | 1 |
| Mancia, G; Schumacher, H | 1 |
| Inoue, T; Kawagoe, Y; Koide, H; Nakamura, T; Node, K; Suzuki, T; Ueda, Y | 1 |
| Abe, H; Adachi, H; Hattori, S; Irino, H; Kitada, H; Miyatake, K; Morisawa, D; Noda, Y; Sasaki, T; Yasuoka, Y | 1 |
| Baliga, V; Sharma, A | 1 |
| Plosker, GL; White, WB | 1 |
| Edwards, C; Neldam, S | 2 |
| Abiko, A; Makita, S; Moriai, Y; Naganuma, Y; Nakamura, M | 2 |
| Enjoji, M; Higuchi, N; Kato, M; Kohjima, M; Kotoh, K; Nakamuta, M; Nakashima, M | 1 |
| Atar, D; Hanley, DF; Serebruany, VL | 1 |
| Shi, XY; Xi, GL; Yuan, HB; Zhu, QF; Zou, Z | 1 |
| Fischer, P; Masnatta, LD; Pesiney, C; Ramirez, AJ; Sanchez, RA | 1 |
| Cao, T; Chen, X; Feng, X; He, H; Liu, D; Luo, Z; Ma, L; Tepel, M; Wang, L; Yan, Z; Yang, D; Zhu, Z | 1 |
| McInnes, GT | 1 |
| Hamamoto, Y; Honjo, S; Ikeda, H; Koshiyama, H; Nabe, K; Wada, Y | 1 |
| Chen, JZ; Chen, SL; Chen, SX; DU, FH; Ke, YN; Pu, K; Qin, YW; Yan, XW; Zhang, CZ; Zhang, J; Zhu, DL | 1 |
| Hilgers, KF; Ott, C; Raff, U; Ritt, M; Schlaich, MP; Schmieder, RE; Schneider, MP; Schuster, I | 1 |
| Eder, M; Perl, S; Pressl, H; Schmölzer, I; Sourij, H; Wascher, TC; Zweiker, R | 1 |
| Doumas, M; Papademetriou, V | 1 |
| Bressolle, C; Fichet, J | 1 |
| Achard, JM; Fournier, A; Fournier, RO | 1 |
| Gosse, P; Lacourcière, Y; Neutel, JM; Schumacher, H; Williams, B | 1 |
| Brazhnik, VA; Makolkin, VI; Petriĭ, VV; Sergushkina, NG | 1 |
| Bando, S; Ito, S; Nakaya, Y; Ono, Y; Sata, M; Soeki, T | 1 |
| Furukata, S; Ishimitsu, T; Matsuoka, H; Minami, J | 1 |
| Georgescu, EF; Ionescu, R; Mogoanta, L; Niculescu, M; Vancica, L | 1 |
| Abiko, A; Makita, S; Naganuma, Y; Nakamura, M; Tamada, M | 1 |
| Guthrie, R; Kobe, M; Littlejohn, TW; Majul, CR; Oigman, W; Olvera, R; Seeber, M | 2 |
| Terrosu, P; Verdecchia, P | 1 |
| Davidai, G; Schumacher, H; White, WB | 1 |
| Kuji, T; Masuda, S; Okano, Y; Tamura, K; Tochikubo, O; Umemura, S | 1 |
| Falvey, H; Lowy, A; Müller, E; Nixon, RM | 1 |
| Hirose, H; Itoh, H; Kawabe, H; Komiya, N; Saito, I | 1 |
| Guthrie, R | 1 |
| Mazerska, M; Myśliwiec, M | 1 |
| Iuchi, A; Miyoshi, H; Mizuguchi, Y; Nagase, N; Oishi, Y; Oki, T | 2 |
| Böhm, M; Fagard, R; Gao, P; Koon, T; Mancia, G; Pogue, J; Redon, J; Schumacher, H; Sleight, P; Verdecchia, P; Weber, M; Williams, B; Yusuf, S | 1 |
| Ekinci, EI; Finch, S; Houlihan, CA; Jerums, G; Johnson, C; Macisaac, RJ; O'Callaghan, C; Panagiotopoulos, S; Thomas, D; Thomas, G | 1 |
| Faruqui, AA | 1 |
| Ambrosioni, E; Borghi, C; Cicero, AF; Di Gregori, V; Prandin, MG; Veronesi, M | 1 |
| Fu, L; Mao, ZX; Wang, J; Wang, SL; Zhang, J; Zheng, TR | 1 |
| Mancia, G; Unger, T; Zanchetti, A | 1 |
| Sleight, P | 2 |
| Ferrari, R | 1 |
| Weber, M | 2 |
| Ando, K; Isshiki, M; Takahashi, K | 1 |
| Chang, L; Chen, YE; Hamblin, M; Zhang, J | 1 |
| Hoshino, J; Hosoi, T; Iwasaki, T; Kawachi, K; Kurabayashi, M; Morishita, K; Nakamura, T; Ohyama, Y; Saito, T; Saito, Y | 1 |
| Harada, N; Okajima, K; Shimozawa, N | 1 |
| Bähr, IN; Fleck, E; Fritzsche, J; Goebel, M; Gust, R; Hässle, PL; Kappert, K; Kaufmann, J; Kintscher, U; Ott, I; Stawowy, P; Tsuprykov, O; Unger, T | 1 |
| Elisaf, MS; Liberopoulos, EN; Rizos, CV | 1 |
| Derosa, G; Ferrari, I; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Zoppi, A | 1 |
| Azuma, K; Dejima, T; Kanaoka, T; Maeda, A; Masuda, S; Ohsawa, M; Tamura, K; Umemura, S; Wakui, H; Yanagi, M | 1 |
| Cao, T; Chen, X; Feng, X; He, H; Liu, D; Luo, Z; Ma, L; Ma, S; Tepel, M; Yan, Z; Yang, D; Zhu, Z | 1 |
| Grossman, E; Kamari, Y; Koren, F; Peleg, E; Sharabi, Y; Shimoni, N | 1 |
| Christensen, A; Christrup, LL; Chrostowska, M; Fabricius, PE; Hansen, EH; Narkiewicz, K; Wronka, M | 1 |
| Bath, PM; Cotton, D; Diener, HC; Estol, C; Martin, RH; Palesch, Y; Roberts, R; Sacco, R; Toni, D; Yusuf, S | 1 |
| Bellomo, A; D'Ottavio, E; Formosa, V; Gianturco, V; Iori, A; Lo Iacono, C; Mancinella, M; Marigliano, V; Troisi, G | 1 |
| Anderson, C; Cowan, BR; Doughty, RN; Jennings, GL; Krittayaphong, R; Lonn, E; Marwick, TH; Reid, CM; Sanderson, JE; Schmieder, RE; Teo, K; Wadham, AK; Worthley, SG; Young, AA; Yu, CM; Yusuf, S | 1 |
| Masuda, S; Okano, Y; Ozawa, M; Tamura, K; Tochikubo, O; Umemura, S | 1 |
| Neldam, S | 1 |
| Mordovina, AG; Morozova, OI; Pozdniakova, NV; Sekerko, SA; Tatarchenko, IP | 1 |
| Deng, Q; Huang, J; Li, W; Lin, SG; Liu, LS; Liu, MB; Ma, LY; Wang, W; Zhang, YQ; Zhu, DL | 1 |
| Cianfrocca, C; Gaudio, C; Mercuro, G; Pasceri, V; Pelliccia, F; Rosano, GM; Speciale, G; Vitale, C | 1 |
| Antonelli, A; Carpi, A; Fallahi, P; Franzoni, F; Galetta, F; Graci, F; Santoro, G; Tocchini, L | 1 |
| Dawes, M | 1 |
| Limor, R; Oron, Y; Rosenthal, T; Stern, N; Younis, F; Zangen, S | 1 |
| Cheng, XM; Chu, WW; Du, M; Li, Y; Ma, SM | 1 |
| Ando, C; Inoue, Y; Kakuma, T; Kodama, S; Miyoshi, K; Niimura, H; Nonaka, Y; Okamura, K; Sumi, S; Tsuchiya, Y; Urata, H; Yamanouchi, Y | 1 |
| Kjeldsen, SE; Mancia, G; Schmieder, RE; Unger, T | 1 |
| Alonso, D; Botello-Amaro, CA; Jimenez-Ferrer, E; Perez, YY; Zamilpa, A | 1 |
| Arnesen, Ø; Bye, A; Johansen, OE; Kontny, F; Risanger, T | 1 |
| Abe, M; Maruyama, T; Matsumoto, K; Matsumoto, S; Okada, K | 1 |
| Hamada, T; Hirai, M; Hisatome, I; Igawa, O; Kato, M; Kondo, T; Mizuta, E; Ninomiya, H; Shigemasa, C; Yamada, K; Yamamoto, Y | 1 |
| Ekinci, EI; Finch, S; Hao, H; Houlihan, C; Jerums, G; Johnson, C; MacIsaac, RJ; O'Callaghan, C; Panagiotopoulos, S; Premaratne, E; Thomas, G | 1 |
| Ara, N; Iuchi, A; Miyoshi, H; Mizuguchi, Y; Nagase, N; Oishi, Y; Oki, T | 1 |
| Fujita, T; Fuke, Y; Matsumoto, K; Satomura, A; Wada, Y | 1 |
| Elisaf, MS; Florentin, M; Kostapanos, MS; Kostara, CE; Liberopoulos, EN; Milionis, HJ; Rizos, CV | 1 |
| Barrios, V; Echarri, R; Escobar, C | 1 |
| Deng, Q; Liu, L; Liu, M; Ma, L; Wang, W; Zhang, Y | 1 |
| Capogrosso, C; Di Michele, S; Galzerano, A; Galzerano, D; Gaudio, C; Lama, D; Paparello, P | 1 |
| Czuczwar, SJ; Jakubus, T; Janowska, A; Tochman-Gawda, A; Łukawski, K | 1 |
| Arif, AF; Joshi, C; Kadam, GG | 1 |
| Mordovina, AG; Morozova, OI; Pozdniakova, NV; Tatarchenko, IP; Zaĭtseva, AV | 1 |
| Chachibaia, ZK; Gerasimenko, ON; Shpagin, IS; Shpagina, LA; Zueva, MA | 1 |
| Cakir, M | 1 |
| Kondo, K; Nomura, Y; Oiso, Y; Ozaki, N; Sobajima, H | 1 |
| Aoki, A; Ichikawa, S; Kumakura, H; Nitta, K; Ogawa, T; Sumino, H; Takayama, Y | 1 |
| Ahrens, K; Bramlage, P | 1 |
| Azevedo, F; Cunha, AP; Ferreira, O; Morais, P; Mota, A | 1 |
| Alonso, I; Ayala, DE; Fernández, JR; Fontao, MJ; Hermida, RC; Mojón, A | 1 |
| Akaza, I; Doi, M; Hirata, Y; Izumiyama, H; Tsuchiya, K; Wago, T; Yoshimoto, T | 1 |
| Budzyn, K; Drummond, GR; Sobey, CG | 1 |
| Atkinson, J; Capdeville-Atkinson, C; Chillon, JM; Dupuis, F; Limiñana, P; Vincent, JM | 1 |
| Lin, S; Shi, H; Zheng, Z | 1 |
| Littlejohn, TW; Majul, CR; Mancia, G; Oigman, W; Olvera, R; Schumacher, H; Seeber, M; White, WB | 1 |
| Andrassy, M; Blessing, E; Ivandic, B; Katus, HA; Krumsdorf, U; Tiefenbacher, CP; Volz, HC; Zankl, AR | 1 |
| Frána, P; Plachý, M; Rihácek, I; Schwarz, D; Soucek, M | 1 |
| Hu, ZP; Qian, HY; Wang, BN; Wang, Y; Wei, W; Zhou, Q | 1 |
| Davidai, G; Haertter, S; Norman, P; Portman, R; Wells, TG | 1 |
| Awata, T; Ikebukuro, K; Inukai, K; Ito, D; Katayama, S; Kurihara, S; Ono, H; Sumita, T; Watanabe, M | 1 |
| Davidai, G; Henry, R; Hsueh, W; Mudaliar, S | 1 |
| Kim, IS; Kim, Y; Lee, JJ; Lee, KH; Myung, CS; Park, HJ; Shin, CY; Zhang, WY | 1 |
| Moen, MD | 1 |
| Gismondi, RA; Neves, MF; Oigman, W | 1 |
| Amano, Y; Higaki, J; Horiuchi, M; Kakuta, H; Kim-Mitsuyama, S; Komuro, I; Miyata, K; Mori, Y; Morishita, R; Niimi, T; Ohno, K; Orita, M; Sakashita, H; Takakura, S; Takeuchi, M; Yamagishi, S | 1 |
| Arfanakis, DA; Chlouverakis, G; Kochiadakis, GE; Kontaraki, JE; Marketou, ME; Parthenakis, F; Tsakountakis, NA; Vardas, PE; Zacharis, EA | 1 |
| Jugdutt, BI | 1 |
| Comi-Diaz, C; Macias-Batista, A; Martinez-Martin, FJ; Pedrianes-Martin, P; Rodriguez-Rosas, H; Soriano-Perera, P | 1 |
| Abe, S; Inoue, T; Node, K; Sakuma, M; Taguchi, I; Toyoda, S | 1 |
| Costo, A; Crespo, L; Doncel, C; Fernandez Toro, JM; Fraile, J; Rivas, MD; Sanchez Muñoz-Torrero, JF; Zamorano, J | 1 |
| Bilo, G; Choi, J; Kilama, MO; Mancia, G; Parati, G; Ruilope, LM | 1 |
| Gu, XF; Liu, AJ; Liu, W; Ma, XJ; Song, SW; Su, DF; Su, FY; Wang, W; Zhang, H | 1 |
| Ikeda, N; Kanno, Y; Kobayashi, K; Ohno, Y; Okada, H; Suzuki, H; Takenaka, T | 1 |
| Derosa, G; Destro, M; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Zoppi, A | 1 |
| Imig, JD; Khan, AH | 1 |
| Ge, JB; Guan, AL; Li, JM; Liang, YY; Ma, Z; Mi, SL; Wu, J; Yao, ZF; Zou, YZ | 1 |
| Bekki, H; Fukami, K; Homma, T; Nakata, M; Nohara, M; Okuda, S; Sone, M; Yamagishi, S; Yamamoto, K | 1 |
| Morozova, OI; Petrushin, IA; Pozdniakova, NV; Sekerko, SA; Tatarchenko, IP | 1 |
| Brown, L; Sernia, C | 1 |
| Ahn, CM; Choi, SC; Hong, SJ; Kim, JS; Lim, DS; Park, JH | 1 |
| Ruilope, LM; Segura, J; Zamorano, JL | 1 |
| Matsuura, K; Mori, Y; Tanaka, T; Utsunomiya, K; Yokoyama, J | 1 |
| Fujiwara, N; Kawagoe, Y; Koide, H; Nakamura, T; Sato, E; Ueda, Y; Yamada, S | 1 |
| Jones, R; Lang, M; Neldam, S | 1 |
| Hasegawa, H; Kobayashi, Y; Komuro, I; Mizuguchi, T; Namiki, T; Narumi, H; Ohtsuka, M; Takano, H | 1 |
| De Caterina, R; Di Iorio, A; Falasca, K; Mancino, P; Ucciferri, C; Vecchiet, J | 1 |
| Limor, R; Oron, Y; Rosenthal, T; Stern, N; Younis, F | 1 |
| Poolsup, N; Prasit, T; Suksomboon, N | 1 |
| Dahlöf, B; Guthrie, RM; Jamerson, KA; Oigman, W; Olvera, R; Schumacher, H; Seeber, M | 1 |
| Hanyu, H; Iwamoto, T; Kume, K; Onuma, T; Sakurai, H; Takada, Y | 1 |
| Cao, Z; Cooper, ME | 1 |
| Edwards, C; Jones, R; Neldam, S | 1 |
| He, WK; He, ZC; Lai, Q; Liang, LY; Lu, DF; Luo, JD; Pan, XD; Wang, W; Wen, YH; Xiao, AY; Zeng, ZH | 1 |
| Derosa, G; Fogari, R; Lazzari, P; Maffioli, P; Mugellini, A; Zoppi, A | 1 |
| Hu, TJ; Huang, GZ; Tang, YH; Wang, BY; Zhang, B; Zhang, L; Zhang, XY; Zhong, Y | 1 |
| Cevik, C; Dindar, I; Kılıcarslan, F; Oduncu, V; Ozveren, O; Semiz, E; Sengul, C; Sunbul, A | 1 |
| Cagnoni, F; Cavalleri, C; Destro, M; Dognini, GP; Galimberti, V; Galli, E; Taietti, C | 1 |
| Suárez, C | 1 |
| Derosa, G; Maffioli, P | 1 |
| Guthrie, RM | 1 |
| Akhrass, PR; McFarlane, SI | 1 |
| Böhm, M; Fagard, R; Gao, P; Mancia, G; Pogue, J; Redon, J; Schumacher, H; Sleight, P; Teo, K; Verdecchia, P; Weber, M; Williams, B; Yusoff, K; Yusuf, S | 1 |
| Hasegawa, H; Kameda, Y; Kobayashi, Y; Komuro, I; Kubota, A; Takano, H | 1 |
| Danser, AH; Maggioni, AP; Menard, J; Mueller, DN; Ruilope, LM; Volpe, M; Waeber, B | 1 |
| Trenkwalder, P | 1 |
| Deng, Q; Liu, L; Liu, M; Ma, L; Sun, H; Wang, J; Wang, W; Zhang, Y; Zhao, Y | 1 |
| Chang, SW; Kao, YC; Lee, WK; Ma, CC; Shiah, IS | 1 |
| Ehara, M; Habara, M; Ito, T; Kaneda, H; Kimura, M; Kinoshita, Y; Matsuo, H; Nasu, K; Rathore, S; Suzuki, T; Suzuki, Y; Tanaka, N; Terashima, M | 1 |
| Adamczak, M; Chudek, J; Kubik, M; Wiecek, A | 1 |
| Bakris, G; Kobe, M; Ley, L; Littlejohn, TW; Neutel, JM; Sharma, AM; Ting, N | 1 |
| Arimura, T; Fujisawa, K; Inoue, A; Kuwano, T; Matsunaga, E; Mitsutake, R; Miura, S; Morii, J; Nagata, I; Norimatsu, K; Saku, K; Shiga, Y; Shimizu, T; Shirotani, T; Uehara, Y | 1 |
| Balakumar, P; Bishnoi, HK; Mahadevan, N | 1 |
| Baek, I; Baschiera, F; Brunel, P; Düsing, R | 2 |
| Black, HR; Dahlöf, B; Defeo, H; Ley, L; Mancia, G; Neutel, JM; Vinisko, R | 1 |
| Boiocchi, C; Bozzini, S; Buzzi, MP; Choi, J; D'Angelo, A; Esposito, C; Falcone, C; Mancia, G; Ochan Kilama, M; Schirinzi, S; Torreggiani, M | 1 |
| Guthrie, R; Neldam, S; Schumacher, H | 1 |
| Derosa, G; Fogari, R; Maffioli, P; Mugellini, A; Perrone, T; Preti, P; Zoppi, A | 1 |
| Carbotta, S; Cittadini, A; Di Michele, S; Galzerano, D; Gaudio, C; Lama, D; Paolisso, G; Tedesco, MA; Tuccillo, B | 1 |
| Horiguchi, CS; Makino, H; Miyoshi, T; Murakami, K; Nakamura, Y; Ogawa, D; Sasaki, M; Uchida, HA; Wada, J | 1 |
| Demin, AA; Shuliat'eva, OIu | 1 |
| Kikuchi, T; Kimura, H; Mitsuhashi, T; Otsuka, K; Tsuchida, Y; Watanabe, Y | 1 |
| Di Iorio, A; Falasca, K; Mancino, P; Ucciferri, C; Vecchiet, J | 1 |
| Bays, H; Gao, P; Mattheus, M; Ruilope, LM; Voelker, B; Zhu, DL | 1 |
| Hirooka, Y; Kishi, T; Konno, S; Sunagawa, K | 2 |
| Ieiri, I; Iwase, M; Kitazono, T; Matsuyama, N; Ohdo, S; Sonoki, K; Takata, Y | 1 |
| Deguchi, I; Fukuoka, T; Furuya, D; Tanahashi, N | 1 |
| Fujimoto, K; Hamamoto, Y; Honjo, S; Ikeda, H; Iwasaki, Y; Kawasaki, Y; Koshiyama, H; Mori, K; Nomura, K; Tatsuoka, H; Wada, Y | 1 |
| Arao, T; Mori, H; Nishida, K; Okada, Y; Tanaka, Y | 2 |
| Lacourcière, Y | 1 |
| Fares, H; Frohlich, ED; Susic, D | 1 |
| Ding, KN; Gao, DF; Li, YQ; Niu, XL; Wang, CX; Wang, SJ | 1 |
| Atkinson, J; Capdeville-Atkinson, C; Dupuis, F; Foulquier, S; Gatè, KM; Lartaud, I; Leroy, P; Liminana, P; Perrin-Sarrado, C | 1 |
| Volpe, M | 1 |
| Dohi, Y; Kimura, G; Kojima, M; Ohashi, M | 1 |
| Ruilope, LM; Schumacher, H | 1 |
| Bilo, G; Czuriga, I; Fagard, R; Gao, P; Mancia, G; Parati, G; Polák, M; Redon, J; Ribeiro, JM; Sanchez, R; Sleight, P; Teo, K; Trimarco, B; van Mieghem, W; Verdecchia, P; Yusuf, S | 1 |
| Dohi, K; Hiraoka, N; Hoshino, K; Ito, M; Kitai, T; Kumagai, N; Nakamori, S; Nakamura, M; Okamoto, S; Onishi, K; Oota, M; Ueda, Y; Yamada, T; Yazu, T | 1 |
| Dahlöf, B; Kobe, M; Majul, CR; Oigman, W; Olvera, R; Punzi, HA; Schumacher, H; Seeber, M; Webster, D | 1 |
| Huang, F; Lin, F; Lin, H; Zhu, PL | 1 |
| Ley, L; Schumacher, H | 1 |
| Middeke, M | 1 |
| Ando, H; Fujimura, A; Ushijima, K | 1 |
| Boor, P; Cohen, CD; Denecke, B; Eitner, F; Floege, J; Gan, L; Konieczny, A; Kunter, U; Neusser, MA; Ostendorf, T; Scholl, T; van Roeyen, CR; Villa, L | 1 |
| Goto, SN; Mizuno, Y; Takagi, H; Umemoto, T | 2 |
| Chatzikyrkou, C; Menne, J | 1 |
| Bednarski, R; Donderski, R; Heleniak, Z; Lizakowski, S; Manitius, J; Przybylska, M; Renke, M; Rutkowski, B; Rutkowski, P; Sulikowska, B; Tylicki, L | 1 |
| Goto, SN; Mizuno, Y; Takagi, H; Umemoto, T; Yamamoto, H | 1 |
| Bai, YY; Li, W; Liu, HQ; Lu, F; Ma, MM; Suo, AQ; Wang, JQ; Zhang, JW | 1 |
| Aoyama, T; Goto, M; Goto, N; Hiei, K; Iwasa, M; Kawai, N; Kida, K; Kobayashi, H; Kojima, S; Minagawa, T; Minatoguchi, S; Oda, M; Sugishita, F; Takai, K; Tanaka, R; Watanabe, I; Yamamoto, N; Yasue, T | 1 |
| Freytag, F; Holwerda, NJ; Karlberg, BE; Meinicke, TW; Schumacher, H | 1 |
| Fakouhi, K; He, W; Krause, S; Krum, H; Nolly, H; Roniker, B; Workman, D | 1 |
| Plavnik, FL; Ribeiro, AB | 1 |
| Buranakitjaroen, P; Phoojaroenchanachai, M; Sangprasert, P; Saravich, S | 1 |
| Klein, C; Meinicke, TW; Neutel, JM; Schumacher, H | 1 |
| Smith, DH | 1 |
| Jurkevicius, R; Kavoliūniene, A; Sakalyte, G; Vainoras, A | 1 |
| Chernova, NA; Fomicheva, OA; Ivanova, OV; Karpov, YA; Rogoza, AN; Sergakova, LM | 2 |
| Bourkaib, R; Ezzaher, A; Herpin, D; Meunier, A; Poterre, M; Ragot, S | 1 |
| Asmar, R; Dudley, A; Gosse, P; N'tela, G; Shepherd, GL; Topouchian, J | 1 |
| Hankey, GJ | 1 |
| Alföldi, S | 1 |
| Bakris, GL; Davidai, G; Giles, TD; Smith, DH; Weber, MA | 1 |
| Byrne, M; Gil-Extremera, B; Lacourcière, Y; Mueller, O; Williams, L | 1 |
| Terra, SG | 1 |
| Battegay, E; Dieterle, T; Martina, B; Sigle, JP; Surber, C | 1 |
| Kolloch, RE; Meinicke, TW; Neutel, JM; Plouin, PF; Schumacher, H | 1 |
| Cramer, MJ; Hettiarachchi, R; Koval, S; Neutel, JM; Smith, DH | 1 |
| Chazova, IE | 1 |
| Fenton, C; Keating, GM; Scott, LJ | 1 |
| Efstathiou, SP; Mountokalakis, TD; Roussias, LG; Stergiou, GS | 1 |
| Ballary, C; Desai, A; Dongre, N; Samra, SS | 1 |
| Dominiak, P; Häuser, W | 1 |
| Kulbertus, H | 2 |
| Larocca, GM; White, WB | 1 |
| Breglio, R; Capogrosso, P; Cerciello, A; Galzerano, D; Lama, D; Mallardo, M; Tammaro, P; Tuccillo, B | 1 |
| Dahlöf, B; Dietz, R; Friedrich, MG; Knecht, M; Sechtem, U; Unger, T | 1 |
| Gil-Extremera, B; Harkin, N; Kalnins, U; Ma, PT; Williams, L; Yulde, J | 1 |
| Ishii, M | 1 |
| Kurtz, TW; Pershadsingh, HA | 1 |
| Bohner, H; Heemann, U; Köster, J; Michel, MC; Schäfers, R | 1 |
| Davidai, G; Lacourciere, Y; White, WB | 1 |
| de Zeeuw, D; Köster, J; Manolis, AJ; Murphy, MB; Reid, JL; Seewaldt-Becker, E | 1 |
| Ayala, DE; Calvo, C; Hermida, RC; Ruilope, LM | 1 |
| Unger, T; Zimmermann, M | 1 |
| Arakawa, K | 1 |
| Ciccarelli, L; Derosa, G; Fogari, R; Mugellini, A; Ragonesi, PD | 1 |
| Davidai, G; Krzesinski, JM; Lacourcière, Y; Schumacher, H; White, WB | 1 |
| Lacourciere, Y; White, WB | 1 |
| Chaves, J; Giner, V; Iradi, A; Lozano, JV; Redón, J; Sáez, GT; Tormos, C | 1 |
| de Champlain, J; Lacourcière, Y; Lamarre-Cliche, M; Larochelle, P; Poirier, L | 1 |
| Bertone, G; Ciccarelli, L; Cicero, AF; Derosa, G; Fogari, E; Fogari, R; Piccinni, MN | 1 |
| Kaihara, M; Makino, H; Nakamura, Y; Norii, H; Sasaki, M; Sato, H; Sugimoto, T; Uchida, H | 1 |
| Gao, YJ; He, CC; Lee, RM; Li, N; Luo, BH; Su, CJ; Yi, JJ; Zeng, ZH | 1 |
| Igarashi, T; Sarashina, A; Tanigawara, Y; Tatami, S; Yamamura, N; Yong, CL | 1 |
| Schmieder, RE | 1 |
| Doggrell, SA | 2 |
| Chaves, FJ; Luque-Otero, M; Martell, N; Redon, J | 1 |
| Redon, J | 1 |
| Arriaga, R; Bahena, J; Barrera, M; Bonilla, C; Estrella, M; Fernández, M; Fonseca, S; García Luna Viesca, MD; Lepe, L; Miranda, S; Olivares Ruiz, R; Parra Carrillo, JZ; Segovia, C | 1 |
| Chiang, HT; Chu, KM; Ding, PY; Shu, KH | 1 |
| Alcocer, L; Campos, E; de la Fuente, JJ; Dominguez-Henkel, R; Fernandez-Bonetti, P; Segovia-Ayala, C | 1 |
| Chen, CY; Chen, JH; Cheng, JJ; Cherng, WJ; Chiou, HC; Fu, MM; Huang, TY; Tsai, CD | 1 |
| Huang, HC; Huang, LC; Kuo, WK; Lee, CM; Lee, YT; Lin, CS; Sheu, SH; Tsai, CW; Tseng, WK; Wang, JS | 1 |
| Alcocer, L; Bahena, J; Campos, E; de la Fuente, JJ; Dominguez-Henkel, R; Fernández-Bonetti, P; Olvera Ruiz, R; Segovia-Ayala, C | 1 |
| Bai, J; Cai, NS; Cheng, NN; Fan, WH; Guo, JX; Guo, JZ; Ke, YN; Lu, ZY; Sheng, LH; Tang, B; Zhu, JR | 1 |
| Aytimur, M; Gürgün, C; Nalbantgil, I; Nalbantgil, S; Onder, R; Ozerkan, F; Yilmaz, H; Zoghi, M | 1 |
| Takeuchi, M; Yamagishi, S | 1 |
| Chrysant, GS; Chrysant, SG; Desai, A | 1 |
| de Champlain, J; Karas, M; Lacourcière, Y; Lamarre-Cliche, M; Larochelle, P; Poirier, L | 1 |
| Eguchi, Y; Miura, Y; Oiso, Y; Ozaki, N; Taguchi, S; Tsunekawa, S; Yamamoto, N | 1 |
| Dimopoulos, V; Fountoulaki, K; Giannakoulis, J; Triposkiadis, F; Zintzaras, E | 1 |
| Fedoseeva, LA; Leus, AI; Preobrazhenskiĭ, DV; Skavronskaia, TV | 1 |
| Atkinson, J; Chillon, JM; Dupuis, F; Limiñana, P | 1 |
| Hollander, A; Köster, J; Sharma, AM | 1 |
| Dahlöf, B; Ritz, E | 1 |
| Barnett, AH | 1 |
| Kurtz, TW | 2 |
| Corradi, L; Fogari, R; Mugellini, A; Pasotti, C; Preti, P; Rinaldi, A; Zoppi, A | 1 |
| Chandrasekharan, S; Desai, A; Ganesan, R; Gawde, A; Jain, SD; Jayaram, S; Kadam, GS; Lahoti, S; Mishra, AB; Muralidharan, RS; Rajadhyaksha, GC; Sodhi, SS | 1 |
| Burnier, M; Maillard, M | 1 |
| de Champlain, J; Dubé, B; Florescu, M; Karas, M; Lacourcière, Y; Lamarre-Cliche, M; Larochelle, P; LeBlanc, AR; Nadeau, R; Poirier, L | 1 |
| Bakris, GL; Davidai, G; Giles, T; Neutel, JM; Weber, MA; White, WB | 2 |
| Ivleva, AIa | 1 |
| Amasyali, B; Celik, T; Demirkol, S; Isik, E; Iyisoy, A; Kilic, S; Kose, S; Kursaklioglu, H; Yilmaz, MI | 1 |
| Asayama, K; Hashimoto, J; Imai, Y; Kikuya, M; Metoki, H; Nishimura, T; Ohkubo, T; Totsune, K | 1 |
| Altuntas, Y; Aydin, L; Kürklü, A; Sengul, AM | 1 |
| Bolotova, EV; Pavlishchuk, SA; Porkhanov, VA | 1 |
| Baliga, V; Desai, A; Gawde, A; Hariharan, RS; Kulkarni, BN; Kulkarni, RB; Naikwadi, A | 1 |
| de Zeeuw, D; Köster, J; Manolis, AJ; Navis, G; Reid, JL; Vogt, L | 1 |
| Conrady, AO; Kiselev, IO; Krutikov, AN; Ovchinnikova, OA; Panov, AV; Polunicheva, EV; Usachev, NI; Yakovleva, OI | 1 |
| Babic, R; Dragicevic, J; Petrovic, D; Petrovic, I; Vasiljevic, Z; Vukovic, N; Zivanovic, B | 1 |
| Bakris, GL; Davidai, G; Giles, TD; Smith, DH; Weber, MA; White, WB | 1 |
| Bonatti, S; Mattioli, AV; Mattioli, G; Monopoli, D; Zennaro, M | 1 |
| Imaizumi, T; Jinnouchi, Y; Matsui, T; Nakamura, K; Nakamura, Y; Takenaka, K; Yamagishi, S | 1 |
| Marlow, B | 1 |
| Lexchin, J | 1 |
| Destro, M; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Rinaldi, A; Zoppi, A | 1 |
| Aranda, FJ; Aranda, P; Frutos, MA; López de Novales, E; López, V; Ruilope, LM; Segura, J | 1 |
| Gosse, P; Harper, R; Lowe, L; Williams, B | 1 |
| Jin, D; Kirimura, K; Mino, Y; Miyazaki, M; Muramatsu, M; Takai, S; Yoshikawa, K | 1 |
| Breglio, R; Capogrosso, P; del Viscovo, L; Galzerano, A; Galzerano, D; Lama, D; Paolisso, G; Tammaro, P; Tuccillo, B | 1 |
| Lacourcière, Y; Neutel, JM; Schumacher, H | 1 |
| Battershill, AJ; Scott, LJ | 1 |
| Böger, RH; Maas, R; Quispe-Bravo, S; Schwedhelm, E; Skamira, C | 1 |
| Davidai, G; Koval, S; Lacourcière, Y; Neutel, JM | 1 |
| Bakris, GL; Davidai, G; Giles, TD; Neutel, JM; Smith, DH; Weber, MA; White, WB | 1 |
| Jasiński, B; Niegowska, J; Niegowska, M | 1 |
| Ding, DY; Ji, H; Li, YQ; Ye, XL; Zhang, YH | 1 |
| Devereux, RB; Krauser, DG | 1 |
| Appel, D; Benndorf, RA; Böger, RH; Maas, R; Rudolph, T; Schulze, F; Schwedhelm, E; Silberhorn, E | 1 |
| Davidai, G; Koval, SE; Murwin, D; Neutel, JM; Punzi, HA; White, WB | 1 |
| Clemenz, M; Goebel, M; Unger, T | 1 |
| Maki, K; Morimoto, S; Sawada, K; Yano, Y | 1 |
| Ak, ND; Fujisaka, S; Hachiya, H; Iwata, M; Kobayashi, M; Murakami, S; Sasaoka, T; Satoh, A; Senda, S; Takano, A; Takata, M; Temaru, R; Urakaze, M; Usui, I; Yamazaki, K; Yamazaki, Y | 1 |
| Black, S; Cassis, LA; Gibson, LL; Hahner, L; Osborne-Lawrence, S; Samols, D; Schwartz, R; Shaul, PW; Thomas, GD; Vongpatanasin, W | 1 |
| Ernsberger, P; Koletsky, RJ | 1 |
| Hassan, H; Negro, R | 1 |
| Appel, D; Bajcetic, M; Benndorf, RA; Böger, RH; Maas, R; Riekhof, D; Schulze, F; Schwedhelm, E | 1 |
| Gosse, P | 1 |
| Delles, C; Fauvel, JP; Mimran, A; Ruilope, LM; Schmieder, RE | 1 |
| Shimabukuro, M; Shimabukuro, T; Tanaka, H | 1 |
| Derosa, G; Destro, M; Fogari, E; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Rinaldi, A; Zoppi, A | 1 |
| Higaki, J; Horie, Y; Takeuchi, M | 1 |
| Bahadir, MA; Bahadir, O; Oguz, A; Uzunlulu, M | 1 |
| Aznaouridis, KA; Karatzis, EN; Lekakis, JP; Papamichael, CM; Protogerou, AD; Stamatelopoulos, KS | 1 |
| Hoshide, S; Ishikawa, J; Ishikawa, S; Kanemaru, Y; Kario, K; Noguchi, C; Shimada, K; Tada, M; Takanori, H; Tukui, D; Yano, A; Yano, Y | 1 |
| Davidai, G; Gosse, P; Lacourcière, Y; Neutel, JM; Schumacher, H; Williams, B | 1 |
| Appel, D; Benndorf, RA; Böger, R; Gehling, UM; Hossfeld, DK; Maas, R; Rogiers, X; Schlagner, K; Schwedhelm, E; Silberhorn, E | 1 |
| Ikeda, H; Inoue, T; Moroe, K; Morooka, T; Node, K | 1 |
| Ludvik, B; Tripp, B | 1 |
| Mitsuyama, S | 1 |
| Hironaga, T; Ishima, H; Kawauchi, K; Masaki, R; Masubuchi, Y; Nakayama, T; Shimabukuro, H; Torigoe, M | 1 |
| Klocke, RK; Landen, H | 2 |
| Ayala, DE; Calvo, C; Fernández, JR; Hermida, RC | 1 |
| Dörffel, Y; Moebes, A; Scholze, J; Swidsinski, A; Syrbe, U | 1 |
| Dahlöf, B | 1 |
| Stoppelhaar, M; Unger, T | 1 |
| Burnier, M; Maillard, MP | 1 |
| Petkow-Dimitrow, P | 1 |
| Kariv, N; Nachman, R; Rosenthal, T; Younis, F; Zangen, S | 1 |
| Ichikawa, Y | 1 |
| Dai, Q; Sun, B; Xu, M; Yao, M | 1 |
| Choi, JI; Hong, SJ; Joo, HJ; Lim, DS; Lim, SY; Park, SM; Shim, WJ; Shin, SY | 1 |
| Koji, Y; Shiina, K; Tomiyama, H; Yamada, J; Yamashina, A; Yoshida, M | 1 |
| Appel, D; Benndorf, RA; Böger, RH; Maas, R; Schwedhelm, E; Wenzel, UO | 1 |
| Janez, A; Jensterle, M; Kocjan, T; Meden-Vrtovec, H; Pfeifer, M; Prezelj, J; Vrtovec, B | 1 |
| Blumenfeld, JD | 1 |
| Ishimitsu, T; Matsuoka, H; Minami, J | 1 |
| Chrysant, SG; Davidai, G; Guthrie, R; Koval, SE; Murwin, D; White, WB | 1 |
| Fitchett, D | 1 |
| Bagchi, A; Baliga, VP; Bollmall, C; Kinagi, SB; Sharma, A; Sharma, YK | 1 |
| Itagaki, K; Nakamoto, H; Nishida, E; Ryuzaki, M; Sone, M; Suzuki, H; Yoshimoto, M | 1 |
| Durina, J; Kratochvíl'ová, H; Remková, A | 1 |
| Celoria, BM; Francischetti, A; Francischetti, EA; Genelhu, VA | 1 |
| Asano, A; Chujo, D; Kobayashi, J; Mabuchi, H; Muramoto, H; Ohnishi, A; Sakai, S; Shintaku-Kubota, M; Yagi, K; Yamagishi, M | 1 |
| Jin, D; Kimura, M; Kirimura, K; Miyazaki, M; Sakonjo, H; Takai, S; Tanaka, K | 1 |
| Basso, V; Licitra, R; Pannarale, G | 1 |
| Fujitani, Y; Hirose, T; Ikeda, F; Kawamori, R; Mita, T; Nakayama, S; Shimizu, T; Uchino, H; Watada, H | 1 |
| Grossman, E; Harari, A; Harats, D; Kamari, Y; Peleg, E; Shaish, A; Sharabi, Y | 1 |
| Leenen, FH; Liang, B | 1 |
| Hendra, TJ; Rosario, BH | 1 |
| Cheng, JW; Lu, GC; Xi, GL | 1 |
| Fukushima, H; Hirata, H; Kobayashi, N; Machida, Y; Mamada, Y; Matsuoka, H; Nomura, M; Ohno, T; Shinoda, M; Suzuki, N; Yoshida, K | 1 |
| Böger, RH; Galle, J; Pinnetti, S; Schwedhelm, E; Wanner, C | 1 |
| Bakris, G; Burgess, E; Davidai, G; Koval, S; Weir, M | 1 |
| Bader, M; Böhm, M; Djavidani, B; Kaling, M; Kim, S; Kreutz, R; Lee, M; Schinke, M; Wagner, J; Wienen, W | 1 |
| Amann, K; Bohlender, J; Drab, M; Ganten, D; Wagner, J; Wienen, W | 1 |
| Hermansson, K; Karlberg, BE; Lins, LE | 1 |
| Kirk, JK | 1 |
| Frishman, WH; Guthrie, G; Neutel, JM; Oparil, S; Papademitriou, V | 1 |
| Meredith, PA | 1 |
| Zanchetti, A | 1 |
| Kaplan, NM | 1 |
| Messerli, FH | 1 |
| Lacourcière, Y; Mallion, J; Siche, J | 1 |
| Grossman, E; Messerli, FH; Neutel, JM | 1 |
| Howes, L; Wong, W | 1 |
| Dubiel, RF; Littlejohn, T; Marbury, T; Mroczek, W; VanderMaelen, CP | 1 |
| Keefe, DL | 1 |
| Kempthorne-Rawson, J; Matzek, KM; Smith, DH | 1 |
| McGill, JB; Reilly, PA | 2 |
| Deichsel, G; Freytag, F; Meinicke, T; Schelling, A | 1 |
| Neutel, JM | 1 |
| Meredith, PA; Weber, MA | 1 |
| Magometschnigg, D | 1 |
| Dombeck, M; Gondek, K; Lamb, S; Ostrowski, C; Richter, A | 1 |
| Goa, KL; Jarvis, B; Sharpe, M | 1 |
| de Bruin, H; Jonkman, JH; Meinicke, T; Stangier, J; Su, CA; Tamminga, WJ; van Heiningen, PN; van Lier, JJ | 1 |
| Lacourcière, Y; Lenis, J; Martin, K; O'Keefe, D; Orchard, R; Tytus, R | 1 |
| Braun, M | 1 |
| Audeval-Gerard, C; Champeroux, P; Richard, S; Wienen, W | 1 |
| Asmar, R | 1 |
| Schierok, HJ; Wienen, W | 1 |
| Rapi, J | 1 |
107 review(s) available for telmisartan and Hypertension
| Article | Year |
|---|---|
Telmisartan.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Biotransformation; Dose-Response Relationship, Drug; Drug Administration Schedule; Half-Life; Humans; Hypertension; Intestinal Absorption; Telmisartan | 1998 |
Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites.
Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Growth Hormone; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Models, Molecular; Receptor, Angiotensin, Type 1; Tetrazoles; Thiophenes; Thromboxane A2 | 2003 |
Multitarget PPARγ agonists as innovative modulators of the metabolic syndrome.
Topics: Animals; Antihypertensive Agents; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Humans; Hypertension; Hypoglycemic Agents; Metabolic Syndrome; Molecular Structure; PPAR gamma; Structure-Activity Relationship | 2019 |
Antihypertensive effect of telmisartan versus perindopril in hypertensive patients.
Topics: Antihypertensive Agents; Benzimidazoles; Essential Hypertension; Humans; Hypertension; Perindopril; Telmisartan | 2023 |
Efficacy of single-pill combination in uncontrolled essential hypertension: A systematic review and network meta-analysis.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Essential Hypertension; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Losartan; Network Meta-Analysis; Telmisartan; Tetrazoles; Valine; Valsartan | 2023 |
Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Calcium Channel Blockers; Humans; Hypertension; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Telmisartan | 2021 |
Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Drug Therapy, Combination; Female; Follow-Up Studies; Hospitalization; Humans; Hypertension; Hypotension; Male; Middle Aged; Multicenter Studies as Topic; Ramipril; Randomized Controlled Trials as Topic; Telmisartan | 2017 |
Long-term safety and efficacy of telmisartan/amlodipine single pill combination in the treatment of hypertension.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Drug Combinations; Humans; Hypertension; Patient Selection; Risk Factors; Telmisartan; Time Factors; Treatment Outcome | 2013 |
Telmisartan/Hydrochlorothiazide combination therapy for the treatment of hypertension: a pooled analysis in older and younger patients.
Topics: Age Factors; Aged; Benzimidazoles; Benzoates; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Randomized Controlled Trials as Topic; Telmisartan; Treatment Outcome | 2013 |
An update on telmisartan/hydrochlorothiazide combinations for the management of hypertensive patients with additional cardiovascular risk factors.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; International Cooperation; Practice Guidelines as Topic; Risk Factors; Severity of Illness Index; Telmisartan | 2013 |
[A fixed dose combination of telmisartan, and a thiazide diuretic in the treatment of hypertension].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Telmisartan | 2013 |
A meta-analysis of randomized trials of telmisartan versus losartan for reduction of ambulatory blood pressure.
Topics: Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Humans; Hypertension; Losartan; Randomized Controlled Trials as Topic; Telmisartan | 2013 |
Early combination therapy with telmisartan plus amlodipine for rapid achievement of blood pressure goals.
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Randomized Controlled Trials as Topic; Telmisartan; Treatment Outcome | 2013 |
Potential of the angiotensin receptor blockers (ARBs) telmisartan, irbesartan, and candesartan for inhibiting the HMGB1/RAGE axis in prevention and acute treatment of stroke.
Topics: Acute Disease; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Benzoates; Biphenyl Compounds; HMGB1 Protein; Humans; Hypertension; Irbesartan; Neurons; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Risk Factors; Stroke; Telmisartan; Tetrazoles | 2013 |
A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide.
Topics: Administration, Oral; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Tablets; Telmisartan; Time Factors; Treatment Outcome | 2013 |
Blood pressure variability over 24 h: prognostic implications and treatment perspectives. An assessment using the smoothness index with telmisartan-amlodipine monotherapy and combination.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Drug Combinations; Drug Therapy, Combination; Humans; Hypertension; Prognosis; Telmisartan; Treatment Outcome | 2014 |
Effect of telmisartan on atrial fibrillation recurrences in patients with hypertension: a systematic review and meta-analysis.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atrial Fibrillation; Benzimidazoles; Benzoates; Chi-Square Distribution; Humans; Hypertension; Kaplan-Meier Estimate; Odds Ratio; Recurrence; Risk Assessment; Risk Factors; Telmisartan; Treatment Outcome | 2014 |
Comparative review of the blood pressure-lowering and cardiovascular benefits of telmisartan and perindopril.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Humans; Hypertension; Perindopril; Preventive Health Services; Risk Assessment; Risk Factors; Telmisartan; Treatment Outcome | 2014 |
Telmisartan in combination with hydrochlorothiazide 12.5 mg for the management of patients with hypertension.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Benzimidazoles; Benzoates; Clinical Trials, Phase III as Topic; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Retrospective Studies; Severity of Illness Index; Telmisartan; Treatment Outcome | 2014 |
A meta-analysis of randomized trials of telmisartan versus active controls for insulin resistance in hypertensive patients.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Humans; Hypertension; Insulin Resistance; Randomized Controlled Trials as Topic; Telmisartan; Treatment Outcome | 2014 |
Telmisartan.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Chemistry, Pharmaceutical; Drug Interactions; Drug Stability; Humans; Hypertension; Molecular Structure; Technology, Pharmaceutical; Telmisartan | 2015 |
Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Antihypertensive Agents; Atherosclerosis; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Culture Techniques; Disease Models, Animal; Drug Therapy, Combination; Endothelium, Vascular; Gene Knockout Techniques; Glucose; Humans; Hypertension; Kidney; Lipid Metabolism; Metabolic Diseases; Oxadiazoles; Renin-Angiotensin System; Stroke; Telmisartan | 2016 |
Target Blood Pressure in Patients with Diabetes: Asian Perspective.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Hypotension; Male; Middle Aged; Ramipril; Randomized Controlled Trials as Topic; Reference Values; Risk Factors; Stroke; Telmisartan | 2016 |
Cardioprotective effects of telmisartan in uncomplicated and complicated hypertension.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Pressure; Cardiotonic Agents; Heart Diseases; Humans; Hypertension; Telmisartan | 2008 |
Telmisartan/Hydrochlorothiazide: a review of its use as fixed-dose combinations in essential hypertension.
Topics: Angiotensin II Type 2 Receptor Blockers; Antihypertensive Agents; Area Under Curve; Benzimidazoles; Benzoates; Drug Combinations; Half-Life; Humans; Hydrochlorothiazide; Hypertension; Randomized Controlled Trials as Topic; Telmisartan; Treatment Outcome | 2008 |
Telmisartan versus angiotension-converting enzyme inhibitors in the treatment of hypertension: a meta-analysis of randomized controlled trials.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Enalapril; Humans; Hypertension; Lisinopril; Models, Statistical; Perindopril; Ramipril; Randomized Controlled Trials as Topic; Telmisartan; Treatment Outcome | 2009 |
Valsartan vs. other angiotensin II receptor blockers in the treatment of hypertension: a meta-analytical approach.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Dose-Response Relationship, Drug; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Middle Aged; Prospective Studies; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2009 |
Recent advances in cardiovascular risk reduction: implications of ONTARGET.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hypertension; Ramipril; Risk Reduction Behavior; Telmisartan | 2009 |
Achieving blood pressure goals: should angiotensin II receptor blockers become first-line treatment in hypertension?
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Humans; Hypertension; Ramipril; Telmisartan; Treatment Outcome | 2009 |
Are the pleiotropic effects of telmisartan clinically relevant?
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Body Fat Distribution; Cholesterol, LDL; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Glucose; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Insulin Resistance; Kidney; PPAR gamma; Randomized Controlled Trials as Topic; Telmisartan | 2009 |
Choosing an angiotensin-receptor blocker: blood pressure lowering, cardiovascular protection or both?
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Cardiovascular Diseases; Humans; Hypertension; Losartan; Ramipril; Risk Factors; Telmisartan; Tetrazoles | 2010 |
Telmisartan and hydrochlorothiazide combination therapy for the treatment of hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Black People; Comorbidity; Diabetes Mellitus; Drug Combinations; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Hydrochlorothiazide; Hypertension; Telmisartan | 2010 |
New standards in hypertension and cardiovascular risk management: focus on telmisartan.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Calcium Channel Blockers; Cardiovascular Diseases; Cardiovascular System; Humans; Hypertension; Ramipril; Risk Factors; Telmisartan | 2010 |
Importance of a fixed combination of telmisartan and amlodipine for the treatment of hypertension.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood; Cardiovascular Diseases; Clinical Trials as Topic; Drug Combinations; Humans; Hypertension; Risk Factors; Severity of Illness Index; Telmisartan | 2010 |
A systematic review and meta-analysis of telmisartan versus valsartan in the management of essential hypertension.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Confidence Intervals; Diastole; Diuretics; Humans; Hydrochlorothiazide; Hypertension; Renin-Angiotensin System; Risk; Systole; Telmisartan; Tetrazoles; Valine; Valsartan | 2010 |
Telmisartan/amlodipine: single-pill combination in hypertension.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Clinical Trials as Topic; Drug Combinations; Humans; Hypertension; Telmisartan | 2010 |
Combination of telmisartan plus amlodipine in the treatment of hypertension: review of results.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hypertension; Medication Adherence; Telmisartan; Treatment Outcome | 2010 |
Clinical effectiveness of telmisartan alone or in combination therapy for controlling blood pressure and vascular risk in the elderly.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Comorbidity; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Polypharmacy; PPAR gamma; Prevalence; Renin-Angiotensin System; Sex Factors; Stroke; Telmisartan | 2010 |
Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Biphenyl Compounds; Case-Control Studies; Double-Blind Method; Humans; Hypertension; Irbesartan; Losartan; Neoplasms; Randomized Controlled Trials as Topic; Telmisartan; Tetrazoles | 2011 |
Systematic review of the effect of telmisartan on insulin sensitivity in hypertensive patients with insulin resistance or diabetes.
Topics: Adiponectin; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Humans; Hyperglycemia; Hyperinsulinism; Hypertension; Insulin Resistance; PPAR gamma; Randomized Controlled Trials as Topic; Telmisartan | 2012 |
Efficacy of renin-angiotensin system (RAS) blockers on cardiovascular and renal outcomes in patients with type 2 diabetes.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Hypertension; Renin-Angiotensin System; Risk Factors; Telmisartan | 2012 |
Telmisartan: just an antihypertensive agent? A literature review.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atrial Fibrillation; Benzimidazoles; Benzoates; Costs and Cost Analysis; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Diseases; Renin-Angiotensin System; Telmisartan | 2011 |
Single-pill telmisartan and amlodipine: a rational combination for the treatment of hypertension.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Clinical Trials as Topic; Drug Combinations; Humans; Hypertension; Telmisartan | 2011 |
Nifedipine and telmisartan for the treatment of hypertension: the TALENT study.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Calcium Channel Blockers; Cardiovascular Diseases; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Hypertension; Nifedipine; Randomized Controlled Trials as Topic; Risk Factors; Telmisartan | 2011 |
Review: a single-pill combination of telmisartan plus amlodipine for the treatment of hypertension.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Calcium Channel Blockers; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hypertension; Telmisartan; Treatment Outcome | 2011 |
Telmisartan and cardioprotection.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Cardiotonic Agents; Cardiovascular Diseases; Diabetes Mellitus; Humans; Hypertension; Risk; Telmisartan | 2011 |
Inhibition of the renin-angiotensin-aldosterone system: is there room for dual blockade in the cardiorenal continuum?
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Diabetes Complications; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Hypertension; Mineralocorticoid Receptor Antagonists; Ramipril; Renin; Renin-Angiotensin System; Telmisartan | 2012 |
Telmisartan reduces triglyceride levels over other angiotensin II receptor blockers: a meta-analysis of randomized head-to-head trials.
Topics: Angiotensin Receptor Antagonists; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Humans; Hypertension; Prospective Studies; Randomized Controlled Trials as Topic; Telmisartan; Triglycerides | 2012 |
Telmisartan in the management of diabetic nephropathy: a contemporary view.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Diabetes Mellitus; Diabetic Nephropathies; Disease Progression; Female; Humans; Hypertension; Kidney Diseases; Male; Telmisartan; Treatment Outcome | 2012 |
Telmisartan 80 mg/hydrochlorothiazide 25 mg provides clinically relevant blood pressure reductions across baseline blood pressures.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Randomized Controlled Trials as Topic; Retrospective Studies; Telmisartan; Treatment Outcome | 2012 |
Telmisartan or valsartan alone or in combination with hydrochlorothiazide: a review.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diuretics; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Randomized Controlled Trials as Topic; Telmisartan; Tetrazoles; Valine; Valsartan | 2013 |
Preventing cardiovascular events with angiotensin II receptor blockers: a closer look at telmisartan and valsartan.
Topics: Angiotensin II Type 2 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Evidence-Based Medicine; Humans; Hypertension; Telmisartan; Tetrazoles; Valine; Valsartan | 2012 |
Telmisartan 80 mg/hydrochlorothiazide 25 mg single-pill combination in the treatment of hypertension.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Telmisartan | 2012 |
Telmisartan plus amlodipine single-pill combination for the management of hypertensive patients with a metabolic risk profile (added-risk patients).
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Clinical Trials as Topic; Diabetes Complications; Humans; Hypertension; MEDLINE; Obesity; Risk Factors; Telmisartan | 2013 |
A meta-analysis of randomized head-to-head trials of telmisartan versus other angiotensin II receptor blocker in combination with hydrochlorothiazide for reduction of blood pressure.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Randomized Controlled Trials as Topic; Telmisartan | 2013 |
Overview of telmisartan for blood pressure reduction among angiotensin II receptor blockers: a meta-analysis of head-to-head randomized trials.
Topics: Angiotensin Receptor Antagonists; Benzimidazoles; Benzoates; Blood Pressure; Humans; Hypertension; Randomized Controlled Trials as Topic; Telmisartan | 2013 |
Effects of telmisartan therapy on interleukin-6 and tumor necrosis factor-alpha levels: a meta-analysis of randomized controlled trials.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Confidence Intervals; Cross-Over Studies; Double-Blind Method; Humans; Hypertension; Hypertension, Renal; Imidazoles; Interleukin-6; Obesity; Prospective Studies; Publication Bias; Randomized Controlled Trials as Topic; Stents; Telmisartan; Tetrazoles; Tumor Necrosis Factor-alpha; Valine; Valsartan | 2013 |
A meta-analysis of randomized trials of telmisartan vs. valsartan therapy for blood pressure reduction.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Publication Bias; Randomized Controlled Trials as Topic; Telmisartan; Tetrazoles; Valine; Valsartan | 2013 |
Telmisartan. BIBR 277, Micardis, Pritor.
Topics: Animals; Benzimidazoles; Benzoates; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Hypertension; Telmisartan | 2002 |
Treatment of hypertension with an angiotensin II-receptor antagonist compared with an angiotensin-converting enzyme inhibitor: a review of clinical studies of telmisartan and enalapril.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Clinical Trials as Topic; Enalapril; Humans; Hypertension; Kidney Diseases; Renin-Angiotensin System; Telmisartan | 2002 |
Angiotensin-converting enzyme inhibitors for stroke prevention: is there HOPE for PROGRESS After LIFE?
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Life Style; Practice Guidelines as Topic; Ramipril; Risk; Risk Factors; Stroke; Telmisartan | 2003 |
[Diurnal blood pressure control in the optimal treatment of hypertension].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Circadian Rhythm; Humans; Hypertension; Irbesartan; Losartan; Telmisartan; Tetrazoles; Valine; Valsartan | 2003 |
Comparison of telmisartan versus losartan: meta-analysis of titration-to-response studies.
Topics: Adult; Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Prospective Studies; Randomized Controlled Trials as Topic; Telmisartan; Titrimetry | 2003 |
[Telmisartan (micardis) -- an antagonist of angiotensin 2 of type 1 receptors: another antihypertensive drug or something greater?].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Clinical Trials as Topic; Humans; Hypertension; Telmisartan; Treatment Outcome | 2003 |
Telmisartan/hydrochlorothiazide: in the treatment of essential hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Clinical Trials as Topic; Diuretics; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Telmisartan | 2003 |
The telmisartan programme of research tO show Telmisartan End-organ proteCTION (PROTECTION) programme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Hypertension; Kidney Diseases; Telmisartan | 2003 |
[Kinzalkomb, a fixed telmisartan-hydrochlorothiazide combination for the treatment of hypertension].
Topics: Antihypertensive Agents; Benzimidazoles; Benzoates; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Telmisartan | 2003 |
[Clinical profiles of new angiotensin II receptor blockers: telmisartan, olmesartan medoxomil, and irbesartan].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Humans; Hypertension; Imidazoles; Irbesartan; Olmesartan Medoxomil; Telmisartan; Tetrazoles | 2004 |
[Development of combined drugs (ARB and diuretics)].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Clinical Trials as Topic; Diuretics; Drug Combinations; Drug Design; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Kidney Tubules, Proximal; Losartan; Olmesartan Medoxomil; Practice Guidelines as Topic; Renin-Angiotensin System; Sodium; Telmisartan; Tetrazoles | 2004 |
Telmisartan/hydrochlorothiazide combination therapy in the treatment of essential hypertension.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Controlled Clinical Trials as Topic; Diuretics; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Sodium Chloride Symporter Inhibitors; Telmisartan | 2004 |
Telmisartan - killing two birds with one stone.
Topics: 3T3-L1 Cells; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biphenyl Compounds; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Hypertension; Insulin Resistance; Irbesartan; Mice; PPAR gamma; Rats; Rats, Zucker; Telmisartan; Tetrazoles | 2004 |
Current status of angiotensin receptor blockers for the treatment of cardiovascular diseases: focus on telmisartan.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Heart Failure; Humans; Hypertension; Renal Insufficiency; Stroke; Telmisartan; Treatment Outcome | 2005 |
Editorial overview: The 'sartans': is it premature to consider PPARgamma receptor agonism a bonus?
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Hypertension; Irbesartan; Losartan; PPAR gamma; Rats; Rats, Zucker; Telmisartan; Tetrazoles | 2005 |
Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enalapril; Female; Glomerular Filtration Rate; Humans; Hypertension; Longitudinal Studies; Male; Randomized Controlled Trials as Topic; Telmisartan | 2005 |
Treating the metabolic syndrome: telmisartan as a peroxisome proliferator-activated receptor-gamma activator.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Hypertension; Metabolic Syndrome; PPAR gamma; Telmisartan | 2005 |
Telmisartan/hydrochlorothiazide: a new fixed dose combination.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Clinical Trials as Topic; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Telmisartan | 2005 |
[New perspectives of preventive pharmacotherapy in metabolic syndrome].
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Humans; Hypertension; Insulin; Lipoproteins; Metabolic Syndrome; Telmisartan | 2005 |
Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, pros
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diuretics; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Telmisartan | 2005 |
Telmisartan: a review of its use in the management of hypertension.
Topics: Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Drug Combinations; Drug Therapy, Combination; Drug Tolerance; Humans; Hydrochlorothiazide; Hypertension; Hypertension, Renal; Metabolic Syndrome; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Telmisartan | 2006 |
New treatment strategies for patients with hypertension and insulin resistance.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atherosclerosis; Benzimidazoles; Benzoates; Coronary Artery Disease; Diabetes Mellitus, Type 2; Humans; Hypertension; Insulin Resistance; Metabolic Syndrome; PPAR gamma; Renin-Angiotensin System; Telmisartan | 2006 |
Hypertension treatment and implications of recent cardiovascular outcome trials.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Enalapril; Humans; Hypertension; Randomized Controlled Trials as Topic; Telmisartan | 2006 |
Ventricular hypertrophy and hypertension: prognostic elements and implications for management.
Topics: Adrenergic Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Carbazoles; Carvedilol; Chi-Square Distribution; Cohort Studies; Coronary Disease; Death, Sudden, Cardiac; Diuretics; Drug Therapy, Combination; Echocardiography; Electroencephalography; Enalapril; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Logistic Models; Losartan; Male; Multivariate Analysis; Prognosis; Propanolamines; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Sex Factors; Stroke; Survival Analysis; Telmisartan | 2006 |
Effective treatment of hypertension by AT(1) receptor antagonism: the past and future of telmisartan.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Diuretics; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Hydrochlorothiazide; Hypertension; Telmisartan; Treatment Outcome | 2006 |
Metabolic actions of angiotensin receptor antagonists: PPAR-gamma agonist actions or a class effect?
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Humans; Hypertension; Irbesartan; PPAR gamma; Receptors, Angiotensin; Renin-Angiotensin System; Telmisartan; Tetrazoles | 2007 |
A review of telmisartan in the treatment of hypertension: blood pressure control in the early morning hours.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Drug Therapy, Combination; Humans; Hypertension; Telmisartan; Tetrazoles; Valine; Valsartan | 2006 |
[ARB: characteristics, mechanisms of action, pharmacokinetics, indication, contraindication, clinical data, and side effects].
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biphenyl Compounds; Clinical Trials as Topic; Contraindications; Heart Failure; Humans; Hypertension; Imidazoles; Losartan; Telmisartan; Tetrazoles; Valine; Valsartan | 2007 |
Prevention of stroke in patients with hypertension.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Europe; Humans; Hypertension; Stroke; Telmisartan | 2007 |
Rationale for double renin-angiotensin-aldosterone system blockade.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Drug Therapy, Combination; Humans; Hypertension; Ramipril; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Telmisartan | 2007 |
Is the fixed-dose combination of telmisartan and hydrochlorothiazide a good approach to treat hypertension?
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Telmisartan | 2007 |
[New therapeutic targets for ACE inhibitors and angiotensin receptor blockers].
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypertension; Losartan; Metabolic Syndrome; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Risk Reduction Behavior; Telmisartan; Treatment Outcome | 2007 |
[Observational study of an AT1-antagonist].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Diastole; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Product Surveillance, Postmarketing; Systole; Telmisartan; Time Factors; Treatment Outcome | 2007 |
Clinical trial update: focus on the ONTARGET study.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Hypertension; Ramipril; Randomized Controlled Trials as Topic; Telmisartan | 2007 |
Treatment of hypertension in individuals with the cardiometabolic syndrome: role of an angiotensin II receptor blocker, telmisartan.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Diet, Reducing; Female; Humans; Hypertension; Life Style; Male; Meta-Analysis as Topic; Metabolic Syndrome; Prevalence; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Survival Analysis; Telmisartan; Treatment Outcome | 2008 |
Telmisartan in the treatment of hypertension.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Carbohydrate Metabolism; Clinical Trials as Topic; Humans; Hypertension; Lipid Metabolism; Telmisartan; Treatment Outcome | 2008 |
Meta-analysis of randomized controlled trials comparing telmisartan with losartan in the treatment of patients with hypertension.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Research Design; Telmisartan; Treatment Outcome | 2008 |
Angiotensin-II receptor antagonists: their place in therapy.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Clinical Trials as Topic; Drug Administration Schedule; Drug Interactions; Heart Failure; Humans; Hypertension; Irbesartan; Losartan; Renin-Angiotensin System; Telmisartan; Tetrazoles; Valine; Valsartan | 1999 |
Optimal dosing characteristics of the angiotensin II receptor antagonist telmisartan.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Hypertension; Telmisartan; Treatment Outcome | 1999 |
Impact of hypertension and antihypertensive treatment on organ damage.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Carotid Stenosis; Cause of Death; Clinical Trials as Topic; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Survival Rate; Telmisartan; Treatment Outcome | 1999 |
Angiotensin II receptor antagonists in the treatment of hypertension.
Topics: Algorithms; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Humans; Hypertension; Irbesartan; Losartan; Receptors, Angiotensin; Telmisartan; Tetrazoles; Valine; Valsartan | 1999 |
. . . and losartan was no better than placebo.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Humans; Hypertension; Losartan; Telmisartan | 1999 |
Angiotensin II receptor blockers: equal or preferred substitutes for ACE inhibitors?
Topics: Acrylates; Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Drug Therapy, Combination; Heart; Humans; Hypertension; Imidazoles; Irbesartan; Kidney; Losartan; Renin-Angiotensin System; Telmisartan; Tetrazoles; Thiophenes | 2000 |
Angiotensin receptor antagonists.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Humans; Hypertension; Irbesartan; Losartan; Telmisartan; Tetrazoles | 2000 |
Ambulatory blood pressure monitoring to assess the comparative efficacy and duration of action of a novel new angiotensin II receptor blocker--telmisartan.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Humans; Hypertension; Telmisartan; Therapeutic Equivalency | 2001 |
[Angiotensin receptor blockers--significance for the therapy of hypertension].
Topics: Acrylates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Austria; Benzimidazoles; Benzoates; Biphenyl Compounds; Humans; Hypertension; Imidazoles; Losartan; Prodrugs; Telmisartan; Tetrazoles; Therapeutic Equivalency; Thiophenes; Valine; Valsartan | 2001 |
Telmisartan: a review of its use in hypertension.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Drug Interactions; Heart Failure; Humans; Hypertension; Randomized Controlled Trials as Topic; Telmisartan; Treatment Outcome | 2001 |
The 24-hour blood pressure pattern: does it have implications for morbidity and mortality?
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Chronotherapy; Circadian Rhythm; Drug Therapy, Combination; Humans; Hypertension; Ramipril; Telmisartan; Treatment Outcome | 2002 |
[Irbesartan: a new possibility in the treatment of hypertension].
Topics: Acrylates; Angiotensin Receptor Antagonists; Antihypertensive Agents; Atenolol; Benzimidazoles; Benzoates; Biological Availability; Biphenyl Compounds; Controlled Clinical Trials as Topic; Drug Administration Schedule; Enalapril; Half-Life; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Telmisartan; Tetrazoles; Thiophenes; Valine; Valsartan | 2002 |
277 trial(s) available for telmisartan and Hypertension
| Article | Year |
|---|---|
Fixed-dose Combination of Metoprolol, Telmisartan, and Chlorthalidone for Essential Hypertension in Adults with Stable Coronary Artery Disease: Phase III Study.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Chlorthalidone; Coronary Artery Disease; Drug Therapy, Combination; Essential Hypertension; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Metoprolol; Telmisartan; Tetrazoles | 2022 |
Achieving the Latest American Heart Association and American College of Cardiology Therapeutic Goals for Hypertension With Combination Therapy and Its Effects on Blood Pressure and Central Hemodynamic Parameters.
Topics: American Heart Association; Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Calcium; Calcium Channel Blockers; Cardiology; Drug Therapy, Combination; Goals; Humans; Hypertension; Prospective Studies; Pulse Wave Analysis; Telmisartan; Treatment Outcome; United States | 2022 |
Effects of high-intensity statin combined with telmisartan versus amlodipine on glucose metabolism in hypertensive atherosclerotic cardiovascular disease patients with impaired fasting glucose: A randomized multicenter trial.
Topics: Amlodipine; Atherosclerosis; Cardiovascular Diseases; Fasting; Glucose; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Insulin Resistance; Prediabetic State; Rosuvastatin Calcium; Telmisartan | 2022 |
Efficacy and safety of low-dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double-blind, parallel, phase II trial.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Chlorthalidone; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Essential Hypertension; Humans; Hypertension; Telmisartan; Treatment Outcome | 2022 |
Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double-blind, active-controlled, multicenter phase 3 trial.
Topics: Aged; Amlodipine; Chlorthalidone; Essential Hypertension; Female; Humans; Hypertension; Leukemia, Myeloid, Acute; Male; Middle Aged; Telmisartan | 2023 |
[Therapy of patients with the high risk of arterial hypertension with the use of telmisartan].
Topics: Aged; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Quality of Life; Telmisartan; Vasodilation | 2019 |
Association of Low-Dose Triple Combination Therapy With Therapeutic Inertia and Prescribing Patterns in Patients With Hypertension: A Secondary Analysis of the TRIUMPH Trial.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Chlorthalidone; Dose-Response Relationship, Drug; Drug Prescriptions; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Retrospective Studies; Telmisartan; Treatment Outcome | 2020 |
Efficacy and safety of co-administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Dyslipidemias; Female; Humans; Hypertension; Male; Middle Aged; Rosuvastatin Calcium; Telmisartan | 2020 |
Central blood pressure lowering effect of telmisartan-rosuvastatin single-pill combination in hypertensive patients combined with dyslipidemia: A pilot study.
Topics: Ankle Brachial Index; Antihypertensive Agents; Benzoates; Blood Pressure; COVID-19; Drug Combinations; Dyslipidemias; Humans; Hypertension; Pandemics; Pilot Projects; Prospective Studies; Pulse Wave Analysis; Rosuvastatin Calcium; SARS-CoV-2; Telmisartan | 2021 |
Telmisartan and hydrochlorothiazide antihypertensive treatment in high sodium intake population: a randomized double-blind trial.
Topics: Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Humans; Hydrochlorothiazide; Hypertension; Sodium, Dietary; Telmisartan | 2017 |
Effects of telmisartan on paroxysmal atrial fibrillation in hypertensive patients.
Topics: Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Fibrillation; Biomarkers; Blood Pressure; C-Reactive Protein; China; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Recurrence; Telmisartan; Time Factors; Treatment Outcome | 2017 |
Efficacy and Safety of Fixed-dose Combination Therapy With Telmisartan and Rosuvastatin in Korean Patients With Hypertension and Dyslipidemia: TELSTA-YU (TELmisartan-rosuvaSTAtin from YUhan), a Multicenter, Randomized, 4-arm, Double-blind, Placebo-control
Topics: Aged; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Combinations; Dyslipidemias; Female; Humans; Hypertension; Male; Middle Aged; Rosuvastatin Calcium; Telmisartan | 2018 |
Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Ramipril; Risk Assessment; Single-Blind Method; Stroke; Telmisartan; Treatment Outcome | 2018 |
S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Chlorthalidone; Clinical Trials, Phase IV as Topic; Diuretics; Double-Blind Method; Drug Combinations; Drug Resistance; Equivalence Trials as Topic; Female; Humans; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Republic of Korea; Telmisartan; Time Factors; Treatment Outcome; Young Adult | 2018 |
Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical Trial.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Chlorthalidone; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Hypertension; Male; Medication Adherence; Middle Aged; Potassium; Sri Lanka; Telmisartan | 2018 |
Efficacy of long-term oral telmisartan treatment in cats with hypertension: Results of a prospective European clinical trial.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cat Diseases; Cats; Double-Blind Method; Europe; Female; Hypertension; Male; Prospective Studies; Random Allocation; Telmisartan; Treatment Outcome | 2019 |
IMPROVEMENT OF TREATMENT IN PERSONS WITH ARTERIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUS.
Topics: Albuminuria; Antihypertensive Agents; Blood Pressure; Comorbidity; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Endothelin-1; Glycated Hemoglobin; Humans; Hypertension; Lisinopril; Middle Aged; Renin-Angiotensin System; Telmisartan; Treatment Outcome | 2018 |
Efficacy and Safety of Triple Therapy With Telmisartan, Amlodipine, and Rosuvastatin in Patients With Dyslipidemia and Hypertension: The Jeil Telmisartan, Amlodipine, and Rosuvastatin Randomized Clinical Trial.
Topics: Aged; Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Humans; Hypertension; Male; Middle Aged; Republic of Korea; Rosuvastatin Calcium; Telmisartan | 2019 |
Even Short-Term Telmisartan Treatment Ameliorated Insulin Resistance But Had No Influence on Serum Adiponectin and Tumor Necrosis Factor-Alpha Levels in Hypertensive Patients with Metabolic Syndrome.
Topics: Adiponectin; Adolescent; Adult; Aged; Antihypertensive Agents; Drug Administration Schedule; Female; Humans; Hypertension; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Telmisartan; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult | 2019 |
Safety and efficacy of orally administered telmisartan for the treatment of systemic hypertension in cats: Results of a double-blind, placebo-controlled, randomized clinical trial.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cat Diseases; Cats; Double-Blind Method; Female; Hypertension; Male; Prospective Studies; Random Allocation; Telmisartan; Treatment Outcome | 2019 |
Efficacy and Tolerability of Telmisartan/Amlodipine and Rosuvastatin Coadministration in Hypertensive Patients with Hyperlipidemia: A Phase III, Multicenter, Randomized, Double-blind Study.
Topics: Aged; Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Double-Blind Method; Drug Combinations; Female; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Rosuvastatin Calcium; Telmisartan; Treatment Outcome | 2019 |
Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Determination; Cardiovascular Diseases; Case-Control Studies; Diabetes Mellitus; Diastole; Drug Therapy, Combination; Heart Failure; Hospitalization; Humans; Hypertension; Myocardial Infarction; Peripheral Arterial Disease; Ramipril; Retrospective Studies; Risk Factors; Stroke; Systole; Telmisartan | 2019 |
Effects of azilsartan compared with telmisartan on insulin resistance in patients with essential hypertension and type 2 diabetes mellitus: An open-label, randomized clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Benzimidazoles; Blood Pressure; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Insulin Resistance; Male; Middle Aged; Oxadiazoles; Telmisartan | 2019 |
Effect of tablets with a combination of telmisartan and amlodipine on patients with hypertension: the Cotalo study.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Drug Combinations; Epinephrine; Female; Humans; Hypertension; Male; Middle Aged; Tablets; Telmisartan | 2013 |
Effect of nifedipine versus telmisartan on prevention of atrial fibrillation recurrence in hypertensive patients.
Topics: Angiotensin II Type 1 Receptor Blockers; Atrial Fibrillation; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Heart Atria; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nifedipine; Prospective Studies; Secondary Prevention; Telmisartan; Treatment Outcome | 2013 |
A comparative pharmacokinetic study of a fixed dose combination for essential hypertensive patients: a randomized crossover study in healthy human volunteers.
Topics: Adolescent; Adult; Amlodipine; Benzimidazoles; Benzoates; Cross-Over Studies; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Hypoglycemic Agents; Middle Aged; Telmisartan | 2013 |
Novel description of the 24-hour circadian rhythms of brachial versus central aortic blood pressure and the impact of blood pressure treatment in a randomized controlled clinical trial: The Ambulatory Central Aortic Pressure (AmCAP) Study.
Topics: Amides; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Aorta, Thoracic; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Brachial Artery; Circadian Rhythm; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Fumarates; Humans; Hypertension; Male; Middle Aged; Prognosis; Prospective Studies; Renin; Reproducibility of Results; Telmisartan | 2013 |
[The impact of telmisartan on angiotensin converting enzyme 2 mRNA expression in monocyte-derived macrophages of diabetic hypertensive patients].
Topics: Aged; Angiotensin-Converting Enzyme 2; Benzimidazoles; Benzoates; Diabetes Mellitus; Female; Humans; Hypertension; Macrophages; Male; Middle Aged; Peptidyl-Dipeptidase A; RNA, Messenger; Telmisartan | 2013 |
Randomized trial of perindopril, enalapril, losartan and telmisartan in overweight or obese patients with hypertension.
Topics: Adult; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Enalapril; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Obesity; Overweight; Perindopril; Single-Blind Method; Telmisartan | 2013 |
A comparative study on the effectiveness of losartan/hydrochlorothiazide and telmisartan/hydrochlorothiazide in patients with hypertension.
Topics: Adult; Aged; Benzimidazoles; Benzoates; Blood Pressure; Dose-Response Relationship, Drug; Drug Combinations; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Prospective Studies; Telmisartan; Treatment Outcome; Uric Acid | 2014 |
Polymorphisms of the angiotensin II type 1 receptor gene affect antihypertensive response to angiotensin receptor blockers in hypertensive Chinese.
Topics: Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Asian People; Benzimidazoles; Benzoates; Blood Pressure; Drug Administration Schedule; Essential Hypertension; Female; Genotype; Humans; Hypertension; Male; Middle Aged; Polymorphism, Genetic; Receptor, Angiotensin, Type 1; Single-Blind Method; Telmisartan; Young Adult | 2013 |
The effects of telmisartan alone or in combination with hydrochlorothiazide on morning home blood pressure control: the SURGE 2 practice-based study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prospective Studies; Telmisartan; Young Adult | 2013 |
Effect of telmisartan vs. ramipril on 'dipping' status and blood pressure variability: pooled analysis of the PRISMA studies.
Topics: Age Factors; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Body Mass Index; Body Weight; Circadian Rhythm; Female; Humans; Hypertension; Male; Meta-Analysis as Topic; Middle Aged; Ramipril; Retrospective Studies; Telmisartan | 2014 |
Comparative effects of telmisartan and valsartan as add-on agents for hypertensive patients with morning blood pressure insufficiently controlled by amlodipine monotherapy.
Topics: Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Chemical Analysis; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Therapy, Combination; Endpoint Determination; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Sleep; Telmisartan; Tetrazoles; Valine; Valsartan | 2014 |
[Blood pressure lowering efficacy of telmisartan and amlodipine taking on the morning or at bedtime: ABPM results].
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure Monitoring, Ambulatory; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan | 2013 |
Effects of telmisartan on inflammatory cytokines and coronary plaque component as assessed on integrated backscatter intravascular ultrasound in hypertensive patients.
Topics: Antihypertensive Agents; Benzimidazoles; Benzoates; Coronary Artery Disease; Cytokines; Female; Follow-Up Studies; Humans; Hypertension; Inflammation Mediators; Male; Plaque, Atherosclerotic; Telmisartan; Ultrasonography, Interventional | 2014 |
The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Creatinine; Drug Therapy, Combination; Female; Heart Failure; Hospitalization; Humans; Hyperkalemia; Hypertension; Hypokalemia; Kidney; Kidney Diseases; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Nonlinear Dynamics; Odds Ratio; Potassium; Proportional Hazards Models; Ramipril; Renal Dialysis; Renin-Angiotensin System; Risk Assessment; Risk Factors; Stroke; Telmisartan; Time Factors; Treatment Outcome | 2014 |
Efficacy and tolerability of a single-pill combination of telmisartan/hydrochlorothiazide 80/25 mg in Chinese and Korean patients with moderate to severe hypertension: a subgroup analysis of a randomized, double-blind, active-controlled trial.
Topics: Adult; Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome | 2013 |
Dialysis-associated hypertension treated with Telmisartan--DiaTel: a pilot, placebo-controlled, cross-over, randomized trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Renal Dialysis; Telmisartan; Young Adult | 2013 |
Combining rosuvastatin with angiotensin-receptor blockers of different PPARγ-activating capacity: effects on high-density lipoprotein subfractions and associated enzymes.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Aged; Angiotensin II Type 1 Receptor Blockers; Aryldialkylphosphatase; Benzimidazoles; Benzoates; Biomarkers; Biphenyl Compounds; Cholesterol, HDL; Drug Therapy, Combination; Dyslipidemias; Female; Fluorobenzenes; Greece; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Imidazoles; Irbesartan; Lipoproteins, HDL; Male; Middle Aged; PPAR gamma; Prediabetic State; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Telmisartan; Tetrazoles; Treatment Outcome | 2015 |
Specific management of anemia and hypertension in renal transplant recipients: influence of renin-angiotensin system blockade.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Benzimidazoles; Benzoates; Darbepoetin alfa; Double-Blind Method; Erythropoietin; Female; Hemoglobins; Humans; Hypertension; Kidney Transplantation; Male; Middle Aged; Myocardial Infarction; Renin-Angiotensin System; Stroke; Telmisartan; Treatment Outcome; Young Adult | 2014 |
A randomized, double-blind study to evaluate the efficacy and safety of a single-pill combination of telmisartan 80 mg/amlodipine 5 mg versus amlodipine 5 mg in hypertensive Asian patients.
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome | 2014 |
Effectiveness of using long-acting angiotensin II type 1 receptor blocker in Japanese obese patients with metabolic syndrome on morning hypertension monitoring by using telemedicine system (FUJIYAMA study).
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Asian People; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cholesterol, LDL; Female; Humans; Hypertension; Japan; Male; Metabolic Syndrome; Middle Aged; Obesity; Prospective Studies; Telemedicine; Telmisartan; Tetrazoles | 2014 |
TRIple pill vs Usual care Management for Patients with mild-to-moderate Hypertension (TRIUMPH): Study protocol.
Topics: Adult; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Prospective Studies; Severity of Illness Index; Telmisartan; Treatment Outcome | 2014 |
Treatment with telmisartan/rosuvastatin combination has a beneficial synergistic effect on ameliorating Th17/Treg functional imbalance in hypertensive patients with carotid atherosclerosis.
Topics: Adult; Aged; Benzimidazoles; Benzoates; Carotid Arteries; Carotid Artery Diseases; Carotid Intima-Media Thickness; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Fluorobenzenes; Humans; Hypertension; Male; Middle Aged; Nuclear Receptor Subfamily 1, Group F, Member 3; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; T-Lymphocytes, Regulatory; Telmisartan; Th17 Cells | 2014 |
Difference in the effects of switching from candesartan to olmesartan or telmisartan to olmesartan in hypertensive patients with type 2 diabetes: the COTO study.
Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Telmisartan; Tetrazoles | 2014 |
Impact of telmisartan on cardiovascular outcome in hypertensive patients at high risk: a Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease subanalysis.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Cardiovascular System; Coronary Artery Disease; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Stroke; Telmisartan; Treatment Outcome | 2014 |
Blood pressure measurement reliability among different racial-ethnic groups in a stroke prevention study.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Determination; Brain Ischemia; Diagnosis, Differential; Double-Blind Method; Ethnicity; False Negative Reactions; Female; Follow-Up Studies; Global Health; Humans; Hypertension; Male; Office Visits; Outpatient Clinics, Hospital; Platelet Aggregation Inhibitors; Racial Groups; Reproducibility of Results; Socioeconomic Factors; Sphygmomanometers; Stroke; Telmisartan; Thrombophilia; Treatment Outcome; White Coat Hypertension | 2014 |
Prevention of metabolic disorders with telmisartan and indapamide in a Chinese population with high-normal blood pressure.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; China; Double-Blind Method; Female; Humans; Hypertension; Indapamide; Male; Metabolic Diseases; Middle Aged; Obesity; Telmisartan; Treatment Outcome | 2015 |
Angiotensin blockade in late autosomal dominant polycystic kidney disease.
Topics: Adolescent; Adult; Albuminuria; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Polycystic Kidney, Autosomal Dominant; Renal Insufficiency, Chronic; Telmisartan; Young Adult | 2014 |
Blood pressure in early autosomal dominant polycystic kidney disease.
Topics: Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Lisinopril; Male; Middle Aged; Organ Size; Polycystic Kidney, Autosomal Dominant; Telmisartan; Young Adult | 2014 |
Dietary flavonoids added to pharmacological antihypertensive therapy are effective in improving blood pressure.
Topics: Adult; Antihypertensive Agents; Benzimidazoles; Benzoates; Biomarkers; Blood Pressure; C-Reactive Protein; Cacao; Candy; Captopril; Combined Modality Therapy; Diet; Female; Flavonoids; Fruit; Humans; Hypertension; Leptin; Lipids; Male; Malus; Mexico; Middle Aged; Tea; Telmisartan; Time Factors; Treatment Outcome; Young Adult | 2015 |
Combined effect of appointment telmisartan and atorvastatin on hemodynamic indicators and the indicators of lipid profile in patients with arterial hypertension combined with obesity and steatohepatitis.
Topics: Acetamides; Adipokines; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Benzimidazoles; Benzoates; Breath Tests; Cholesterol, LDL; Drug Therapy, Combination; Fatty Liver; Female; Hemodynamics; Heptanoic Acids; Humans; Hypertension; Lipids; Male; Middle Aged; Obesity; Pyrroles; Telmisartan; Triglycerides | 2014 |
Short-term dietary salt supplementation blunts telmisartan induced increases in plasma renin activity in hypertensive patients with type 2 diabetes mellitus.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arterial Pressure; Benzimidazoles; Benzoates; Biomarkers; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Renin; Renin-Angiotensin System; Sodium Chloride, Dietary; Telmisartan; Time Factors; Treatment Outcome | 2015 |
Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus.
Topics: Adipokines; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diuretics; Double-Blind Method; Drug Combinations; Female; Glucose Clamp Technique; Humans; Hydrochlorothiazide; Hypertension; Insulin Resistance; Losartan; Male; Middle Aged; Nifedipine; Telmisartan | 2015 |
A trial of telmisartan prevention of cardiovascular diseases (ATTEMPT-CVD): Biomarker study.
Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Biomarkers; Blood Pressure; Cardiovascular Diseases; Creatinine; Female; Humans; Hypertension; Incidence; Japan; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Risk Factors; Telmisartan; Time Factors; Treatment Outcome | 2016 |
Comparison of telmisartan/amlodipine and telmisartan/hydrochlorothiazide in the treatment of Japanese patients with uncontrolled hypertension: the TAT-Kobe study.
Topics: Aged; Aged, 80 and over; Amlodipine; Benzimidazoles; Benzoates; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Japan; Male; Middle Aged; Prospective Studies; Telmisartan | 2016 |
Dose Timing of an Angiotensin II Receptor Blocker/Calcium Channel Blocker Combination in Hypertensive Patients With Paroxysmal Atrial Fibrillation.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Atrial Fibrillation; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Circadian Rhythm; Drug Combinations; Female; Humans; Hypertension; Male; Natriuretic Peptide, Brain; Prospective Studies; Telmisartan; Treatment Outcome | 2016 |
Blood pressure response to six-minute walk test in hypertensive subjects exposed to high altitude: effects of antihypertensive combination treatment.
Topics: Adult; Altitude; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Telmisartan; Treatment Outcome; Walk Test | 2016 |
The efficacy and long-term safety of a triple combination of 80 mg telmisartan, 5 mg amlodipine and 12.5 mg hydrochlorothiazide in Japanese patients with essential hypertension: a randomized, double-blind study with open-label extension.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Hypertension; Japan; Male; Middle Aged; Telmisartan; Treatment Outcome | 2017 |
Treatment-associated change in apelin concentration in patients with hypertension and its relationship with left ventricular diastolic function.
Topics: Amlodipine; Antihypertensive Agents; Apelin; Biomarkers; Case-Control Studies; Echocardiography; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Telmisartan; Treatment Outcome; Ventricular Dysfunction, Left | 2017 |
Comparison of the Efficacy and Safety of Fixed-dose S-Amlodipine/Telmisartan and Telmisartan in Hypertensive Patients Inadequately Controlled with Telmisartan: A Randomized, Double-blind, Multicenter Study.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan | 2016 |
Effect of hydrochlorothiazide in addition to telmisartan/amlodipine combination for treating hypertensive patients uncontrolled with telmisartan/amlodipine: a randomized, double-blind study.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome | 2017 |
A comparison study of the echocardiographic changes in hypertensive patients treated with telmisartan vs. enalapril.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Echocardiography, Doppler; Enalapril; Female; Follow-Up Studies; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Retrospective Studies; Single-Blind Method; Telmisartan; Treatment Outcome; Ventricular Function, Left | 2017 |
Comparing the clinical efficacy of resting and antihypertensive medication in patients of hypertensive urgency: a randomized, control trial.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Female; Humans; Hypertension; Male; Middle Aged; Rest; Telmisartan; Treatment Outcome | 2017 |
Mobile Device-Based Electronic Data Capture System Used in a Clinical Randomized Controlled Trial: Advantages and Challenges.
Topics: Adult; Antihypertensive Agents; Benzimidazoles; Benzoates; Cell Phone; Data Collection; Double-Blind Method; Electronic Data Processing; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Randomized Controlled Trials as Topic; Telemedicine; Telmisartan | 2017 |
Telmisartan but not candesartan affects adiponectin expression in vivo and in vitro.
Topics: 3T3-L1 Cells; Adipocytes; Adiponectin; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Biphenyl Compounds; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; In Vitro Techniques; Insulin Resistance; Male; Mice; Middle Aged; PPAR gamma; RNA, Messenger; Telmisartan; Tetrazoles; Treatment Outcome | 2008 |
Telmisartan, an angiotensin II type 1 receptor blocker, improves coronary microcirculation and insulin resistance among essential hypertensive patients without left ventricular hypertrophy.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Coronary Circulation; Echocardiography; Female; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Insulin Resistance; Lipids; Male; Microcirculation; Middle Aged; Telmisartan | 2008 |
The effect of enalapril and telmisartan on clinical and biochemical indices of sympathetic activity in hypertensive patients.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Enalapril; Epinephrine; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Neuropeptide Y; Norepinephrine; Posture; Sympathetic Nervous System; Telmisartan; Treatment Outcome | 2008 |
The angiotensin II receptor blocker telmisartan improves insulin resistance and has beneficial effects in hypertensive patients with type 2 diabetes and poor glycemic control.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hypertension; Insulin Resistance; Male; Middle Aged; Telmisartan; Treatment Outcome | 2008 |
The safety profile of telmisartan as monotherapy or combined with hydrochlorothiazide: a retrospective analysis of 50 studies.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Retrospective Studies; Telmisartan | 2008 |
Comparison of renal and vascular protective effects between telmisartan and amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency.
Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Cholesterol; Chronic Disease; Creatinine; Female; Humans; Hypertension; Interleukin-6; Kidney Diseases; Male; Matrix Metalloproteinase 9; Middle Aged; Renal Insufficiency; Telmisartan; Triglycerides | 2008 |
Comparison of the effects of telmisartan and olmesartan on home blood pressure, glucose, and lipid profiles in patients with hypertension, chronic heart failure, and metabolic syndrome.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Chronic Disease; Female; Glycated Hemoglobin; Heart Failure; Heart Rate; Humans; Hypertension; Imidazoles; Lipid Metabolism; Lipids; Longitudinal Studies; Male; Metabolic Syndrome; Middle Aged; Natriuretic Peptide, Brain; Telmisartan; Tetrazoles | 2008 |
Evaluation of fixed dose combination (FDC) of telmisartan+ramipril usage in patients with micro-albuminuria and persistent hypertension: A TRIUMPH study.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biomarkers; Female; Humans; Hypertension; Male; Middle Aged; Product Surveillance, Postmarketing; Prospective Studies; Ramipril; Telmisartan | 2008 |
Results of increasing doses of hydrochlorothiazide in combination with an angiotensin receptor blocker in patients with uncontrolled hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome | 2008 |
Effects of telmisartan on adiponectin levels and body weight in hypertensive patients with glucose intolerance.
Topics: Adiponectin; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Body Weight; C-Reactive Protein; Cholesterol; Female; Glucose Intolerance; Glycated Hemoglobin; Humans; Hypertension; Insulin; Linear Models; Male; Middle Aged; Prospective Studies; Telmisartan; Tetrazoles; Triglycerides | 2008 |
Therapeutic effect of ARBs on insulin resistance and liver injury in patients with NAFLD and chronic hepatitis C: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Benzimidazoles; Benzoates; Fatty Liver; Female; Hepatitis C, Chronic; Homeostasis; Humans; Hypertension; Imidazoles; Incidence; Insulin Resistance; Japan; Male; Middle Aged; Pilot Projects; Telmisartan; Tetrazoles | 2008 |
Telmisartan improves insulin resistance in high renin nonmodulating salt-sensitive hypertensives.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; C-Reactive Protein; Cross-Over Studies; Female; Humans; Hypertension; Insulin Resistance; Lipids; Male; Oxidative Stress; PPAR gamma; Ramipril; Renin; Salt Tolerance; Telmisartan | 2008 |
Olmesartan reduced microalbuminuria in Japanese subjects with type 2 diabetes.
Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Asian People; Benzimidazoles; Benzoates; Biphenyl Compounds; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hypertension; Imidazoles; Losartan; Male; Middle Aged; Telmisartan; Tetrazoles; Valine; Valsartan | 2009 |
[A randomized, double-blind, double-dummy study comparing a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide 12.5 mg to telmisartan 80 mg in Chinese hypertensive patients who failed to respond adequately to telmisartan 80 mg].
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome | 2008 |
Telmisartan improves vascular function independently of metabolic and antihypertensive effects in hypertensive subjects with impaired glucose tolerance.
Topics: Adult; Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Cross-Over Studies; Double-Blind Method; Female; Glucose Intolerance; Humans; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Prospective Studies; Telmisartan; Vascular Diseases | 2010 |
Long-term, open-label evaluation of the safety and efficacy of telmisartan 80 mg/hydrochlorothiazide 25 mg fixed-dose combination alone or with other antihypertensive medication.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diuretics; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Patient Compliance; Telmisartan | 2009 |
Antihypertensive efficacy of telmisartan vs ramipril over the 24-h dosing period, including the critical early morning hours: a pooled analysis of the PRISMA I and II randomized trials.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Circadian Rhythm; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Ramipril; Telmisartan | 2009 |
[Antihypertensive and organ-protective action of a 36-week monotherapy with telmisartan in hypertensive patients].
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Echocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Organ Size; Telmisartan; Time Factors; Tunica Intima; Ventricular Remodeling | 2008 |
Comparison of therapies between fixed-dose telmisartan/hydrochlorothiazide and losartan/hydrochlorothiazide in patients with mild to moderate hypertension.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Telmisartan; Treatment Outcome | 2009 |
Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis.
Topics: Alanine Transaminase; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Aspartate Aminotransferases; Benzimidazoles; Benzoates; Blood Pressure; Fatty Liver; Female; Humans; Hypertension; Liver Function Tests; Male; Middle Aged; Patient Selection; Telmisartan; Tetrazoles; Valine; Valsartan | 2009 |
Efficacy of low-dose hydrochlorothiazide in combination with telmisartan on early morning blood pressure in uncontrolled hypertensive patients.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Case-Control Studies; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Telmisartan; Time Factors; Treatment Outcome | 2009 |
Telmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4 x 4 factorial study.
Topics: Amlodipine; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan | 2009 |
Impact of angiotensin receptor blockade in combination with hydrochlorothiazide 25 mg in 2121 patients with stage 1-2 hypertension.
Topics: Adult; Age Factors; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Racial Groups; Sex Factors; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2009 |
Effects of angiotensin II receptor blockers on relationships between 24-hour blood pressure, autonomic function, and health-related QOL.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Autonomic Nervous System; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Circadian Rhythm; Dose-Response Relationship, Drug; Female; Health Surveys; Heart Rate; Humans; Hypertension; Imidazoles; Losartan; Male; Middle Aged; Quality of Life; Telmisartan; Tetrazoles; Valine; Valsartan | 2009 |
Effects of telmisartan therapy on metabolic profiles and serum high molecular weight (HMW)-adiponectin level in Japanese male hypertensive subjects with abdominal obesity.
Topics: Adiponectin; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Female; Humans; Hypertension; Lipoproteins, LDL; Male; Metabolome; Obesity; Sex Factors; Telmisartan | 2009 |
Telmisartan lowers albuminuria in type 2 diabetic patients treated with angiotensin enzyme inhibitors.
Topics: Aged; Albuminuria; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Pilot Projects; Telmisartan | 2009 |
Beneficial effects of telmisartan on left ventricular structure and function in patients with hypertension determined by two-dimensional strain imaging.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Echocardiography; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan; Torsion, Mechanical; Ventricular Function, Left; Ventricular Remodeling | 2009 |
Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Prognosis; Ramipril; Telmisartan; Treatment Outcome | 2009 |
Effects of salt supplementation on the albuminuric response to telmisartan with or without hydrochlorothiazide therapy in hypertensive patients with type 2 diabetes are modulated by habitual dietary salt intake.
Topics: Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 2; Dietary Supplements; Female; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Sodium Chloride; Sodium, Dietary; Telmisartan | 2009 |
Effects of AT1 receptor and beta1 receptor blocking on blood pressure, peripheral hemodynamic and lipid profile in statin-treated hypertensive hypercholesterolemic patients.
Topics: Adolescent; Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Anticholesteremic Agents; Antihypertensive Agents; Benzimidazoles; Benzoates; Bisoprolol; Blood Pressure; Cross-Over Studies; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypercholesterolemia; Hypertension; Lipids; Male; Middle Aged; Receptor, Angiotensin, Type 1; Simvastatin; Telmisartan; Treatment Outcome; Young Adult | 2009 |
[Effects of Songling Xuemaikang Capsule on ambulatory blood pressure in treatment of essential hypertension: a single-blind randomized controlled trial].
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antineoplastic Agents; Benzimidazoles; Benzoates; Blood Pressure Monitoring, Ambulatory; Capsules; Drugs, Chinese Herbal; Female; Humans; Hypertension; Male; Middle Aged; Single-Blind Method; Telmisartan | 2009 |
Effects of ARB or ACE-inhibitor administration on plasma levels of aldosterone and adiponectin in hypertension.
Topics: Adiponectin; Adult; Aged; Aged, 80 and over; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Perindopril; Telmisartan | 2009 |
Results of treatment with telmisartan-amlodipine in hypertensive patients.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Drug Therapy, Combination; Edema; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome | 2009 |
Chronic treatment with losartan results in sufficient serum levels of the metabolite EXP3179 for PPARgamma activation.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Biphenyl Compounds; Cell Movement; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Male; Middle Aged; Muscle Cells; PPAR gamma; Telmisartan; Tetrazoles | 2009 |
Comparative effects of telmisartan and eprosartan on insulin sensitivity in the treatment of overweight hypertensive patients.
Topics: Acrylates; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Glucose; Female; Humans; Hypertension; Imidazoles; Insulin; Male; Middle Aged; Overweight; Telmisartan; Thiophenes | 2009 |
Effects of angiotensin II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathy.
Topics: Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Ankle Brachial Index; Benzimidazoles; Benzoates; Blood Pressure; Circadian Rhythm; Cross-Over Studies; Diabetic Nephropathies; Double-Blind Method; Electrocardiography; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Prospective Studies; Proteinuria; Regression Analysis; Telmisartan; Young Adult | 2009 |
The impact of an electronic monitoring and reminder device on patient compliance with antihypertensive therapy: a randomized controlled trial.
Topics: Adult; Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Female; Humans; Hypertension; Male; Medication Adherence; Middle Aged; Reminder Systems; Surveys and Questionnaires; Telmisartan; Treatment Outcome | 2010 |
Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis.
Topics: Aged; Benzimidazoles; Benzoates; Blood Pressure; Brain Ischemia; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Secondary Prevention; Stroke; Telmisartan | 2009 |
The treatment of hypertension with telmisartan in the sphere of circadian rhythm in metabolic syndrome in the elderly.
Topics: Age Factors; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Circadian Rhythm; Follow-Up Studies; Humans; Hypertension; Metabolic Syndrome; Prospective Studies; Telmisartan; Treatment Outcome | 2009 |
Left ventricular mass and volume with telmisartan, ramipril, or combination in patients with previous atherosclerotic events or with diabetes mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET]).
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Atherosclerosis; Benzimidazoles; Benzoates; Diabetes Complications; Drug Therapy, Combination; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Male; Ramipril; Survival Analysis; Telmisartan; Treatment Outcome; Ventricular Dysfunction, Left | 2009 |
Effects of angiotensin II receptor blockers on the relationships between ambulatory blood pressure and anti-hypertensive effects, autonomic function, and health-related quality of life.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Female; Heart Rate; Humans; Hypertension; Imidazoles; Losartan; Male; Middle Aged; Quality of Life; Sympathetic Nervous System; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2009 |
[Effects of amlodipine plus telmisartan or amlodipine plus amiloride regimen on blood pressure control in hypertensive patients: preliminary report of Chinese Hypertension Intervention Efficacy (CHIEF) trial].
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan | 2009 |
Angiotensin II receptor antagonism with telmisartan increases number of endothelial progenitor cells in normotensive patients with coronary artery disease: a randomized, double-blind, placebo-controlled study.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Brachial Artery; Coronary Artery Disease; Double-Blind Method; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; Placebos; Prospective Studies; Receptors, Angiotensin; Stem Cells; Telmisartan | 2010 |
Effect of telmisartan on QT interval variability and autonomic control in hypertensive patients with left ventricular hypertrophy.
Topics: Angiotensin II Type 1 Receptor Blockers; Autonomic Nervous System; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cardiovascular System; Echocardiography; Electrocardiography; Female; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Parasympathetic Nervous System; Telmisartan; Treatment Outcome | 2010 |
[Perindopril, amlodipine and telmisartan improve arterial stiffness in patients with hypertension].
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Brachial Artery; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Telmisartan; Vascular Resistance | 2009 |
Blood pressure-lowering and antiproteinuric effect of switching from high-dose angiotensin receptor blockers to normal-dose telmisartan and low-dose hydrochlorothiazide in hypertensive patients with chronic kidney disease.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Pressure; Dose-Response Relationship, Drug; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Proteinuria; Renal Insufficiency, Chronic; Telmisartan | 2010 |
Effects of a low-dose antihypertensive diuretic in combination with losartan, telmisartan, or candesartan on serum urate levels in hypertensive patients.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Glucose; Diuretics; Double-Blind Method; Female; Humans; Hypertension; Lipids; Losartan; Male; Middle Aged; Telmisartan; Tetrazoles; Uric Acid | 2010 |
Salt supplementation blunts the blood pressure response to telmisartan with or without hydrochlorothiazide in hypertensive patients with type 2 diabetes.
Topics: Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Sodium Chloride, Dietary; Telmisartan | 2010 |
Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Glucose; C-Reactive Protein; Drug Therapy, Combination; Fasting; Female; Fluorobenzenes; Greece; Homeostasis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Imidazoles; Insulin; Irbesartan; Male; Middle Aged; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Telmisartan; Tetrazoles | 2010 |
The combination of amlodipine and angiotensin receptor blocker or diuretics in high-risk hypertensive patients: rationale, design and baseline characteristics.
Topics: Aged; Amiloride; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Chi-Square Distribution; China; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Kaplan-Meier Estimate; Male; Middle Aged; Research Design; Risk Assessment; Risk Factors; Telmisartan; Time Factors; Treatment Outcome | 2011 |
Telmisartan improves morphologic and functional changes in both left ventricular myocardium and carotid arterial wall in patients with hypertension: assessment by tissue Doppler imaging and carotid ultrasonography.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Carotid Arteries; Elasticity Imaging Techniques; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome; Ventricular Dysfunction, Left | 2010 |
Treatment of hypertension: postmarketing surveillance study results of telmisartan monotherapy, fixed dose combination of telmisartan + hydrochlorothiazide/amlodipine.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; India; Male; Middle Aged; Telmisartan; Treatment Outcome | 2009 |
[The clinical and hemodynamic efficacy of telmisartan and enalapril in the treatment of arterial hypertension in patients with type 2 diabetes mellitus].
Topics: Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Carbohydrate Metabolism; Diabetes Mellitus, Type 2; Enalapril; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome; Ventricular Function, Left | 2009 |
[Peripheral vascular remodeling in arterial hypertension in conditions of occupational risk: the issues of pathogenesis and telmisartan therapy].
Topics: Antihypertensive Agents; Benzimidazoles; Benzoates; Brachial Artery; Cytokines; Endothelium, Vascular; Humans; Hypertension; Male; Middle Aged; Occupational Diseases; Radial Artery; Telmisartan; Treatment Outcome; Ultrasonography, Doppler; Vibration | 2009 |
Comparison of the effects of three angiotensin II receptor type 1 blockers on metabolic parameters in hypertensive patients with type 2 diabetes mellitus.
Topics: Adiponectin; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Glucose; Blood Pressure; C-Reactive Protein; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Glycated Hemoglobin; Humans; Hypertension; Insulin Resistance; Lipids; Male; Middle Aged; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2010 |
Improvement of endothelial function in patients with hypertension and type 2 diabetes after treatment with telmisartan.
Topics: Adiponectin; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; C-Reactive Protein; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Prospective Studies; Telmisartan; Treatment Outcome; Vasodilation | 2010 |
Effects of telmisartan and amlodipine in combination on ambulatory blood pressure in stages 1-2 hypertension.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome | 2010 |
Telmisartan improves absolute walking distance and endothelial function in patients with peripheral artery disease.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Ankle Brachial Index; Benzimidazoles; Benzoates; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Peripheral Arterial Disease; Prospective Studies; Quality of Life; Single-Blind Method; Telmisartan; Treatment Outcome; Vasodilation; Walking | 2010 |
[The normalized smoothness index and parametric population RDH index of telmisartane in patients with newly diagnosed hypertension and metabolic syndrome].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Female; Humans; Hypertension; Male; Metabolic Syndrome; Middle Aged; Telmisartan | 2010 |
Fixed-dose telmisartan/hydrochlorothiazide in comparison with losartan/hydrochlorothiazide in decreasing serum hepatocyte growth factor and improving endothelial dysfunction in hypertensive patients.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Biomarkers; Cohort Studies; Drug Combinations; Endothelins; Endothelium, Vascular; Female; Hepatocyte Growth Factor; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Nitric Oxide; Telmisartan | 2010 |
Safety, efficacy, and pharmacokinetics of telmisartan in pediatric patients with hypertension.
Topics: Adolescent; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Child; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Male; Telmisartan; Treatment Outcome | 2010 |
Effects of telmisartan on insulin resistance in Japanese type 2 diabetic patients.
Topics: Adiponectin; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Homeostasis; Humans; Hypertension; Insulin Resistance; Japan; Lipoproteins, LDL; Male; Metabolic Syndrome; Middle Aged; Obesity; Oxidative Stress; PPAR gamma; Telmisartan; Tetrazoles | 2010 |
Telmisartan effects on insulin resistance in obese or overweight adults without diabetes or hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; Humans; Hypertension; Insulin Resistance; Male; Middle Aged; Obesity; Overweight; Telmisartan | 2010 |
Differential effect of telmisartan and amlodipine on monocyte chemoattractant protein-1 and peroxisome proliferator-activated receptor-gamma gene expression in peripheral monocytes in patients with essential hypertension.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Chemokine CCL2; Female; Gene Expression; Humans; Hypertension; Male; Middle Aged; Monocytes; PPAR gamma; Severity of Illness Index; Telmisartan | 2011 |
Effects of manidipine and its combination with an ACE inhibitor on insulin sensitivity and metabolic, inflammatory and prothrombotic markers in hypertensive patients with metabolic syndrome: the MARCADOR study.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biomarkers; Blood Pressure; Dihydropyridines; Drug Combinations; Female; Humans; Hypertension; Insulin Resistance; Lisinopril; Male; Metabolic Syndrome; Middle Aged; Nitrobenzenes; Piperazines; Prospective Studies; Spain; Telmisartan | 2011 |
Inhibition of intestinal cholesterol absorption might explain cholesterol-lowering effect of telmisartan.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Anticholesteremic Agents; Benzimidazoles; Benzoates; Biomarkers; Cholestanol; Cholesterol; Cholesterol, LDL; Fatty Acids, Monounsaturated; Female; Fluvastatin; Gastrointestinal Agents; Humans; Hypercholesterolemia; Hypertension; Indoles; Intestinal Absorption; Male; Middle Aged; PPAR gamma; Telmisartan | 2011 |
Blood pressure control by the nifedipine GITS-telmisartan combination in patients at high cardiovascular risk: the TALENT study.
Topics: Adult; Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cardiovascular Diseases; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Prospective Studies; Risk; Telmisartan | 2011 |
Effect of telmisartan and ramipril on atrial fibrillation recurrence and severity in hypertensive patients with metabolic syndrome and recurrent symptomatic paroxysmal and persistent atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Benzimidazoles; Benzoates; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Male; Metabolic Syndrome; Prospective Studies; Ramipril; Secondary Prevention; Severity of Illness Index; Telmisartan; Treatment Outcome | 2012 |
Beneficial cardiometabolic actions of telmisartan plus amlodipine therapy in elderly patients with poorly controlled hypertension.
Topics: Adiponectin; Age Factors; Aged; Aged, 80 and over; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Drug Substitution; Drug Therapy, Combination; Female; Humans; Hypertension; Japan; Male; Prospective Studies; Telmisartan; Tetrazoles; Time Factors; Treatment Outcome; Up-Regulation; Valine; Valsartan | 2011 |
[Clinical- functional assessment of organoprotective efficacy of enalapril and telmisartan in patients with arterial hypertension].
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Brachial Artery; Echocardiography; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome; Vasodilation; Ventricular Function, Left; Ventricular Remodeling | 2011 |
Telmisartan reduces neointima volume and pulse wave velocity 8 months after zotarolimus-eluting stent implantation in hypertensive type 2 diabetic patients.
Topics: Adiponectin; Aged; Ankle Brachial Index; Anti-Inflammatory Agents; Benzimidazoles; Benzoates; C-Reactive Protein; Coronary Stenosis; Diabetes Mellitus, Type 2; Disease Progression; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Hypertension; Interleukin-6; Male; Middle Aged; Neointima; Prospective Studies; Single-Blind Method; Sirolimus; Telmisartan; Tetrazoles; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha; Ultrasonography, Interventional; Valine; Valsartan | 2011 |
Influence of telmisartan on insulin response after glucose loading in obese patients with hypertension: ARB trial of hypertension in obese patients with hyperinsulinemia assessed by oral glucose tolerance test (ATHLETE).
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Glucose; Blood Pressure; Female; Glucose; Glucose Tolerance Test; Humans; Hyperinsulinism; Hypertension; Insulin Resistance; Male; Obesity; Telmisartan; Tetrazoles; Valine; Valsartan | 2011 |
Changes in urinary albumin excretion, inflammatory and oxidative stress markers in ADPKD patients with hypertension.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Biomarkers; Creatinine; Deoxyguanosine; Enalapril; Female; HMGB1 Protein; Humans; Hypertension; Inflammation; Interleukin-6; Male; Middle Aged; Oxidative Stress; Polycystic Kidney, Autosomal Dominant; Telmisartan | 2012 |
Telmisartan and amlodipine single-pill combinations vs amlodipine monotherapy for superior blood pressure lowering and improved tolerability in patients with uncontrolled hypertension: results of the TEAMSTA-5 study.
Topics: Adult; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dose-Response Relationship, Drug; Drug Combinations; Drug Monitoring; Drug Substitution; Drug Synergism; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome | 2011 |
Effects of telmisartan and losartan on cardiovascular protection in Japanese hypertensive patients.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Atherosclerosis; Benzimidazoles; Benzoates; Cardiovascular Diseases; Carotid Intima-Media Thickness; Female; Follow-Up Studies; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Japan; Losartan; Male; Middle Aged; Prospective Studies; Risk Factors; Severity of Illness Index; Single-Blind Method; Telmisartan; Treatment Outcome | 2011 |
Efficacy and tolerability of telmisartan plus amlodipine in added-risk hypertensive patients.
Topics: Adult; Age Factors; Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Risk Factors; Telmisartan | 2011 |
Effects of telmisartan on cognition and regional cerebral blood flow in hypertensive patients with Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Brain; Cerebrovascular Circulation; Cognition; Female; Humans; Hypertension; Male; Prospective Studies; Regional Blood Flow; Single-Blind Method; Telmisartan | 2012 |
Switching patients with uncontrolled hypertension on amlodipine 10 mg to single-pill combinations of telmisartan and amlodipine: results of the TEAMSTA-10 study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome | 2011 |
The effects of simvastatin on left ventricular hypertrophy and left ventricular function in patients with essential hypertension.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Drug Therapy, Combination; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Lipids; Male; Simvastatin; Telmisartan; Treatment Outcome; Ultrasonography; Ventricular Function, Left | 2011 |
Effect of telmisartan addition to amlodipine on ankle edema development in treating hypertensive patients.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Ankle; Antihypertensive Agents; Benzimidazoles; Benzoates; Cross-Over Studies; Drug Combinations; Edema; Female; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Telmisartan | 2011 |
Effects of telmisartan on insulin resistance and visceral fat distribution in Chinese hypertensive patients with obesity.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; China; Female; Humans; Hypertension; Insulin Resistance; Intra-Abdominal Fat; Male; Middle Aged; Obesity; Telmisartan | 2011 |
Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial).
Topics: Aged; Benzimidazoles; Benzoates; Blood Pressure Determination; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Hypotension; Kaplan-Meier Estimate; Male; Middle Aged; Patient Safety; Ramipril; Reference Values; Risk Assessment; Survival Rate; Telmisartan; Treatment Outcome | 2012 |
Effect of switching from telmisartan, valsartan, olmesartan, or losartan to candesartan on morning hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Asian People; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Female; Humans; Hypertension; Imidazoles; Japan; Losartan; Male; Middle Aged; Prospective Studies; Telmisartan; Tetrazoles; Valine; Valsartan | 2012 |
Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
Topics: Aged; Amiloride; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; China; Diuretics; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prospective Studies; Risk Factors; Telmisartan; Time Factors; Treatment Outcome | 2012 |
Protective effect of telmisartan against endothelial dysfunction after coronary drug-eluting stent implantation in hypertensive patients.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Chi-Square Distribution; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Endothelium, Vascular; Female; Humans; Hypertension; Male; Statistics as Topic; Statistics, Nonparametric; Telmisartan; Vasoconstriction | 2012 |
Single-pill combination of telmisartan/amlodipine versus amlodipine monotherapy in diabetic hypertensive patients: an 8-week randomized, parallel-group, double-blind trial.
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Severity of Illness Index; Telmisartan; Treatment Outcome | 2012 |
Efficacy and safety of a single-pill fixed-dose combination of high-dose telmisartan/hydrochlorothiazide in patients with uncontrolled hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Dosage Forms; Dose-Response Relationship, Drug; Drug Combinations; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Metabolic Syndrome; Potassium; Telmisartan; Treatment Outcome; Uric Acid | 2012 |
Sustained decrease in blood pressure following missed doses of aliskiren or telmisartan: the ASSERTIVE double-blind, randomized study.
Topics: Adult; Aged; Amides; Antihypertensive Agents; Benzimidazoles; Benzoates; Biomarkers; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diabetes Complications; Double-Blind Method; Female; Fumarates; Humans; Hypertension; International Cooperation; Male; Medication Adherence; Middle Aged; Placebos; Telmisartan; Time Factors; Treatment Outcome | 2012 |
Single-pill combination of telmisartan/amlodipine in patients with severe hypertension: results from the TEAMSTA severe HTN study.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Likelihood Functions; Male; Middle Aged; Severity of Illness Index; Telmisartan | 2012 |
Microalbuminuria and sRAGE in high-risk hypertensive patients treated with nifedipine/telmisartan combination treatment: a substudy of TALENT.
Topics: Adolescent; Adult; Aged; Albuminuria; Antihypertensive Agents; Benzimidazoles; Benzoates; Drug Combinations; Female; Glycation End Products, Advanced; Humans; Hypertension; Male; Middle Aged; Nifedipine; Telmisartan; Young Adult | 2012 |
Effect of telmisartan on paroxysmal atrial fibrillation recurrence in hypertensive patients with normal or increased left atrial size.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial Fibrillation; Benzimidazoles; Benzoates; Calcium Channel Blockers; Double-Blind Method; Female; Heart Atria; Humans; Hypertension; Male; Recurrence; Risk Factors; Telmisartan | 2012 |
A multicentre, randomized study of telmisartan versus carvedilol for prevention of atrial fibrillation recurrence in hypertensive patients.
Topics: Adult; Aged; Antihypertensive Agents; Atrial Fibrillation; Benzimidazoles; Benzoates; Carbazoles; Carvedilol; Female; Heart Ventricles; Humans; Hypertension; Kaplan-Meier Estimate; Male; Middle Aged; Organ Size; Propanolamines; Recurrence; Telmisartan | 2012 |
The effects of telmisartan treatment on the abdominal fat depot in patients with metabolic syndrome and essential hypertension: Abdominal fat Depot Intervention Program of Okayama (ADIPO).
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Body Mass Index; Body Weight; Female; Humans; Hypertension; Insulin Resistance; Intra-Abdominal Fat; Male; Metabolic Syndrome; Middle Aged; PPAR gamma; Subcutaneous Fat; Telmisartan; Tetrazoles; Tomography, X-Ray Computed; Treatment Outcome; Valine; Valsartan; Waist Circumference | 2013 |
Administration of angiotensin receptor II blockade improves vascular function, urinary albumin excretion, and left ventricular hypertrophy in low-risk essential hypertensive patients receiving antihypertensive treatment with calcium channel blockers.
Topics: Aged; Aged, 80 and over; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Incidence; Male; Middle Aged; Risk Factors; Sodium Chloride; Telmisartan; Treatment Outcome | 2013 |
Efficacy and tolerability of initial therapy with single-pill combination telmisartan/hydrochlorothiazide 80/25 mg in patients with grade 2 or 3 hypertension: a multinational, randomized, double-blind, active-controlled trial.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Severity of Illness Index; Telmisartan; Treatment Outcome | 2012 |
Angiotensin II receptor blockers improve endothelial dysfunction associated with sympathetic hyperactivity in metabolic syndrome.
Topics: Angiotensin II Type 1 Receptor Blockers; Arteries; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Flow Velocity; Blood Pressure; Diet Therapy; Endothelium, Vascular; Female; Forearm; Humans; Hypertension; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Sympathetic Nervous System; Telmisartan; Tetrazoles; Vascular Resistance; Vasodilation | 2012 |
Telmisartan and N-acetylcysteine suppress group V secretory phospholipase A2 expression in TNFα-stimulated human endothelial cells and reduce associated atherogenicity.
Topics: Acetylcysteine; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Atherosclerosis; Benzimidazoles; Benzoates; Chemokine CCL2; Diabetes Mellitus, Type 2; Female; Gene Expression Regulation; Group V Phospholipases A2; Human Umbilical Vein Endothelial Cells; Humans; Hypertension; Lipoproteins, LDL; Lysophosphatidylcholines; Male; Middle Aged; RNA, Messenger; Telmisartan; Tumor Necrosis Factor-alpha | 2012 |
Telmisartan at 80 mg/day increases high-molecular-weight adiponectin levels and improves insulin resistance in diabetic patients.
Topics: Adipocytes; Adiponectin; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Insulin; Insulin Resistance; Lipid Metabolism; Male; Middle Aged; PPAR gamma; Telmisartan; Triglycerides | 2012 |
Effect of peroxisome proliferator activated receptor γ agonist on angiotensin converting enzyme 2 mRNA expression in monocyte-derived macrophages of essential hypertensive patients.
Topics: Aged; Angiotensin-Converting Enzyme 2; Benzazepines; Benzimidazoles; Benzoates; Female; Humans; Hypertension; Macrophages; Male; Middle Aged; Peptidyl-Dipeptidase A; PPAR gamma; RNA, Messenger; Telmisartan | 2012 |
Titration of telmisartan, but not addition of amlodipine, reduces urine albumin in diabetic patients treated with telmisartan-diuretic.
Topics: Adult; Aged; Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Telmisartan; Treatment Outcome | 2013 |
Ambulatory blood pressure values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET).
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Therapy, Combination; Female; Humans; Hypertension; Longitudinal Studies; Male; Middle Aged; Ramipril; Telmisartan; Treatment Outcome | 2012 |
The effects of telmisartan and amlodipine in treatment-naïve and previously treated hypertensive patients: a subanalysis from a 4 × 4 factorial design study.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome | 2013 |
The enhanced renin-angiotensin-aldosteron system pharmacological blockade--which is the best?.
Topics: Adult; Albuminuria; Amides; Angiotensin Receptor Antagonists; Benzimidazoles; Benzoates; Comorbidity; Cross-Over Studies; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Eplerenone; Female; Fumarates; Humans; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Prospective Studies; Proteinuria; Renal Insufficiency, Chronic; Renin; Renin-Angiotensin System; Severity of Illness Index; Spironolactone; Telmisartan; Treatment Outcome | 2012 |
Sustained blood pressure-lowering effect of aliskiren compared with telmisartan after a single missed dose.
Topics: Adult; Amides; Antihypertensive Agents; Benzimidazoles; Benzoates; Double-Blind Method; Drug Administration Schedule; Female; Fumarates; Humans; Hypertension; Least-Squares Analysis; Male; Patient Compliance; Telmisartan; Treatment Outcome | 2013 |
[Effects of telmisartan on the level of Aβ1-42, interleukin-1β, tumor necrosis factor α and cognition in hypertensive patients with Alzheimer's disease].
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amlodipine; Amyloid beta-Peptides; Antihypertensive Agents; Benzimidazoles; Benzoates; Cognition; Female; Humans; Hypertension; Interleukin-1beta; Male; Middle Aged; Peptide Fragments; PPAR gamma; Telmisartan; Tumor Necrosis Factor-alpha | 2012 |
Antihypertensive and metabolic effects of high-dose olmesartan and telmisartan in type 2 diabetes patients with hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Benzimidazoles; Benzoates; C-Reactive Protein; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Resistance; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypoglycemic Agents; Imidazoles; Insulin Resistance; Male; Middle Aged; Telmisartan; Tetrazoles | 2013 |
Comparative effect of candesartan and amlodipine, and effect of switching from valsartan, losartan, telmisartan and olmesartan to candesartan, on early morning hypertension and heart rate.
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Drug Substitution; Female; Heart Rate; Humans; Hypertension; Imidazoles; Losartan; Male; Middle Aged; Prospective Studies; Telmisartan; Tetrazoles; Valine; Valsartan | 2013 |
Long-term exposure to telmisartan as monotherapy or combination therapy: efficacy and safety.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Consumer Product Safety; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Telmisartan; Therapeutic Equivalency | 2002 |
Efficacy of eplerenone added to renin-angiotensin blockade in hypertensive patients.
Topics: Abdominal Pain; Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Eplerenone; Female; Headache; Heart Rate; Humans; Hypertension; Irbesartan; Losartan; Male; Middle Aged; Patient Dropouts; Renin-Angiotensin System; Spironolactone; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2002 |
A multicenter, open-label study of the efficacy and safety of telmisartan in mild to moderate hypertensive patients.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Single-Blind Method; Telmisartan; Treatment Outcome | 2002 |
Long-term efficacy and tolerability of telmisartan as monotherapy and in combination with other antihypertensive medications.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diastole; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Safety; Sodium Chloride Symporter Inhibitors; Systole; Telmisartan | 2002 |
[Angiotensin II receptor blocker telmisartan: effect on 24-hour blood pressure profile and left ventricular hypertrophy in patients with hypertension].
Topics: Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Circadian Rhythm; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Receptors, Angiotensin; Telmisartan | 2002 |
Comparison of trough effect of telmisartan vs perindopril using self blood pressure measurement: EVERESTE study.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure Determination; Diastole; Feasibility Studies; Female; Humans; Hypertension; Incidence; Male; Middle Aged; Perindopril; Prospective Studies; Random Allocation; Severity of Illness Index; Single-Blind Method; Statistics as Topic; Systole; Telmisartan; Treatment Outcome | 2002 |
Effects of telmisartan on arterial stiffness in Type 2 diabetes patients with essential hypertension.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Arteries; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Elasticity; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Pulse; Telmisartan | 2002 |
Defining the antihypertensive properties of the angiotensin receptor blocker telmisartan by a practice-based clinical trial.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Clinical Trials as Topic; Female; Humans; Hypertension; Male; Middle Aged; Residence Characteristics; Telmisartan | 2003 |
Efficacy and tolerability of fixed-dose combinations of telmisartan plus HCTZ compared with losartan plus HCTZ in patients with essential hypertension.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Chi-Square Distribution; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Prospective Studies; Telmisartan | 2003 |
Effects of telmisartan and losartan on left ventricular mass in mild-to-moderate hypertension. A randomized, double-blind trial.
Topics: Adult; Aged; Benzimidazoles; Benzoates; Blood Pressure Determination; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Echocardiography, Doppler; Female; Follow-Up Studies; Humans; Hypertension; Losartan; Male; Middle Aged; Probability; Prospective Studies; Severity of Illness Index; Statistics, Nonparametric; Telmisartan; Treatment Outcome; Ventricular Function, Left | 2003 |
Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Determination; Diuretics; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Severity of Illness Index; Single-Blind Method; Sodium Chloride Symporter Inhibitors; Telmisartan; Treatment Outcome | 2003 |
Blood pressure- and pulse pressure-lowering effects, trough:peak ratio and smoothness index of telmisartan compared with lisinopril.
Topics: Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Humans; Hypertension; Lisinopril; Telmisartan; Time Factors; Treatment Outcome | 2003 |
Comparison of the efficacy, safety and tolerability of telmisartan with losartan in Indian patients with mild to moderate hypertension: a pilot study.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Double-Blind Method; Female; Humans; Hypertension; India; Losartan; Male; Middle Aged; Pilot Projects; Prospective Studies; Telmisartan | 2003 |
Improving the utility of the nocturnal hypertension definition by using absolute sleep blood pressure rather than the "dipping" proportion.
Topics: Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Circadian Rhythm; Databases, Factual; Female; Humans; Hypertension; Male; Middle Aged; Monitoring, Ambulatory; Outcome Assessment, Health Care; Sleep; Telmisartan | 2003 |
Freehand three-dimensional echocardiographic evaluation of the effect of telmisartan compared with hydrochlorothiazide on left ventricular mass in hypertensive patients with mild-to-moderate hypertension: a multicentre study.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Echocardiography, Three-Dimensional; Female; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Telmisartan; Treatment Outcome | 2004 |
Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Male; Metoprolol; Middle Aged; Research Design; Telmisartan; Treatment Outcome | 2003 |
The adjunctive effect of telmisartan in patients with hypertension uncontrolled on current antihypertensive therapy.
Topics: Adult; Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Telmisartan | 2003 |
Safety of telmisartan in patients with arterial hypertension : an open-label observational study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II; Angiotensin Receptor Antagonists; Benzimidazoles; Benzoates; Female; Humans; Hypertension; Male; Middle Aged; Product Surveillance, Postmarketing; Risk Factors; Telmisartan | 2004 |
Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Canada; Circadian Rhythm; Cross-Over Studies; Diastole; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Receptors, Angiotensin; Systole; Telmisartan; Tetrazoles; Treatment Outcome; United States; Valine; Valsartan | 2004 |
Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study: efficacy and safety of telmisartan 20, 40 or 80 mg versus hydrochlorothiazide 12.5 mg or placebo.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Placebos; Receptors, Angiotensin; Telmisartan | 2004 |
Effects of telmisartan 80 mg and valsartan 160 mg on ambulatory blood pressure in patients with essential hypertension.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Tablets; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan; White People | 2004 |
Challenges in improving prognosis and therapy: the Ongoing Telmisartan Alone and in Combination with Ramipril Global End point Trial programme.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Germany; Heart Diseases; Humans; Hypertension; Prognosis; Ramipril; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Risk Reduction Behavior; Telmisartan; Treatment Outcome | 2004 |
Effects of telmisartan compared with eprosartan on blood pressure control, glucose metabolism and lipid profile in hypertensive, type 2 diabetic patients: a randomized, double-blind, placebo-controlled 12-month study.
Topics: Acrylates; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Female; Glucose; Homeostasis; Humans; Hypertension; Imidazoles; Lipids; Male; Middle Aged; Telmisartan; Thiophenes | 2004 |
Sustained antihypertensive activity of telmisartan compared with valsartan.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diastole; Double-Blind Method; Female; Half-Life; Humans; Hypertension; Male; Middle Aged; Placebos; Single-Blind Method; Systole; Telmisartan; Tetrazoles; Valine; Valsartan | 2004 |
Factors related to the impact of antihypertensive treatment in antioxidant activities and oxidative stress by-products in human hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Antioxidants; Atenolol; Benzimidazoles; Benzoates; DNA Damage; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Oxidative Stress; Telmisartan; Treatment Outcome | 2004 |
A comparison of the efficacy and duration of action of telmisartan, amlodipine and ramipril in patients with confirmed ambulatory hypertension.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Female; Humans; Hypertension; Male; Middle Aged; Ramipril; Renin; Telmisartan; Therapeutic Equivalency | 2004 |
Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, doubl
Topics: Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Nifedipine; Telmisartan; Treatment Outcome; Triglycerides | 2004 |
Practical efficacy of telmisartan for decreasing morning home blood pressure and pulse wave velocity in patients with mild-to-moderate hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Circadian Rhythm; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Telmisartan | 2004 |
Renin-angiotensin system gene polymorphisms: relationship with blood pressure and microalbuminuria in telmisartan-treated hypertensive patients.
Topics: Aged; Albuminuria; Benzimidazoles; Benzoates; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Polymorphism, Genetic; Prospective Studies; Renin-Angiotensin System; Telmisartan | 2005 |
Effect of telmisartan 80 mg once daily on 24-h blood pressure profile in patients with mild-to-moderate hypertension failing to respond to prior antihypertensive therapy.
Topics: Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Telmisartan; Treatment Outcome | 2004 |
A double-blind ambulatory blood pressure monitoring study of the efficacy and tolerability of once-daily telmisartan 40 mg in comparison with losartan 50 mg in the treatment of mild-to-moderate hypertension in Taiwanese patients.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome | 2004 |
Clinical efficacy and safety of telmisartan 80 mg once daily compared with enalapril 20 mg once daily in patients with mild-to-moderate hypertension: results of a multicentre study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Single-Blind Method; Telmisartan | 2004 |
Comparison of the efficacy and tolerability of telmisartan 40 mg vs. enalapril 10 mg in the treatment of mild-to-moderate hypertension: a multicentre, double-blind study in Taiwanese patients.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Patient Compliance; Telmisartan; Treatment Outcome | 2004 |
A double-blind comparison of the efficacy and tolerability of telmisartan 40-80 mg vs. losartan 50-100 mg in Taiwanese hypertensive patients.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Patient Compliance; Telmisartan | 2004 |
Clinical efficacy and safety of telmisartan 80 mg once daily vs. atenolol 50 mg once daily in patients with mild-to-moderate hypertension.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Telmisartan; Treatment Outcome | 2004 |
Efficacy and safety of telmisartan vs. losartan in control of mild-to-moderate hypertension: a multicentre, randomised, double-blind study.
Topics: Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Telmisartan | 2004 |
The efficacy of telmisartan compared with perindopril in patients with mild-to-moderate hypertension.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Single-Blind Method; Telmisartan | 2004 |
Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives.
Topics: Adult; Aged; Aldosterone; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Calcium Channel Blockers; Circadian Rhythm; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Posture; Prospective Studies; Ramipril; Reference Values; Renin; Renin-Angiotensin System; Telmisartan; Treatment Outcome | 2005 |
Replacement of valsartan and candesartan by telmisartan in hypertensive patients with type 2 diabetes: metabolic and antiatherogenic consequences.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan; Tetrazoles; Valine; Valsartan | 2005 |
Left ventricular mass and mechanics in mild-to-moderate hypertension: effect of nebivolol versus telmisartan.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Benzopyrans; Blood Flow Velocity; Blood Pressure; Diastole; Echocardiography; Ethanolamines; Female; Humans; Hypertension; Male; Middle Aged; Mitral Valve; Myocardial Contraction; Nebivolol; Regional Blood Flow; Severity of Illness Index; Telmisartan; Ventricular Function, Left | 2005 |
Telmisartan in patients with mild/moderate hypertension and chronic kidney disease.
Topics: Administration, Oral; Adult; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Creatinine; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Single-Blind Method; Telmisartan; Treatment Outcome | 2005 |
The ONTARGET/TRANSCEND Trial Programme: baseline data.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Female; Humans; Hypertension; Male; Prospective Studies; Ramipril; Telmisartan | 2005 |
Effect of telmisartan/hydrochlorothiazide combination versus nifedipine GITS on ambulatory blood pressure and sympathetic activation.
Topics: Adult; Aged; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nifedipine; Norepinephrine; Prospective Studies; Sympathetic Nervous System; Telmisartan | 2005 |
Assessment of efficacy, safety and tolerability of fixed dose combination of telmisartan 40mg and hydrochlorothiazide 12.5mg in adult Indian patients with mild to moderate hypertension.
Topics: Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Dizziness; Drug Therapy, Combination; Fatigue; Female; Humans; Hydrochlorothiazide; Hypertension; India; Male; Middle Aged; Nausea; Prospective Studies; Telmisartan; Treatment Outcome | 2004 |
Effect of the renin-angiotensin system or calcium channel blockade on the circadian variation of heart rate variability, blood pressure and circulating catecholamines in hypertensive patients.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Circadian Rhythm; Epinephrine; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Ramipril; Renin-Angiotensin System; Telmisartan; Treatment Outcome | 2005 |
Ambulatory blood pressure monitoring in the primary care setting: assessment of therapy on the circadian variation of blood pressure from the MICCAT-2 Trial.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Cohort Studies; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Telmisartan | 2005 |
The comparative effects of telmisartan and ramipril on P-wave dispersion in hypertensive patients: a randomized clinical study.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Ramipril; Stroke Volume; Telmisartan; Treatment Outcome | 2005 |
Beneficial effect of lisinopril plus telmisartan in patients with type 2 diabetes, microalbuminuria and hypertension.
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Creatinine; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Prospective Studies; Telmisartan | 2006 |
A pilot study for evaluation of the efficacy and safety of telmisartan in reducing microalbuminuria in hypertensive patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Albuminuria; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hypertension; Infant; Male; Middle Aged; Pilot Projects; Prospective Studies; Safety; Single-Blind Method; Telmisartan | 2005 |
The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Back Pain; Benzimidazoles; Benzoates; Blood Pressure; Bronchitis; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome | 2005 |
Angiotensin II receptor blocker telmisartan: effect on blood pressure profile and left ventricular hypertrophy in patients with arterial hypertension.
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Monitoring, Ambulatory; Telmisartan; Time Factors | 2005 |
Effect of 24-week treatment with telmisartan on myocardial structure and function: relationship to insertion/deletion polymorphism of the angiotensin-converting enzyme gene.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Echocardiography, Doppler; Female; Gene Deletion; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardium; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Telmisartan; Time Factors | 2005 |
Ventricular and vascular remodelling effects of the angiotensin II receptor blocker telmisartan and/or the angiotensin-converting enzyme inhibitor ramipril in hypertensive patients.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Carotid Arteries; Drug Therapy, Combination; Echocardiography, Doppler; Female; Humans; Hypertension; Male; Middle Aged; Muscle, Smooth, Vascular; Ramipril; Retrospective Studies; Telmisartan; Time Factors; Tunica Intima; Tunica Media; Ventricular Remodeling | 2005 |
Comparative antihypertensive efficacy of angiotensin receptor blocker-based treatment in African-American and white patients.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Black or African American; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prospective Studies; Telmisartan; Treatment Outcome; White People | 2005 |
Influence of regression of left ventricular hypertrophy on left atrial size and function in patients with moderate hypertension.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Atrial Function, Left; Benzimidazoles; Benzoates; Echocardiography, Doppler, Color; Female; Heart Atria; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Telmisartan | 2005 |
Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients.
Topics: Aged; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Determination; Cognition; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Prospective Studies; Sodium Chloride Symporter Inhibitors; Statistics, Nonparametric; Telmisartan; Treatment Outcome | 2006 |
Long-term renoprotective effects of standard versus high doses of telmisartan in hypertensive nondiabetic nephropathies.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Creatinine; Dose-Response Relationship, Drug; Dyslipidemias; Female; Follow-Up Studies; Humans; Hypertension; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Proteinuria; Renin-Angiotensin System; Telmisartan; Treatment Outcome | 2005 |
The prospective, randomized investigation of the safety and efficacy of telmisartan versus ramipril using ambulatory blood pressure monitoring (PRISMA I).
Topics: Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Cough; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Ramipril; Single-Blind Method; Telmisartan; Time Factors | 2006 |
Three-dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Carbazoles; Carvedilol; Circadian Rhythm; Echocardiography, Three-Dimensional; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Propanolamines; Telmisartan | 2005 |
Measuring the efficacy of antihypertensive therapy by ambulatory blood pressure monitoring in the primary care setting.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure Monitoring, Ambulatory; Female; Humans; Hypertension; Male; Middle Aged; Primary Health Care; Telmisartan | 2006 |
A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Female; Humans; Hypertension; Longitudinal Studies; Male; Middle Aged; Ramipril; Single-Blind Method; Telmisartan | 2006 |
An effectiveness study comparing algorithm-based antihypertensive therapy with previous treatments using conventional and ambulatory blood pressure measurements.
Topics: Aged; Algorithms; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Determination; Blood Pressure Monitoring, Ambulatory; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Telmisartan | 2006 |
[Telmisartan in monotherapy of essential hypertension in young men--time of drug administration and 24-hours blood pressure and heart rate].
Topics: Adult; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Chronotherapy; Circadian Rhythm; Drug Administration Schedule; Heart Rate; Humans; Hypertension; Male; Single-Blind Method; Telmisartan; Treatment Outcome | 2005 |
Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension.
Topics: Adiponectin; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Body Mass Index; Calcium Channel Blockers; Cohort Studies; Female; Humans; Hypertension; Insulin Resistance; Male; Middle Aged; Nisoldipine; PPAR gamma; Telmisartan | 2006 |
Effects of the angiotensin II receptor blockers telmisartan vs valsartan in combination with hydrochlorothiazide 25 mg once daily for the treatment of hypertension.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Placebos; Telmisartan; Tetrazoles; United States; Valine; Valsartan | 2006 |
Renal and vascular protective effects of telmisartan in patients with essential hypertension.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Arteriosclerosis; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Endothelium, Vascular; Female; Heart Rate; Humans; Hypertension; In Vitro Techniques; Kidney; Male; Middle Aged; Telmisartan; Vasodilation | 2006 |
Telmisartan reduced blood pressure and HOMA-IR with increasing plasma leptin level in hypertensive and type 2 diabetic patients.
Topics: Adiponectin; Adult; Aged; Aged, 80 and over; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diet, Diabetic; Female; Humans; Hypertension; Hypoglycemic Agents; Leptin; Lipids; Male; Middle Aged; Telmisartan | 2007 |
The effects of telmisartan and amlodipine on metabolic parameters and blood pressure in type 2 diabetic, hypertensive patients.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Humans; Hypertension; Insulin Resistance; Middle Aged; PPAR gamma; Telmisartan | 2006 |
Pharmacokinetics of oral doses of telmisartan and nisoldipine, given alone and in combination, in patients with essential hypertension.
Topics: Administration, Oral; Aged; Angiotensin II Type 1 Receptor Blockers; Area Under Curve; Benzimidazoles; Benzoates; Biological Availability; Calcium Channel Blockers; Dizziness; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Edema; Female; Half-Life; Headache; Humans; Hypertension; Male; Middle Aged; Nisoldipine; Single-Blind Method; Telmisartan; Time Factors | 2007 |
Impact of telmisartan versus ramipril on renal endothelial function in patients with hypertension and type 2 diabetes.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Flow Velocity; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; Ramipril; Renal Circulation; Telmisartan | 2007 |
Effects of telmisartan on fat distribution in individuals with the metabolic syndrome.
Topics: Adipose Tissue, White; Adult; Aged; Amlodipine; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Aorta; Benzimidazoles; Benzoates; Biomarkers; Blood Glucose; Blood Pressure; Body Fat Distribution; Calcium Channel Blockers; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin; Insulin Resistance; Intra-Abdominal Fat; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Research Design; Telmisartan; Tomography, X-Ray Computed; Treatment Outcome; Vascular Resistance | 2007 |
Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria.
Topics: Adult; Aged; Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan | 2007 |
Design, statistical analysis and sample size calculation of dose response study of telmisartan and hydrochlorothiazide.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Research Design; Sample Size; Statistics as Topic; Telmisartan | 2007 |
Effects of telmisartan and losartan on insulin resistance in hypertensive patients with metabolic syndrome.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Cholesterol, HDL; Fasting; Female; Humans; Hypertension; Insulin Resistance; Losartan; Male; Metabolic Syndrome; Middle Aged; Telmisartan | 2007 |
Acute effects of renin-angiotensin system blockade on arterial function in hypertensive patients.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Brachial Artery; Captopril; Double-Blind Method; Female; Forearm; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; Quinapril; Regional Blood Flow; Telmisartan; Tetrahydroisoquinolines | 2007 |
The differential effects of angiotensin II type 1 receptor blockers on microalbuminuria in relation to low-grade inflammation in metabolic hypertensive patients.
Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; C-Reactive Protein; Female; Humans; Hypertension; Inflammation; Male; Metabolic Syndrome; PPAR gamma; Telmisartan; Treatment Outcome | 2007 |
The effect of telmisartan and ramipril on early morning blood pressure surge: a pooled analysis of two randomized clinical trials.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Asian People; Benzimidazoles; Benzoates; Black People; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Female; Humans; Hypertension; Male; Middle Aged; Ramipril; Telmisartan; Time Factors; White People | 2007 |
Mobilization of putative high-proliferative-potential endothelial colony-forming cells during antihypertensive treatment in patients with essential hypertension.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antigens, CD; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Cells, Cultured; Colony-Forming Units Assay; Endothelial Cells; Female; Humans; Hypertension; Male; Middle Aged; Nisoldipine; Phenotype; Stem Cells; Telmisartan | 2007 |
[Antihypertensive and metabolic effects of telmisartan in patients with the metabolic syndrome in primary care--a field study].
Topics: Aged; Antihypertensive Agents; Austria; Benzimidazoles; Benzoates; Comorbidity; Female; Humans; Hypertension; Male; Metabolic Syndrome; Middle Aged; Prevalence; Primary Health Care; Risk Assessment; Risk Factors; Telmisartan; Treatment Outcome | 2007 |
Beneficial effect of beraprost sodium plus telmisartan in the prevention of arterial stiffness development in elderly patients with hypertension and cerebral infarction.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Arteriosclerosis; Benzimidazoles; Benzoates; Blood Flow Velocity; Cerebral Infarction; Double-Blind Method; Drug Therapy, Combination; Epoprostenol; Female; Humans; Hypertension; Male; Platelet Aggregation Inhibitors; Telmisartan; Treatment Outcome | 2007 |
Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan; Time Factors; Treatment Outcome | 2007 |
Effects of the angiotensin II type 1 receptor antagonist telmisartan on monocyte adhesion and activation in patients with essential hypertension.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; B7-1 Antigen; B7-2 Antigen; Benzimidazoles; Benzoates; Case-Control Studies; CD11a Antigen; CD11b Antigen; Cell Adhesion; Female; Humans; Hypertension; Intercellular Adhesion Molecule-1; Male; Middle Aged; Monocytes; Receptors, Chemokine; Telmisartan | 2007 |
Comparative effects of telmisartan and valsartan on insulin resistance in hypertensive patients with metabolic syndrome.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Female; Humans; Hypertension; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Telmisartan; Tetrazoles; Valine; Valsartan | 2007 |
Comparison of effects of telmisartan and valsartan on late lumen loss and inflammatory markers after sirolimus-eluting stent implantation in hypertensive patients.
Topics: Adiponectin; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Biomarkers; Cholesterol; Cholesterol, LDL; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Hypertension; Immunosuppressive Agents; Interleukin-6; Male; Middle Aged; Single-Blind Method; Sirolimus; Telmisartan; Tetrazoles; Tumor Necrosis Factor-alpha; Valine; Valsartan | 2007 |
Effect of telmisartan on forearm postischemic hyperemia and serum asymmetric dimethylarginine levels.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Arginine; Benzimidazoles; Benzoates; Blood Pressure; Endothelium, Vascular; Female; Forearm; Humans; Hyperemia; Hypertension; Male; Middle Aged; Telmisartan; Tetrazoles; Valine; Valsartan | 2007 |
Telmisartan improves endothelial function in patients with essential hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Drug Therapy, Combination; Endothelium, Vascular; Female; Humans; Hypertension; Kidney; Male; Middle Aged; Nisoldipine; Prospective Studies; Single-Blind Method; Telmisartan; Treatment Outcome; Vascular Resistance; Vasodilation | 2007 |
Pretreatment plasma renin activity levels correlate with the blood pressure response to telmisartan in essential hypertension.
Topics: Administration, Oral; Adult; Angiotensin II Type 1 Receptor Blockers; Asian People; Benzimidazoles; Benzoates; Biomarkers; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Administration Schedule; Female; Humans; Hypertension; Japan; Male; Middle Aged; Patient Selection; Prospective Studies; Renin; Telmisartan; Treatment Outcome | 2008 |
Effects of the angiotensin II receptor blockers telmisartan versus valsartan in combination with hydrochlorothiazide: a large, confirmatory trial.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Telmisartan; Tetrazoles; Valine; Valsartan | 2008 |
Results of a comparative, phase III, 12-week, multicenter, prospective, randomized, double-blind assessment of the efficacy and tolerability of a fixed-dose combination of telmisartan and amlodipine versus amlodipine monotherapy in Indian adults with stag
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Cough; Diastole; Diet; Double-Blind Method; Drug Combinations; Edema; Exercise; Female; Headache; Humans; Hypertension; India; Male; Middle Aged; Prospective Studies; Systole; Telmisartan; Treatment Outcome | 2007 |
Telmisartan treatment decreases visceral fat accumulation and improves serum levels of adiponectin and vascular inflammation markers in Japanese hypertensive patients.
Topics: Adiponectin; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; C-Reactive Protein; Cholesterol, HDL; Female; Humans; Hypertension; Insulin Resistance; Interleukin-6; Intra-Abdominal Fat; Japan; Male; Middle Aged; PPAR gamma; Regional Blood Flow; Telmisartan; Vasculitis | 2007 |
Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Arginine; Benzimidazoles; Benzoates; Blood Pressure; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dinoprost; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Proteinuria; Renin-Angiotensin System; Telmisartan; Tetrazoles; Valine; Valsartan | 2008 |
Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy.
Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Creatinine; Diabetic Nephropathies; Double-Blind Method; Female; Half-Life; Humans; Hypertension; Losartan; Male; Middle Aged; Proteinuria; Telmisartan | 2008 |
Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group.
Topics: Administration, Oral; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Enalapril; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Quality of Life; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Safety; Sodium Chloride Symporter Inhibitors; Supine Position; Telmisartan; Treatment Outcome | 1999 |
Comparison of telmisartan with lisinopril in patients with mild-to-moderate hypertension.
Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Cough; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Patient Dropouts; Telmisartan; Time Factors | 1999 |
ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Safety; Telmisartan; Treatment Outcome | 1999 |
A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Female; Humans; Hypertension; Male; Middle Aged; Patient Compliance; Single-Blind Method; Telmisartan; Tetrazoles; Valine; Valsartan | 2000 |
Clinical pharmacology of telmisartan:.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Humans; Hypertension; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Telmisartan | 2000 |
Dose response and safety of telmisartan in patients with mild to moderate hypertension.
Topics: Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome | 2000 |
Combination treatment with telmisartan and hydrochlorothiazide in black patients with mild to moderate hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Black or African American; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Telmisartan | 2001 |
Comparison of 26-week efficacy and tolerability of telmisartan and atenolol, in combination with hydrochlorothiazide as required, in the treatment of mild to moderate hypertension: a randomized, multicenter study.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Benzimidazoles; Benzoates; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Sodium Chloride Symporter Inhibitors; Telmisartan | 2001 |
Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Determination; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Renin; Telmisartan; Water-Electrolyte Imbalance | 2001 |
Inhibitory effect of telmisartan on the blood pressure response to angiotensin II challenge.
Topics: Adult; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Area Under Curve; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Headache; Humans; Hypertension; Male; Plethysmography; Pulse; Telmisartan | 2001 |
Efficacy and tolerability of a fixed-dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapy.
Topics: Adult; Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Canada; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Patient Compliance; Prospective Studies; Telmisartan; Treatment Outcome | 2001 |
Effect of telmisartan on arterial distensibility and central blood pressure in patients with mild to moderate hypertension and Type 2 diabetes mellitus.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Pulsatile Flow; Telmisartan; Treatment Outcome | 2001 |
227 other study(ies) available for telmisartan and Hypertension
| Article | Year |
|---|---|
N-Phenyl indole derivatives as AT1 antagonists with anti-hypertension activities: Design, synthesis and biological evaluation.
Topics: Administration, Oral; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Drug Design; Hypertension; Indoles; Molecular Structure; Rats; Rats, Inbred SHR; Receptors, Angiotensin; Structure-Activity Relationship | 2016 |
Diarrhea and angiotensin II receptor blockers: Is there any difference between the different drugs?
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diarrhea; Female; Humans; Hypertension; Telmisartan | 2022 |
Endothelial MicroRNA-483-3p Is Hypertension-Protective.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Endothelial Cells; Exosomes; Humans; Hypertension; MicroRNAs; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Telmisartan | 2022 |
RP-HPLC method development and validation for simultaneous estimation of telmisartan, rosuvastatin calcium, and amlodipine besylate in combination.
Topics: Amlodipine; Antihypertensive Agents; Chromatography, High Pressure Liquid; Humans; Hypertension; Rosuvastatin Calcium; Telmisartan | 2022 |
Effect of Angiotensin receptor blockade on Plasma Osmolality and Neurohumoral Responses to High Environmental Temperature in Rats Fed a High Salt Diet.
Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Diet; Hypertension; Male; Osmolar Concentration; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Sodium Chloride; Sodium Chloride, Dietary; Telmisartan; Temperature | 2021 |
A new Febuxostat-Telmisartan Drug-Drug Cocrystal for Gout-Hypertension Combination Therapy.
Topics: Combined Modality Therapy; Febuxostat; Gout; Humans; Hypertension; Sodium Chloride; Sodium Chloride, Dietary; Telmisartan | 2022 |
Puerarin ameliorates myocardial remodeling of spontaneously hypertensive rats through inhibiting TRPC6-CaN-NFATc3 pathway.
Topics: Animals; Antihypertensive Agents; Calcineurin; Calmodulin; Cyclosporine; Hypertension; Isoflavones; Male; Myocardium; NFATC Transcription Factors; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Telmisartan; Transforming Growth Factor beta1; Transient Receptor Potential Channels; TRPC Cation Channels; TRPC6 Cation Channel | 2022 |
Financial implications of protocol-based hypertension treatment: an insight into medication costs in public and private health sectors in India.
Topics: Amlodipine; Chlorthalidone; Humans; Hypertension; India; Private Sector; Telmisartan | 2023 |
Population-based discovery and Mendelian randomization analysis identify telmisartan as a candidate medicine for Alzheimer's disease in African Americans.
Topics: Alzheimer Disease; Black or African American; Diabetes Mellitus; Genome-Wide Association Study; Humans; Hypertension; Mendelian Randomization Analysis; Middle Aged; Telmisartan | 2023 |
Heterogenous improvements in endothelial function by sub-blood pressure lowering doses of ARBs result in major anti-aortic root remodeling effects.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzoates; Blood Pressure; Endothelium; Humans; Hypertension; Marfan Syndrome; Telmisartan | 2023 |
Exploring the repurposing potential of telmisartan drug in breast cancer: an in-silico and in-vitro approach.
Topics: Antihypertensive Agents; Benzoates; Breast Neoplasms; Drug Repositioning; Female; Humans; Hypertension; Pharmaceutical Preparations; Telmisartan | 2023 |
Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID-19.
Topics: Antihypertensive Agents; COVID-19; Humans; Hypertension; Losartan; Telmisartan | 2023 |
Pioglitazone and PPAR-γ modulating treatment in hypertensive and type 2 diabetic patients after ischemic stroke: a national cohort study.
Topics: Aged; Antihypertensive Agents; Brain Ischemia; Databases, Factual; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Recurrence; Retrospective Studies; Risk Assessment; Risk Factors; Stroke; Taiwan; Telmisartan; Time Factors; Treatment Outcome | 2020 |
Telmisartan-induced sprue-like enteropathy: a case report.
Topics: Aged, 80 and over; Antihypertensive Agents; Celiac Disease; Female; Follow-Up Studies; Humans; Hypertension; Telmisartan | 2020 |
Telmisartan improves myocardial remodeling by inhibiting leptin autocrine activity and activating PPARγ.
Topics: Animals; Antihypertensive Agents; Autocrine Communication; Hypertension; Leptin; Male; Myocardium; PPAR gamma; Rats; Rats, Sprague-Dawley; Telmisartan; Ventricular Remodeling | 2020 |
The effect of therapy with olmesartan or telmisartan in patients with arterial hypertension combined with obesity.
Topics: Blood Pressure; Humans; Hypertension; Imidazoles; Obesity; Telmisartan; Tetrazoles | 2020 |
Telmisartan Plus S-Amlodipine Single-Pill Combination Therapy is Safe and Effective in Patients with Hypertension from Large-Scale Nationwide Surveillance Data in Korea (NOVEL) Study.
Topics: Amlodipine; Antihypertensive Agents; Benzoates; Blood Pressure; Drug Combinations; Drug Therapy, Combination; Humans; Hypertension; Republic of Korea; Telmisartan; Treatment Outcome | 2021 |
Zinc complexation improves angiotensin II receptor type 1 blockade and
Topics: Animals; Antihypertensive Agents; Arteries; Calcium; Cell Line; Coordination Complexes; Disease Models, Animal; Humans; Hypertension; Male; Protein Binding; Rats, Wistar; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Telmisartan; Transfection; Zinc | 2021 |
Countering adipose tissue dysfunction could underlie the superiority of telmisartan in the treatment of obesity-related hypertension.
Topics: Adiposity; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Biomarkers; Blood Pressure; Disease Models, Animal; Hypertension; Intra-Abdominal Fat; Kidney; Male; Obesity; Rats, Wistar; Telmisartan | 2021 |
The Impact of Telmisartan on Cardiometabolic Risk Factors in Hypertensive Male Siblings of Women With Polycystic Ovary Syndrome.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Blood Glucose; Blood Pressure; Body Weights and Measures; C-Reactive Protein; Cardiometabolic Risk Factors; Cardiovascular Diseases; Female; Humans; Hypertension; Insulin Resistance; Lipids; Male; Middle Aged; Polycystic Ovary Syndrome; Siblings; Telmisartan; Testosterone | 2021 |
Telmisartan Attenuates the Growth of Epithelium-like Cells and Glomerular Injury in Spontaneously Hypertensive Rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Epithelium; Humans; Hypertension; Hypertension, Renal; Kidney; Nephritis; Rats; Rats, Inbred SHR; Telmisartan | 2021 |
Telmisartan use and risk of dementia in type 2 diabetes patients with hypertension: A population-based cohort study.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Asian People; Cohort Studies; Dementia; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Male; Taiwan; Telmisartan | 2021 |
Revealing new therapeutic opportunities in hypertension through network-driven integrative genetic analysis and drug target prediction approach.
Topics: Antihypertensive Agents; Drug Development; Gene Expression Profiling; Gene Regulatory Networks; High-Throughput Screening Assays; Humans; Hypertension; Kininogens; Limonins; MicroRNAs; Models, Molecular; Molecular Docking Simulation; Protein Interaction Maps; Telmisartan; Transcription Factors | 2021 |
Enhanced Mitochondrial Transient Receptor Potential Channel, Canonical Type 3-Mediated Calcium Handling in the Vasculature From Hypertensive Rats.
Topics: Adenosine Triphosphate; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium; Calcium Signaling; Cells, Cultured; Disease Models, Animal; Energy Metabolism; Hypertension; Male; Mice, Knockout; Mitochondria; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxidation-Reduction; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Telmisartan; Time Factors; TRPC Cation Channels; Up-Regulation; Vasoconstriction | 2017 |
Telmisartan improves vascular remodeling through ameliorating prooxidant and profibrotic mechanisms in hypertension via the involvement of transforming growth factor-β1.
Topics: Antioxidants; Aorta, Thoracic; Benzimidazoles; Benzoates; Collagen Type I; Fibrosis; Gene Expression Regulation; Hypertension; Oxidants; Oxidative Stress; Reactive Oxygen Species; Smad3 Protein; Telmisartan; Transforming Growth Factor beta1; Vascular Remodeling | 2017 |
Assessment of preclinical pharmacokinetics and acute toxicity of pioglitazone and telmisartan combination.
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Diabetes Mellitus; Drug Therapy, Combination; Humans; Hypertension; Hypoglycemic Agents; Insulin; Male; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; Telmisartan; Thiazolidinediones | 2017 |
Comparison of Observational Data and the ONTARGET Results for Telmisartan Treatment of Hypertension: Bull's-eye or Painting the Target Around the Arrow?
Topics: Antihypertensive Agents; Humans; Hypertension; Telmisartan; Tomography, Emission-Computed, Single-Photon | 2018 |
Pulsus alternans induced by spinal anesthesia.
Topics: Anesthesia, Spinal; Angiotensin II Type 1 Receptor Blockers; Female; Heart Rate; Humans; Hypertension; Knee Joint; Middle Aged; Orthopedic Procedures; Oximetry; Pain, Postoperative; Stroke Volume; Telmisartan | 2018 |
Successful management of proteinuria and systemic hypertension in a dog with renal cell carcinoma with surgery, telmisartan, and amlodipine.
Topics: Amlodipine; Animals; Antihypertensive Agents; Carcinoma, Renal Cell; Dog Diseases; Dogs; Hypertension; Kidney Neoplasms; Male; Nephroureterectomy; Proteinuria; Telmisartan | 2018 |
Acute toxic effects of telmisartan in spontaneously hypertensive rats fed a high fructose diet.
Topics: Animals; Antihypertensive Agents; Dietary Sugars; Fructose; Gastrointestinal Tract; Hypertension; Male; Rats; Rats, Inbred SHR; Rats, Wistar; Telmisartan | 2018 |
The effect of short-term perindopril and telmisartan treatment on circulating levels of anti-inflammatory cytokines in hypertensive patients.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Antihypertensive Agents; Cytokines; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Telmisartan | 2018 |
Effects of UGT1A1 Polymorphism, Gender and Triglyceride on the Pharmacokinetics of Telmisartan in Chinese Patients with Hypertension: A Population Pharmacokinetic Analysis.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Asian People; Blood Pressure; Female; Genotype; Glucuronosyltransferase; Humans; Hypertension; Male; Middle Aged; Polymorphism, Single Nucleotide; Telmisartan | 2019 |
Tissue-specific peroxisome proliferator activated receptor gamma expression and metabolic effects of telmisartan.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Glucose; Disease Models, Animal; Hypertension; Insulin Resistance; Mice; Mice, Knockout; PPAR gamma; Telmisartan | 2013 |
Etoricoxib attenuates effect of antihypertensives in a rodent model of DOCA-salt induced hypertension.
Topics: Animals; Antihypertensive Agents; Atenolol; Benzimidazoles; Benzoates; Blood Pressure; Cyclooxygenase 2 Inhibitors; Desoxycorticosterone Acetate; Disease Models, Animal; Etoricoxib; Hypertension; Mineralocorticoids; Pyridines; Ramipril; Rats; Rats, Sprague-Dawley; Sodium Chloride; Sulfones; Telmisartan | 2013 |
Impact of telmisartan on the inflammatory state in patients with coronary atherosclerosis--influence on IP-10, TNF-α and MCP-1.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atherosclerosis; Benzimidazoles; Benzoates; Blood Pressure; Chemokine CCL2; Chemokine CXCL10; Coronary Artery Disease; Female; Humans; Hypertension; Inflammation; Interleukin-6; Male; Middle Aged; Telmisartan; Tumor Necrosis Factor-alpha | 2013 |
Administration of telmisartan reduced systolic blood pressure and oxidative stress probably through the activation of PI3K/Akt/eNOS pathway and NO release in spontaneously hypertensive rats.
Topics: AMP-Activated Protein Kinases; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Enzyme Activation; Hypertension; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Superoxide Dismutase; Telmisartan; Time Factors | 2013 |
Ambulatory central blood pressure: a new opportunity for mechanistic and clinical cardiovascular research.
Topics: Amides; Aorta, Thoracic; Benzimidazoles; Benzoates; Blood Pressure; Brachial Artery; Circadian Rhythm; Female; Fumarates; Humans; Hypertension; Male; Telmisartan | 2013 |
Telmisartan exerts pleiotropic effects in endothelial cells and promotes endothelial cell quiescence and survival.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Apoptosis; Benzimidazoles; Benzoates; Blood Proteins; Cell Cycle Proteins; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Combinations; Endothelial Cells; Enzyme Inhibitors; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Hypertension; Ketocholesterols; Oligonucleotide Array Sequence Analysis; Proto-Oncogene Proteins c-akt; Signal Transduction; Telmisartan | 2013 |
Lower, faster, better: the delusions of surrogate markers in hypertension.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Drug Combinations; Female; Humans; Hypertension; Male; Telmisartan | 2013 |
[Effect of RAAS antagonist on the expression of gap junction cx43 in myocardium of spontaneously hypertensive rat].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Connexin 43; Eplerenone; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Ramipril; Rats; Rats, Inbred SHR; Rats, Wistar; Renin-Angiotensin System; Spironolactone; Telmisartan | 2013 |
Telmisartan delays myocardial fibrosis in rats with hypertensive left ventricular hypertrophy by TGF-β1/Smad signal pathway.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blotting, Western; Collagen; Echocardiography; Fibrosis; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Telmisartan; Transforming Growth Factor beta1 | 2014 |
Telmisartan reduces mortality and left ventricular hypertrophy with sympathoinhibition in rats with hypertension and heart failure.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biphenyl Compounds; Heart Failure; Hypertension; Hypertrophy, Left Ventricular; Medulla Oblongata; Norepinephrine; Rats; Rats, Inbred SHR; Reactive Oxygen Species; Telmisartan; Tetrazoles; Ventricular Function, Left | 2014 |
Comparative effect of angiotensin II type I receptor blockers on serum uric acid in hypertensive patients with type 2 diabetes mellitus: a retrospective observational study.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Biphenyl Compounds; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Imidazoles; Logistic Models; Losartan; Male; Middle Aged; Multivariate Analysis; Olmesartan Medoxomil; Retrospective Studies; Telmisartan; Tetrazoles; Treatment Outcome; Uric Acid; Valine; Valsartan | 2013 |
Metoprolol restores expression and vasodilatation function of AT2R in spontaneously hypertensive rats.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Hypertension; Imidazoles; Male; Metoprolol; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 2; Renin; Renin-Angiotensin System; Telmisartan; Vasodilation | 2014 |
Factors associated with changes in retinal microcirculation after antihypertensive treatment.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Arterioles; Benzimidazoles; Benzoates; Blood Pressure; Drug Combinations; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Logistic Models; Male; Microcirculation; Middle Aged; Retinal Vessels; Telmisartan | 2014 |
Telmisartan protects against vascular dysfunction with peroxisome proliferator-activated receptor-γ activation in hypertensive 5/6 nephrectomized rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Aorta; Benzimidazoles; Benzoates; Blood Pressure; Disease Models, Animal; Drug Partial Agonism; Endothelium, Vascular; Hypertension; Losartan; Male; Nitric Oxide Synthase Type III; PPAR gamma; Rats; Rats, Wistar; Telmisartan; Vasodilation | 2013 |
Chronic blockade of angiotensin AT₁ receptors improves cardinal symptoms of metabolic syndrome in diet-induced obesity in rats.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Obesity Agents; Antihypertensive Agents; Behavior, Animal; Benzimidazoles; Benzoates; Diet, High-Fat; Dietary Sucrose; Drug Therapy, Combination; Energy Intake; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Insulin Resistance; Leptin; Male; Metabolic Syndrome; Obesity; Random Allocation; Rats; Rats, Inbred SHR; Telmisartan; Weight Gain | 2014 |
Single-pill combination of telmisartan and hydrochlorothiazide: studies and pooled analyses of earlier hypertension treatment.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Databases, Factual; Diuretics; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Retrospective Studies; Telmisartan; Treatment Outcome | 2014 |
Examining the association of olmesartan and other angiotensin receptor blockers with overall and cause-specific mortality.
Topics: Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Cardiovascular Diseases; Cohort Studies; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Male; Middle Aged; Proportional Hazards Models; Registries; Retrospective Studies; Survival Rate; Taiwan; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2014 |
Pharmacokinetic-pharmacodynamic model of the antihypertensive interaction between telmisartan and hydrochlorothiazide in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Drug Interactions; Drug Therapy, Combination; Hydrochlorothiazide; Hypertension; Male; Rats; Rats, Inbred SHR; Telmisartan | 2014 |
Protective effect of telmisartan against progressive oxidative brain damage and synuclein phosphorylation in stroke-resistant spontaneously hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Pressure; Brain; Hypertension; Neuroprotective Agents; Oxidative Stress; Phosphorylation; Rats; Rats, Inbred SHR; Rats, Wistar; Reactive Oxygen Species; Synucleins; Telmisartan | 2014 |
Telmisartan improves survival and ventricular function in SHR rats with extensive cardiovascular damage induced by dietary salt excess.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Body Weight; Diastole; Disease Models, Animal; Hypertension; Hypertrophy, Left Ventricular; Male; Random Allocation; Rats, Inbred SHR; Sodium, Dietary; Telmisartan; Ventricular Dysfunction | 2014 |
[Effects of telmisartan on IKCa1 potassium channel after T-lymphocyte activation and proliferation in peripheral blood of hypertensive patients in Xinjiang Kazakh].
Topics: Benzimidazoles; Benzoates; Cells, Cultured; Female; Humans; Hypertension; Intermediate-Conductance Calcium-Activated Potassium Channels; Lymphocyte Activation; Male; Middle Aged; T-Lymphocytes; Telmisartan | 2014 |
Impact of antihypertensive combination and monotreatments on blood pressure variability: assessment by old and new indices. Data from a large ambulatory blood pressure monitoring database.
Topics: Adult; Aged; Algorithms; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Clinical Trials as Topic; Databases, Factual; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Reproducibility of Results; Severity of Illness Index; Telmisartan; Treatment Outcome | 2014 |
Angiotensin receptor blockers - advantages of the new sartans.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Atherosclerosis; Benzimidazoles; Benzoates; Cardiovascular Diseases; Humans; Hypertension; Imidazoles; Olmesartan Medoxomil; Oxadiazoles; Telmisartan; Tetrazoles; Treatment Outcome | 2013 |
Telmisartan reduces progressive oxidative stress and phosphorylated α-synuclein accumulation in stroke-resistant spontaneously hypertensive rats after transient middle cerebral artery occlusion.
Topics: Aldehydes; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Pressure; Brain; Glycation End Products, Advanced; Hypertension; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Oxidative Stress; Phosphorylation; Rats; Rats, Inbred SHR; Rats, Wistar; Synucleins; Telmisartan | 2014 |
Are the effects of telmisartan more marked in hypertensive patients?
Topics: Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Cardiovascular System; Female; Humans; Hypertension; Male; Telmisartan | 2014 |
Antihypertensive agents acting on the renin-angiotensin system and the risk of sepsis.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Case-Control Studies; Databases, Factual; Female; Humans; Hypertension; Male; Renin-Angiotensin System; Retrospective Studies; Risk; Sepsis; Severity of Illness Index; Telmisartan; United Kingdom | 2014 |
Telmisartan exerts sustained blood pressure control and reduces blood pressure variability in metabolic syndrome by inhibiting sympathetic activity.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Autonomic Nervous System; Baroreflex; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Determination; Circadian Rhythm; Disease Models, Animal; Equipment Design; Hypertension; Metabolic Syndrome; Rats; Rats, Inbred SHR; Telemetry; Telmisartan | 2014 |
Blood pressure control and satisfaction of hypertensive patients following a switch to combined drugs of an angiotensin receptor blocker and a calcium channel blocker in clinical practice of nephrology.
Topics: Aged; Amlodipine; Angiotensin Receptor Antagonists; Azetidinecarboxylic Acid; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Drug Combinations; Drug Costs; Drug Substitution; Female; Humans; Hypertension; Imidazoles; Male; Medication Adherence; Middle Aged; Nephrology; Patient Satisfaction; Practice Patterns, Physicians'; Renal Insufficiency, Chronic; Retrospective Studies; Surveys and Questionnaires; Telmisartan; Tetrazoles; Valsartan | 2015 |
TRPC1, CaN and NFATC3 signaling pathway in the pathogenesis and progression of left ventricular hypertrophy in spontaneously hypertensive rats.
Topics: Amlodipine; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Disease Models, Animal; Disease Progression; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Male; NFATC Transcription Factors; Rats; Rats, Inbred SHR; Signal Transduction; Telmisartan; TRPC Cation Channels | 2015 |
Arterial stiffness in atherosclerotic renovascular hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Aorta; Atherosclerosis; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Determination; Essential Hypertension; Female; Humans; Hypertension; Hypertension, Renovascular; Longitudinal Studies; Male; Middle Aged; Pulse Wave Analysis; Renin-Angiotensin System; Risk Factors; Stents; Telmisartan; Vascular Stiffness | 2014 |
Short-term use of telmisartan attenuates oxidation and improves Prdx2 expression more than antioxidant β-blockers in the cardiovascular systems of spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Antioxidants; Aorta; Benzimidazoles; Benzoates; Blood Pressure; Heart; Hypertension; Kidney; Malondialdehyde; Myocardium; Oxidative Stress; Peroxiredoxins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Superoxides; Telmisartan | 2015 |
A quest--halting the progression of autosomal dominant polycystic kidney disease.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Female; Humans; Hypertension; Kidney; Lisinopril; Male; Polycystic Kidney, Autosomal Dominant; Telmisartan | 2014 |
Recent clinical trials.
Topics: Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypertension; Ramipril; Randomized Controlled Trials as Topic; Telmisartan | 2014 |
Safety of olmesartan in a patient with telmisartan-induced myotoxicity: a case report.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Drug Substitution; Drug Therapy, Combination; Humans; Hypertension; Imidazoles; Male; Middle Aged; Myalgia; Telmisartan; Tetrazoles; Treatment Outcome | 2015 |
Single-pill combination therapy in the initial treatment of marked hypertension: a propensity-matched analysis.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Dihydropyridines; Dose-Response Relationship, Drug; Drug Combinations; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Perindopril; Propensity Score; Ramipril; Retrospective Studies; Risk Factors; Telmisartan; Tetrazoles | 2015 |
Long-term use of angiotensin II receptor antagonists and calcium-channel antagonists in Algerian hypertensive patients: effects on metabolic and oxidative parameters.
Topics: Algeria; Amlodipine; Angiotensin Receptor Antagonists; Benzimidazoles; Benzoates; Calcium Channel Blockers; Female; Humans; Hypertension; Male; Middle Aged; Oxidative Stress; Telmisartan | 2015 |
Neurovascular protection by telmisartan via reducing neuroinflammation in stroke-resistant spontaneously hypertensive rat brain after ischemic stroke.
Topics: Acetylglucosamine; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Carrier Proteins; Cerebral Cortex; Collagen Type IV; Disease Models, Animal; Encephalitis; Glial Fibrillary Acidic Protein; Hypertension; Infarction, Middle Cerebral Artery; Inflammasomes; Male; Matrix Metalloproteinase 9; Neuroprotective Agents; NLR Family, Pyrin Domain-Containing 3 Protein; Rats, Inbred SHR; Telmisartan; Time Factors | 2015 |
Systolic blood pressure variation and mean heart rate is associated with cognitive dysfunction in patients with high cardiovascular risk.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Cognition Disorders; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Rate; Humans; Hypertension; Incidence; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Ramipril; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Telmisartan | 2015 |
Protective effect of telmisartan on neurovascular unit and inflammasome in stroke-resistant spontaneously hypertensive rats.
Topics: Aging; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Benzimidazoles; Benzoates; Carrier Proteins; Cerebral Cortex; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Glial Fibrillary Acidic Protein; Hypertension; Immunohistochemistry; Inflammasomes; Male; Matrix Metalloproteinase 9; Neurovascular Coupling; NLR Family, Pyrin Domain-Containing 3 Protein; Rats, Inbred SHR; Rats, Wistar; Telmisartan | 2015 |
Novel oral formulation approach for poorly water-soluble drug using lipocalin-type prostaglandin D synthase.
Topics: Administration, Oral; Amino Acid Substitution; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Chemistry, Pharmaceutical; Digestion; Drug Delivery Systems; Drug Liberation; Enzyme Stability; Excipients; Feasibility Studies; Humans; Hypertension; Intramolecular Oxidoreductases; Lipocalins; Male; Mutant Proteins; Powders; Protein Conformation; Random Allocation; Rats, Inbred SHR; Recombinant Proteins; Solubility; Telmisartan | 2015 |
Postnatal acute renal failure after fetal exposure to angiotensin receptor blockers.
Topics: Acute Kidney Injury; Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Female; Humans; Hypertension; Infant, Newborn; Male; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Exposure Delayed Effects; Telmisartan | 2015 |
Telmisartan reduces atrial arrhythmia susceptibility through the regulation of RAS-ERK and PI3K-Akt-eNOS pathways in spontaneously hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Apoptosis; Arrhythmias, Cardiac; Atrial Remodeling; Benzimidazoles; Benzoates; Blood Pressure; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Heart Rate; Hypertension; Male; Myocytes, Cardiac; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; ras Proteins; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Telmisartan; Time Factors; Valsartan | 2015 |
The pharmacokinetic-pharmacodynamic model of telmisartan and hydrochlorothiazide on blood pressure and plasma potassium after long-term administration in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Determination; Disease Models, Animal; Drug Therapy, Combination; Hydrochlorothiazide; Hypertension; Male; Potassium; Rats; Rats, Inbred SHR; Telmisartan | 2015 |
Hyperpigmentation Induced by Combination Therapy With Telmisartan-Hydrochlorothiazide.
Topics: Aged; Benzimidazoles; Benzoates; Blood Pressure; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hyperpigmentation; Hypertension; Male; Skin; Telmisartan | 2016 |
The renoprotective effect of shichimotsukokato on hypertension-induced renal dysfunction in spontaneously hypertensive rats.
Topics: Albumins; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Chloride Channels; Hypertension; Kidney; Medicine, Kampo; Phytotherapy; Plant Extracts; Rats, Inbred SHR; Rats, Inbred WKY; Telmisartan | 2016 |
Application and validation of superior spectrophotometric methods for simultaneous determination of ternary mixture used for hypertension management.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Drug Combinations; Hydrochlorothiazide; Hypertension; Spectrophotometry; Tablets; Telmisartan | 2016 |
Influence of G-protein β-Polypeptide 3 C825T Polymorphism on Antihypertensive Response to Telmisartan and Amlodipine in Chinese Patients.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Essential Hypertension; Female; Genotype; Heterotrimeric GTP-Binding Proteins; Humans; Hypertension; Male; Middle Aged; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Telmisartan | 2016 |
The velocity of antihypertensive effects of seven angiotensin II receptor blockers determined by home blood pressure measurements.
Topics: Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Blood Pressure Determination; Female; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Male; Middle Aged; Oxadiazoles; Self Care; Telmisartan; Tetrazoles; Time Factors; Valsartan | 2016 |
TLR4/MyD88/NF-κB signaling and PPAR-γ within the paraventricular nucleus are involved in the effects of telmisartan in hypertension.
Topics: Animals; Antihypertensive Agents; Arterial Pressure; Benzimidazoles; Benzoates; Cardiomegaly; Cytokines; Hypertension; Male; Myeloid Differentiation Factor 88; NF-kappa B; Nitric Oxide Synthase Type II; Norepinephrine; Paraventricular Hypothalamic Nucleus; PPAR gamma; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Telmisartan; Toll-Like Receptor 4 | 2016 |
Telmisartan-mediated metabolic profile conferred brain protection in diabetic hypertensive rats as evidenced by magnetic resonance imaging, behavioral studies and histology.
Topics: Animals; Behavior, Animal; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Brain; Cognition; Diabetes Mellitus, Type 2; Hypertension; Magnetic Resonance Imaging; Maze Learning; Metabolome; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Telmisartan | 2016 |
Bone mineral density is reduced by telmisartan in male spontaneously hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Bone Density; Exercise Test; Hypertension; Male; Physical Conditioning, Animal; Rats; Rats, Inbred SHR; Telmisartan | 2016 |
Role of acetazolamide and telmisartan/nifedipine-GITS combination in antagonizing the blood pressure rise induced by high altitude exposure.
Topics: Acetazolamide; Altitude; Altitude Sickness; Benzimidazoles; Benzoates; Blood Pressure; Gastrointestinal Tract; Humans; Hypertension; Nifedipine; Telmisartan | 2016 |
Inhibitory effects of telmisartan on culture and proliferation of and Kv1.3 potassium channel expression in peripheral blood CD4+ T lymphocytes from Xinjiang Kazakh patients with hypertension.
Topics: Benzimidazoles; Benzoates; Blotting, Western; Case-Control Studies; CD4-Positive T-Lymphocytes; Cell Proliferation; Cell Shape; Cells, Cultured; China; Demography; Ethnicity; Female; Humans; Hypertension; Interleukin-17; Interleukin-6; Kv1.3 Potassium Channel; Lymphocyte Count; Male; Middle Aged; RNA, Messenger; Telmisartan | 2016 |
Are diuretic additives fit for uncontrolled hypertensive patients receiving telmisartan and amlodipine treatment?
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diuretics; Drug Combinations; Humans; Hypertension; Telmisartan; Treatment Outcome | 2017 |
Telmisartan-induced lichen planus eruption manifested on vitiliginous skin.
Topics: Adult; Antihypertensive Agents; Benzimidazoles; Benzoates; Humans; Hypertension; Lichen Planus; Male; Pruritus; Telmisartan; Vitiligo | 2017 |
ONTARGET: questions asked, questions answered.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Hypertension; Multicenter Studies as Topic; Ramipril; Randomized Controlled Trials as Topic; Telmisartan; Treatment Outcome | 2008 |
A stunning day in hypertension research - Results of ONTARGET, ACCOMPLISH and HYVET.
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Benzimidazoles; Benzoates; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Ramipril; Telmisartan | 2008 |
[Treatment of patients at high cardiovascular risk: confirmation and surprising results of the ONTARGET-Study].
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Ramipril; Randomized Controlled Trials as Topic; Risk Factors; Telmisartan | 2008 |
Effect of the angiotensin II receptor antagonist telmisartan on lipoprotein lipase mass in preheparin serum.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Female; Heparin; Humans; Hypertension; Lipoprotein Lipase; Male; Middle Aged; Multivariate Analysis; PPAR gamma; Risk Factors; Telmisartan | 2008 |
Pemphigus foliaceus induced by an angiotensin II receptor blocker.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Biphenyl Compounds; Female; Humans; Hypertension; Immunosuppressive Agents; Pemphigus; Prednisolone; Telmisartan; Tetrazoles | 2008 |
Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering?
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Clinical Trials, Phase IV as Topic; Drug Therapy, Combination; Humans; Hypertension; Ramipril; Randomized Controlled Trials as Topic; Stroke; Telmisartan; Treatment Outcome | 2008 |
Increased transient receptor potential canonical type 3 channels in vasculature from hypertensive rats.
Topics: Amlodipine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Benzimidazoles; Benzoates; Blood Pressure; Calcium; Calcium Channel Blockers; Cells, Cultured; Gene Expression Regulation; Hypertension; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Telmisartan; TRPC Cation Channels; Vasoconstrictor Agents | 2009 |
Telmisartan to prevent recurrent stroke: the PRoFESS study: was the baby thrown out with the bathwater?
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Humans; Hypertension; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Telmisartan; Treatment Outcome | 2009 |
Renal vascular endothelial function in hypertensive patients with type 2 diabetes mellitus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Male; Middle Aged; Nitric Oxide; p-Aminohippuric Acid; Ramipril; Renal Plasma Flow; Telmisartan; Vascular Resistance | 2009 |
Telmisartan for prevention of cardiovascular events.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Diabetes Complications; Humans; Hypertension; Secondary Prevention; Stroke; Telmisartan | 2009 |
Telmisartan for prevention of cardiovascular events.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Cerebral Hemorrhage; Humans; Hypertension; Secondary Prevention; Stroke; Telmisartan | 2009 |
Telmisartan for prevention of cardiovascular events.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Humans; Hypertension; Secondary Prevention; Stroke; Telmisartan | 2009 |
ONTARGET, TRANSCEND and PROFESS--clarifying, confusing or misleading?
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Clinical Trials as Topic; Comorbidity; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Ischemia; Ramipril; Renal Insufficiency; Risk; Stroke; Telmisartan; Treatment Outcome | 2009 |
Telmisartan decreases plasma levels of asymmetrical dimethyl-L-arginine and improves lipid and glucose metabolism and vascular function.
Topics: Administration, Oral; Aged; Angiotensin II Type 1 Receptor Blockers; Arginine; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Cholesterol, LDL; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Humans; Hypertension; Male; Nitric Oxide Synthase Type III; PPAR gamma; Telmisartan; Treatment Outcome | 2009 |
[The ONTARGET trial].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Humans; Hypertension; Ramipril; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Research Design; Risk Factors; Telmisartan; Treatment Outcome | 2009 |
Evaluation of safety and efficacy of telmisartan-amlodipine combination in treating hypertension.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Diabetes Complications; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Product Surveillance, Postmarketing; Prospective Studies; Telmisartan; Treatment Outcome | 2008 |
Introduction: Reducing cardiovascular risk: ONTARGET--a new standard in cardiovascular protection.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Humans; Hypertension; Ramipril; Renin-Angiotensin System; Risk Factors; Telmisartan | 2009 |
Clinical evidence from ONTARGET: the value of an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Ramipril; Retrospective Studies; Risk Factors; Telmisartan | 2009 |
Cardiovascular protection: a breakthrough for high-risk patients?
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Hypertension; Ramipril; Renin-Angiotensin System; Risk Factors; Telmisartan | 2009 |
Effect of switching from amlodipine to combination therapy with telmisartan and low-dose hydrochlorothiazide.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Body Mass Index; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome; Uric Acid | 2009 |
The role of peroxisome proliferator-activated receptor gamma in blood pressure regulation.
Topics: Adipocytes; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Endothelium; Hypertension; Models, Animal; Myocytes, Cardiac; Myocytes, Smooth Muscle; PPAR gamma; Telmisartan; Thiazolidinediones | 2009 |
AT(1) receptor blockers increase insulin-like growth factor-I production by stimulating sensory neurons in spontaneously hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Pressure; Calcitonin Gene-Related Peptide; Capsaicin; Cells, Cultured; Ganglia, Spinal; Hypertension; Imidazoles; Insulin-Like Growth Factor I; Kidney; Losartan; Male; Myocardium; Nifedipine; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; RNA, Messenger; Sensory Receptor Cells; Telmisartan; Tetrazoles; Valine; Valsartan; Vasodilator Agents | 2009 |
Increased rhythmicity in hypertensive arterial smooth muscle is linked to transient receptor potential canonical channels.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Arterioles; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Boron Compounds; Calcium; Calcium Channels; Hypertension; Imidazoles; In Vitro Techniques; Muscle, Smooth, Vascular; Norepinephrine; Periodicity; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Telmisartan; Tetrazoles; TRPC Cation Channels; Verapamil | 2010 |
High-salt diet increases plasma adiponectin levels independent of blood pressure in hypertensive rats: the role of the renin-angiotensin-aldosterone system.
Topics: Adiponectin; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Clonidine; Eplerenone; Hydralazine; Hypertension; Male; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Sodium Chloride, Dietary; Spironolactone; Telmisartan | 2010 |
[Arterial hypertension and type 2 diabetes mellitus: clinical evaluation of hemodynamic characteristics, possibility of correction].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure Monitoring, Ambulatory; Diabetes Mellitus, Type 2; Diastole; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Myocardial Contraction; Telmisartan; Treatment Outcome; Ultrasonography; Ventricular Dysfunction, Left | 2009 |
Questioning the efficacy of antihypertensive therapy by ambulatory blood pressure monitoring in the primary care setting.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure Monitoring, Ambulatory; Clinical Trials, Phase IV as Topic; Female; Humans; Hypertension; Male; Middle Aged; Primary Health Care; Prospective Studies; Telmisartan | 2009 |
Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activation.
Topics: Adiponectin; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Pressure; Humans; Hyperglycemia; Hypertension; Insulin; Insulin Resistance; Leptin; PPAR gamma; Rats; Rats, Inbred SHR; Rosiglitazone; Telmisartan; Thiazolidinediones; Tumor Necrosis Factor-alpha; Weight Gain | 2010 |
New drug information: Twynsta 40 mg/5mg.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Drug Combinations; Humans; Hypertension; Telmisartan | 2010 |
Beneficial effect of combination therapy comprising angiotensin II receptor blocker plus calcium channel blocker on plasma adiponectin levels.
Topics: Adiponectin; Age Factors; Aged; Angiotensin II Type 1 Receptor Blockers; Azetidinecarboxylic Acid; Benzimidazoles; Benzoates; Calcium Channel Blockers; Cohort Studies; Dihydropyridines; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Retrospective Studies; Sex Characteristics; Telmisartan | 2010 |
Citrus limetta leaves extract antagonizes the hypertensive effect of angiotensin II.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Citrus; Clinical Trials as Topic; Dosage Forms; Humans; Hypertension; Male; Mexico; Mice; Mice, Inbred ICR; Plant Leaves; Random Allocation; Telmisartan | 2010 |
Effects of telmisartan on office and 24-hour ambulatory blood pressure: an observational study in hypertensive patients managed in primary care.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Primary Health Care; Prospective Studies; Telmisartan | 2010 |
A third amlodipine/ARB combination (Twynsta) for hypertension.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Drug Combinations; Humans; Hypertension; Telmisartan; Treatment Outcome | 2010 |
Possible mechanisms of left ventricular torsion evaluated by cardioreparative effects of telmisartan in patients with hypertension.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Echocardiography; Feasibility Studies; Female; Fibrosis; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Statistics as Topic; Stroke Volume; Telmisartan; Ventricular Function, Left | 2010 |
Alterations of insulin resistance and the serum adiponectin level in patients with type 2 diabetes mellitus under the usual antihypertensive dosage of telmisartan treatment.
Topics: Adiponectin; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hypertension; Insulin Resistance; Male; Middle Aged; Prospective Studies; Telmisartan; Treatment Outcome | 2010 |
New data on ONTARGET: more confusion?
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Drug Therapy, Combination; Heart Failure; Humans; Hypertension; Multicenter Studies as Topic; Ramipril; Randomized Controlled Trials as Topic; Telmisartan | 2010 |
Angiotensin AT1 receptor antagonists enhance the anticonvulsant action of valproate in the mouse model of maximal electroshock.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anticonvulsants; Behavior, Animal; Benzimidazoles; Benzoates; Brain; Disease Models, Animal; Drug Synergism; Electroshock; Hypertension; Losartan; Male; Mice; Receptor, Angiotensin, Type 1; Seizures; Telmisartan; Valproic Acid | 2010 |
Significant hyperkalemia and hyponatremia secondary to telmisartan/hydrochlorothiazide treatment.
Topics: Aged; Benzimidazoles; Benzoates; Blood Pressure; Drug Combinations; Humans; Hydrochlorothiazide; Hyperkalemia; Hypertension; Hyponatremia; Male; Renin-Angiotensin System; Telmisartan | 2010 |
Long-term effects of telmisartan on blood pressure, the renin-angiotensin-aldosterone system, and lipids in hypertensive patients.
Topics: Aged; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atrial Natriuretic Factor; Benzimidazoles; Benzoates; Biomarkers; Blood Pressure; Cholesterol; Drug Administration Schedule; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Peptidyl-Dipeptidase A; Prospective Studies; Renin; Renin-Angiotensin System; Telmisartan; Time Factors; Treatment Outcome; Triglycerides | 2010 |
Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by telmisartan-hydrochlorothiazide.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Drug Combinations; Drug Eruptions; Exanthema; Female; Glucocorticoids; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Telmisartan; Treatment Outcome; Withholding Treatment | 2010 |
Administration-time-dependent effects of spirapril on ambulatory blood pressure in uncomplicated essential hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cardiovascular Diseases; Enalapril; Female; Half-Life; Humans; Hypertension; Hypotension; Male; Middle Aged; Receptors, Angiotensin; Renin-Angiotensin System; Risk; Telmisartan | 2010 |
Reduced cerebrovascular remodeling and functional impairment in spontaneously hypertensive rats following combined treatment with suboptimal doses of telmisartan and ramipril: is less really more?
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Brain Ischemia; Cerebral Arteries; Drug Therapy, Combination; Hypertension; Male; Ramipril; Random Allocation; Rats; Rats, Inbred SHR; Telmisartan; Vasodilation | 2010 |
Effects of suboptimal doses of the AT1 receptor blocker, telmisartan, with the angiotensin-converting enzyme inhibitor, ramipril, on cerebral arterioles in spontaneously hypertensive rat.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arterioles; Benzimidazoles; Benzoates; Blood Pressure; Cerebrovascular Circulation; Drug Therapy, Combination; Hypertension; Male; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Telmisartan | 2010 |
Drug synergism of antihypertensive action in combination of telmisartan with lercanidipine in spontaneous hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Drug Synergism; Heart Rate; Hypertension; Kinetics; Male; Random Allocation; Rats; Rats, Inbred SHR; Statistics as Topic; Telmisartan | 2010 |
Unique "delta lock" structure of telmisartan is involved in its strongest binding affinity to angiotensin II type 1 receptor.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Cattle; Crystallography, X-Ray; Humans; Hypertension; Models, Molecular; Receptor, Angiotensin, Type 1; Telmisartan | 2011 |
[Fixed combination of telmisartan and amlodipine. Lowering blood pressure with dual power].
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Germany; Humans; Hypertension; Medication Adherence; Telmisartan | 2010 |
Telmisartan improves insulin resistance in patients with low cytokine levels.
Topics: Adult; Benzimidazoles; Benzoates; Biomarkers; Blood Glucose; Cytokines; Female; Humans; Hypertension; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Telmisartan | 2011 |
Synergism of telmisartan and amlodipine on blood pressure reduction and cardiorenal protection in hypertensive rats.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Cardiotonic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Hypertension; Kidney; Kidney Diseases; Kidney Glomerulus; Male; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Telmisartan; Time Factors | 2011 |
Telmisartan lowers home blood pressure and improves insulin resistance without correlation between their changes.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Humans; Hypertension; Insulin; Insulin Resistance; Lipids; Middle Aged; Telmisartan | 2011 |
Telmisartan provides better renal protection than valsartan in a rat model of metabolic syndrome.
Topics: Angiotensin II Type 2 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Pressure; Body Weight; Dietary Fats; Disease Models, Animal; Hypertension; Kidney Diseases; Male; Metabolic Syndrome; PPAR gamma; Rats; Rats, Inbred SHR; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2011 |
The therapeutic potential of G-CSF in pressure overload induced ventricular reconstruction and heart failure in mice.
Topics: Animals; Benzimidazoles; Benzoates; Blotting, Western; Carotid Arteries; Constriction; DNA Primers; Echocardiography; Granulocyte Colony-Stimulating Factor; Heart Failure; Hypertension; Hypertrophy, Left Ventricular; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Mice, Inbred C57BL; Microtubules; Reverse Transcriptase Polymerase Chain Reaction; Telmisartan; Vascular Endothelial Growth Factor A | 2012 |
Emerging benefits of AT1 receptor antagonists with pleiotropic anti-inflammatory activity.
Topics: Animals; Benzimidazoles; Benzoates; Hypertension; Kidney Diseases; Male; Metabolic Syndrome; Telmisartan; Tetrazoles; Valine; Valsartan | 2011 |
New clinical concepts after the ONTARGET trial.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Ramipril; Telmisartan | 2011 |
Antihypertensive and metabolic effects of telmisartan in hypertensive HIV-positive patients.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Cystatin C; Endothelin-1; HIV Seropositivity; Humans; Hypertension; Insulin Resistance; Interleukin-18; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; PPAR gamma; Risk Factors; Telmisartan; Triglycerides | 2011 |
Prophylactic treatment with telmisartan induces tissue-specific gene modulation favoring normal glucose homeostasis in Cohen-Rosenthal diabetic hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Glucose; Chemoprevention; Diabetes Mellitus, Experimental; Gene Expression Regulation; Homeostasis; Hypertension; Male; Organ Specificity; Rats; Rats, Inbred Strains; Telmisartan; Up-Regulation | 2012 |
Telmisartan decreases atrial electromechanical delay in patients with newly diagnosed essential hypertension.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Benzimidazoles; Benzoates; Echocardiography; Electrocardiography; Female; Heart Conduction System; Humans; Hypertension; Male; Middle Aged; Reproducibility of Results; Statistics, Nonparametric; Telmisartan; Treatment Outcome | 2012 |
[High blood pressure in the morning].
Topics: Benzimidazoles; Benzoates; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Delayed-Action Preparations; Drug Combinations; Drug Substitution; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Ramipril; Telmisartan | 2011 |
Telmisartan-induced lithium intoxication in a patient with schizoaffective disorder.
Topics: Antihypertensive Agents; Antimanic Agents; Benzimidazoles; Benzoates; Drug Interactions; Female; Humans; Hypertension; Lithium Chloride; Middle Aged; Psychotic Disorders; Telmisartan | 2012 |
Telmisartan improves cardiometabolic profile in obese patients with arterial hypertension.
Topics: Adult; Aged; Benzimidazoles; Benzoates; Female; Humans; Hypertension; Insulin Resistance; Male; Metabolome; Middle Aged; Obesity; Telmisartan | 2012 |
[New effects of telmisartan, an angiotensin 2 receptor blocker, in the treatment of arterial hypertension with metabolic disorders].
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Enalapril; Female; Humans; Hypertension; Male; Metabolic Diseases; Middle Aged; Telmisartan | 2012 |
Sympathoinhibition caused by orally administered telmisartan through inhibition of the AT₁ receptor in the rostral ventrolateral medulla of hypertensive rats.
Topics: Acetophenones; Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Cyclic N-Oxides; Enzyme Inhibitors; Heart Rate; Hydralazine; Hypertension; Medulla Oblongata; Microinjections; NADPH Oxidases; Norepinephrine; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Spin Labels; Sympathetic Nervous System; Sympatholytics; Telmisartan; Tetrazoles; Thiobarbituric Acid Reactive Substances | 2012 |
Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan.
Topics: Adult; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Antiretroviral Therapy, Highly Active; Benzimidazoles; Benzoates; Biomarkers; Blood Pressure; Endothelium, Vascular; Glomerular Filtration Rate; HIV Infections; Humans; Hypertension; Insulin Resistance; Italy; Kidney; Male; Middle Aged; Telmisartan; Time Factors; Treatment Outcome | 2012 |
Effects of telmisartan on the cerebral circulation of hypertensive patients with chronic-stage stroke.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Cerebrovascular Circulation; Chronic Disease; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Stroke; Telmisartan | 2012 |
Relationship between telmisartan dose and glycaemic control in Japanese patients with type 2 diabetes mellitus and hypertension: a retrospective study.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Japan; Male; Middle Aged; Retrospective Studies; Telmisartan | 2012 |
Sympathoinhibitory effects of telmisartan through the reduction of oxidative stress in the rostral ventrolateral medulla of obesity-induced hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Pressure; Brain Stem; Heart Rate; Hypertension; Male; Microinjections; Norepinephrine; Obesity; Oxidative Stress; Rats; Rats, Sprague-Dawley; Telmisartan; Thiobarbituric Acid Reactive Substances | 2012 |
Telmisartan prevents excess-salt-induced exacerbated (malignant) hypertension in spontaneously hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Hypertension; Male; Random Allocation; Rats; Rats, Inbred SHR; Sodium Chloride, Dietary; Telmisartan | 2013 |
Telmisartan protects against cognitive decline via up-regulation of brain-derived neurotrophic factor/tropomyosin-related kinase B in hippocampus of hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Brain-Derived Neurotrophic Factor; Cognition Disorders; Disease Models, Animal; Hippocampus; Hypertension; Male; PPAR gamma; Protein Kinases; Rats, Inbred SHR; Receptor, trkB; Telmisartan; Up-Regulation | 2012 |
Differential effects of short-term treatment with two AT1 receptor blockers on diameter of pial arterioles in SHR.
Topics: Angiotensin Receptor Antagonists; Animals; Arterioles; Benzimidazoles; Benzoates; Biphenyl Compounds; Brain; Cerebrovascular Circulation; Hypertension; Male; Microcirculation; Muscle, Smooth; Nitric Oxide Synthase Type III; Pia Mater; Pioglitazone; PPAR gamma; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; RNA, Messenger; Telmisartan; Tetrazoles; Thiazolidinediones | 2012 |
Improving drug adherence using fixed combinations caused beneficial treatment outcomes and decreased health-care costs in patients with hypertension.
Topics: Aged; Aged, 80 and over; Amlodipine; Angiotensin Receptor Antagonists; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Health Care Costs; Humans; Hypertension; Male; Medication Adherence; Middle Aged; Prospective Studies; Retrospective Studies; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2013 |
The effects of telmisartan alone or with hydrochlorothiazide on morning and 24-h ambulatory BP control: results from a practice-based study (SURGE 2).
Topics: Adolescent; Aged; Aged, 80 and over; Ambulatory Care; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Reference Values; Telmisartan; Treatment Outcome; Young Adult | 2013 |
[Effect of telmisartan and pyridoxamine on oxidative stress in brain tissue of spontaneously hypertensive rats].
Topics: Animals; Benzimidazoles; Benzoates; Brain; Hypertension; Male; NADPH Oxidases; Oxidative Stress; Pyridoxamine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Superoxide Dismutase; Telmisartan | 2012 |
[Dual blockade of the renin-angiotensin system in hypertensive treatment: yes].
Topics: Amides; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Coronary Vasospasm; Drug Therapy, Combination; Early Termination of Clinical Trials; Fumarates; Humans; Hypertension; Ramipril; Randomized Controlled Trials as Topic; Renin; Renin-Angiotensin System; Telmisartan | 2012 |
Does the PPAR-γ-activating property of telmisartan provide a benefit in clinical practice?
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Comorbidity; Diabetes Mellitus; Glucose; Homeostasis; Humans; Hypertension; Insulin; PPAR gamma; Telmisartan; Treatment Outcome | 2013 |
Late angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanisms.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atenolol; Benzimidazoles; Benzoates; Blood Pressure; Cell Dedifferentiation; Cell Line; Chemokine CCL20; Cytoprotection; Disease Models, Animal; Fibrosis; Gene Expression Profiling; Gene Expression Regulation; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Inflammation; Isoantibodies; Macrophages; Male; Mice; Nephrectomy; Podocytes; Proteinuria; Rats; Rats, Wistar; Receptors, CCR6; Receptors, Platelet-Derived Growth Factor; RNA Interference; RNA, Messenger; Telmisartan; Time Factors; Transfection | 2013 |
Targeting albuminuria in arterial hypertension and diabetes: how is it best achieved and what is its clinical relevance?
Topics: Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Female; Humans; Hypertension; Male; Telmisartan | 2013 |
The efficacy and tolerability of an angiotensin II receptor blocker, telmisartan, in Thai patients with mild to moderate essential hypertension.
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Female; Humans; Hypertension; Male; Middle Aged; Single-Blind Method; Telmisartan; Thailand | 2002 |
[Hypotensive effects of telmisartan on blood pressure during rest and exercise in patients with mild and moderate arterial hypertension].
Topics: Adult; Age Factors; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Data Interpretation, Statistical; Echocardiography; Exercise; Exercise Test; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Rest; Sex Factors; Telmisartan; Time Factors | 2002 |
[Lowering blood pressure with sartans. Are there differences?].
Topics: Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Cross-Over Studies; Humans; Hypertension; Losartan; Randomized Controlled Trials as Topic; Telmisartan; Tetrazoles; Valine; Valsartan | 2002 |
[These hypertensive patients are especially at risk for myocardial infarct in the morning. Screen for non-dippers].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Circadian Rhythm; Clinical Trials as Topic; Humans; Hypertension; Myocardial Infarction; Risk Factors; Telmisartan | 2002 |
[Despite therapy morning dangerous RR spikes. Headache and vertigo are alarm signals].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Cerebral Infarction; Drug Administration Schedule; Electrocardiography; Half-Life; Headache; Humans; Hypertension; Telmisartan; Vertigo | 2003 |
[Therapy of hypertension. Pulse pressure must also be reduced].
Topics: Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Receptor, Angiotensin, Type 1; Telmisartan; Treatment Outcome | 2003 |
Cardiology patient page. Angiotensin receptor blockers.
Topics: Acrylates; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Diuretics; Dizziness; Drug Combinations; Drug Interactions; Heart Failure; Humans; Hypertension; Imidazoles; Irbesartan; Kidney Diseases; Losartan; Olmesartan Medoxomil; Telmisartan; Tetrazoles; Thiophenes; Valine; Valsartan | 2003 |
[Improved protection of heart and kidneys in the hypertensive patient. ACE inhibitor and AT1 blocker combined?].
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hypertension; Hypertrophy, Left Ventricular; Ramipril; Renal Insufficiency; Telmisartan | 2003 |
[When morning blood pressure increases steeply. Stroke risk also increases].
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Circadian Rhythm; Humans; Hypertension; Risk Factors; Stroke; Telmisartan | 2003 |
[Therapy of hypertension. Also pulse pressure must be reduced].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Elasticity; Humans; Hypertension; Muscle, Smooth, Vascular; Telmisartan | 2003 |
[Dosage equivalents of AT1-receptor antagonists available in Germany].
Topics: Acrylates; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Clinical Trials as Topic; Germany; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Olmesartan Medoxomil; Placebos; Telmisartan; Tetrazoles; Therapeutic Equivalency; Thiophenes; Time Factors; Valine; Valsartan | 2003 |
[Ask the patient with hypertension about dizziness and headache! High blood pressure in the morning is not a silent killer].
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure Determination; Dizziness; Headache; Humans; Hypertension; Telmisartan; Time Factors | 2003 |
[Therapy of hypertension. Lasting organ protection moves into the foreground].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Clinical Trials as Topic; Drug Therapy, Combination; Heart Failure; Humans; Hypertension; Myocardial Infarction; Ramipril; Receptor, Angiotensin, Type 1; Stroke; Telmisartan; Treatment Outcome | 2003 |
Insulin-sensitizing effects of telmisartan: implications for treating insulin-resistant hypertension and cardiovascular disease.
Topics: Benzimidazoles; Benzoates; Cardiovascular Diseases; Humans; Hypertension; Insulin Resistance; Male; Middle Aged; Telmisartan | 2004 |
[Normal blood pressure values in general practice are not enough. Also measure "morning after" values].
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Circadian Rhythm; Coronary Disease; Drug Administration Schedule; Humans; Hypertension; Hypertrophy, Left Ventricular; Telmisartan; Treatment Outcome | 2004 |
Effects of telmisartan 80 mg and valsartan 160 mg on ambulatory blood pressure in patients with essential hypertension.
Topics: Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Humans; Hypertension; Telmisartan; Tetrazoles; Valine; Valsartan | 2004 |
[Therapy of hypertension. Pulse pressure must also be reduced].
Topics: Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Humans; Hydrochlorothiazide; Hypertension; Receptor, Angiotensin, Type 1; Telmisartan; Treatment Outcome | 2004 |
Control of vascular changes by renin-angiotensin-aldosterone system in salt-sensitive hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Antihypertensive Agents; Arteries; Benzimidazoles; Benzoates; Blood Pressure; Blood Vessels; Body Weight; Capsaicin; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Perindopril; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Sodium, Dietary; Spironolactone; Telmisartan | 2004 |
Pharmacokinetic comparison of an angiotensin II receptor antagonist, telmisartan, in Japanese and western hypertensive patients using population pharmacokinetic method.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Asian People; Benzimidazoles; Benzoates; Female; Humans; Hypertension; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Telmisartan; White People | 2004 |
[Despite drug treatment, ever second hypertensive patient with morning blood pressure too high].
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Circadian Rhythm; Clinical Trials as Topic; Drug Administration Schedule; Humans; Hypertension; Losartan; Telmisartan; Tetrazoles; Valine; Valsartan | 2004 |
Introduction. Telmisartan in the treatment of hypertension--addressing the early morning risk: international experiences in different populations.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Humans; Hypertension; Telmisartan | 2004 |
Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Diabetes Mellitus; Diabetes Mellitus, Type 2; Humans; Hypertension; Insulin Resistance; PPAR gamma; Renin-Angiotensin System; Telmisartan; Tetrazoles; Valine; Valsartan | 2005 |
[Assessment of antihypertensive effect of telmizartan in patients with hypertensive disease].
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Humans; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome | 2005 |
Comparative effects of the angiotensin II receptor blocker, telmisartan, and the angiotensin-converting enzyme inhibitor, ramipril, on cerebrovascular structure in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arterioles; Benzimidazoles; Benzoates; Cerebral Arteries; Cerebrovascular Circulation; Homeostasis; Hypertension; Male; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Telmisartan; Vasodilation | 2005 |
Introduction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Hypertension; Hypoglycemic Agents; Obesity; Telmisartan | 2005 |
Efficacy and duration of action of the four selective angiotensin II subtype 1 receptor blockers, losartan, candesartan, valsartan and telmisartan, in patients with essential hypertension determined by home blood pressure measurements.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure Monitoring, Ambulatory; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Telmisartan; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan | 2005 |
[Efficacy of telmisartan in chronic obstructive lung disease wtih arterial hypertension].
Topics: Aged; Airway Resistance; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Circadian Rhythm; Dose-Response Relationship, Drug; Forced Expiratory Flow Rates; Humans; Hypertension; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Telmisartan; Treatment Outcome | 2005 |
[Telmisartan].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Humans; Hypertension; Lipids; Metabolic Syndrome; PPAR gamma; Randomized Controlled Trials as Topic; Telmisartan | 2005 |
Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension.
Topics: Administration, Oral; Age Factors; Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antioxidants; Benzimidazoles; Benzoates; Blotting, Western; Coronary Artery Disease; Disease Progression; DNA Primers; Endothelial Cells; Endothelium, Vascular; Female; Humans; Hypertension; Male; Microcirculation; Middle Aged; Oxidative Stress; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Telmisartan; Time Factors; Up-Regulation | 2005 |
A hypertensive snow bird.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Conflict of Interest; Drug Industry; Education, Medical, Continuing; Humans; Hypertension; Practice Guidelines as Topic; Quebec; Schools, Medical; Telmisartan | 2005 |
A hypertensive snow bird.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Conflict of Interest; Drug Industry; Education, Medical, Continuing; Humans; Hypertension; Practice Guidelines as Topic; Quebec; Telmisartan | 2005 |
Significance of angiotensin II receptor blocker lipophilicities and their protective effect against vascular remodeling.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Pressure; Body Weight; Carotid Artery Diseases; Gene Expression; Hypertension; Immunohistochemistry; Lipids; Losartan; Male; Membrane Transport Proteins; Myocardium; NADPH Oxidases; Nitric Oxide Synthase Type III; Organ Size; Phosphoproteins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; Telmisartan; Vasodilation | 2005 |
[Revised blood pressure goals and no elevated glucose readings in between].
Topics: Acarbose; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Glucose Self-Monitoring; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hyperglycemia; Hypertension; Hypoglycemic Agents; Postprandial Period; Risk Factors; Telmisartan | 2005 |
ADMA and oxidative stress may relate to the progression of renal disease: rationale and design of the VIVALDI study.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arginine; Benzimidazoles; Benzoates; Clinical Protocols; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dinoprost; Endothelium, Vascular; Humans; Hypertension; Middle Aged; Multicenter Studies as Topic; Oxidative Stress; Randomized Controlled Trials as Topic; Renal Insufficiency; Telmisartan; Tetrazoles; Valine; Valsartan | 2005 |
Metabolic effects of telmisartan in spontaneously hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; CD36 Antigens; Gene Expression Regulation; Glucose; Glucose Tolerance Test; Hypertension; Insulin Resistance; Liver; Male; Muscle, Skeletal; Rats; Rats, Inbred SHR; Telmisartan; Triglycerides | 2006 |
[In the framework of the 72nd Annual Meeting of the DKG (German CardiologySociety) in Mannheim presented: Ontarget-the until now largest study program on cardiovascular prevention in patients with hypertension].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypertension; Metabolic Syndrome; Ramipril; Randomized Controlled Trials as Topic; Risk Factors; Telmisartan; Time Factors | 2006 |
[Lowering blood pressure substantially--and the diabetes risk as well?].
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitors; Circadian Rhythm; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Germany; Humans; Hypertension; Sodium Chloride Symporter Inhibitors; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2006 |
C-reactive protein causes downregulation of vascular angiotensin subtype 2 receptors and systolic hypertension in mice.
Topics: Angiotensin II; Animals; Benzimidazoles; Benzoates; C-Reactive Protein; Down-Regulation; Hypertension; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Systole; Telmisartan | 2007 |
Effect of telmisartan on cholesterol levels in patients with hypertension - Saga Telmisartan Aggressive Research (STAR).
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Cholesterol; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Male; Prospective Studies; Telmisartan | 2007 |
[Treatment of hypertension in daily practice. Current results of a postmarketing surveillance study with telmisartan].
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Drug Therapy, Combination; Family Practice; Female; Germany; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Product Surveillance, Postmarketing; Prospective Studies; Telmisartan | 2007 |
Potential effects of angiotensin II receptor blockers on glucose tolerance and adiponectin levels in hypertensive patients.
Topics: Adiponectin; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus; Enzyme-Linked Immunosorbent Assay; Female; Glucose Tolerance Test; Humans; Hypertension; Male; Middle Aged; PPAR gamma; Telmisartan | 2007 |
Telmisartan in the treatment of Cohen-Rosenthal Diabetic Hypertensive rats: the benefit of PPAR-gamma agonism.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Disease Models, Animal; Hypertension; Hypoglycemic Agents; Insulin Resistance; Male; PPAR gamma; Rats; Rats, Inbred SHR; Telmisartan | 2007 |
Angiotensin AT1 receptor antagonists exert anti-inflammatory effects in spontaneously hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Aorta; Benzimidazoles; Benzoates; Chemokine CCL2; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Hypertension; Losartan; Macrophages; Male; Mice; Monocytes; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, CCR2; Reverse Transcriptase Polymerase Chain Reaction; Telmisartan | 2007 |
Decreased androgen levels and improved menstrual pattern after angiotensin II receptor antagonist telmisartan treatment in four hypertensive patients with polycystic ovary syndrome: case series.
Topics: Adult; Androgens; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Body Mass Index; Fasting; Female; Humans; Hypertension; Menstruation; Obesity; Polycystic Ovary Syndrome; Telmisartan; Treatment Outcome | 2007 |
Plasma renin activity for predicting antihypertensive drug efficacy.
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Biomarkers; Biphenyl Compounds; Black People; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Body Weight; Drug Administration Schedule; Humans; Hypertension; Patient Selection; Renin; Research Design; Sex Factors; Telmisartan; Tetrazoles; Treatment Outcome; White People | 2008 |
Effect of telmisartan and amlodipine on home blood pressure by monitoring newly developed telemedicine system: monitoring test by using telemedicine. Telmisartan's effect on home blood pressure (TelTelbosu).
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Cell Phone; Female; Humans; Hypertension; Internet; Male; Middle Aged; Self Care; Telemedicine; Telemetry; Telmisartan | 2008 |
[Therapy of hypertension with expanded outlook. Constant pressure decline and organ protection].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Ramipril; Randomized Controlled Trials as Topic; Telmisartan | 2007 |
Impact of the therapy by renin-angiotensin system targeting antihypertensive agents perindopril versus telmisartan on prothrombotic state in essential hypertension.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Biomarkers; Blood Coagulation; Blood Platelets; Case-Control Studies; Chi-Square Distribution; Female; Fibrinolysis; Humans; Hypertension; Male; Middle Aged; Perindopril; Renin-Angiotensin System; Statistics, Nonparametric; Telmisartan; Thrombosis | 2008 |
Inhibition of vascular angiotensin-converting enzyme by telmisartan via the peroxisome proliferator-activated receptor gamma agonistic property in rats.
Topics: Acetylcholine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Carotid Arteries; Disease Models, Animal; Hypertension; Male; NADPH Oxidases; Peptidyl-Dipeptidase A; PPAR gamma; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; Telmisartan; Tetrazoles; Valine; Valsartan; Vasodilation; Vasodilator Agents | 2007 |
A physician with pounding headaches.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure Monitoring, Ambulatory; Drug Resistance; Headache Disorders; Humans; Hypertension; Male; Metoprolol; Telmisartan | 2008 |
Comparison of effects of olmesartan and telmisartan on blood pressure and metabolic parameters in Japanese early-stage type-2 diabetics with hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Imidazoles; Inflammation; Japan; Male; Metabolic Syndrome; Middle Aged; Telmisartan; Tetrazoles | 2008 |
Effect of telmisartan, angiotensin II receptor antagonist, on metabolic profile in fructose-induced hypertensive, hyperinsulinemic, hyperlipidemic rats.
Topics: Adiponectin; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Diet; Fructose; Hyperinsulinism; Hyperlipidemias; Hypertension; Insulin; Male; Metabolic Syndrome; Rats; Rats, Sprague-Dawley; Telmisartan; Triglycerides | 2008 |
Prevention of salt-induced hypertension and fibrosis by AT1-receptor blockers in Dahl S rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Benzimidazoles; Benzoates; Blood Pressure; Cardiomegaly; Dose-Response Relationship, Drug; Fibrosis; Heart Rate; Hypertension; Hypertrophy; Kidney; Losartan; Male; Myocardium; Organ Specificity; Rats; Rats, Inbred Dahl; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sodium, Dietary; Telmisartan | 2008 |
Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Collagen Type I; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; NADPH Oxidases; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Plasminogen Activator Inhibitor 1; PPAR gamma; Protein Kinase C; Protein Kinase Inhibitors; Rats; Rats, Inbred Dahl; Research Design; rho-Associated Kinases; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sodium Chloride, Dietary; Superoxides; Telmisartan; Transcription Factor RelA; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2008 |
Angiotensin II receptor blockade in TGR(mREN2)27: effects of renin-angiotensin-system gene expression and cardiovascular functions.
Topics: Adrenal Glands; Angiotensin Receptor Antagonists; Animals; Animals, Genetically Modified; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular System; Gene Expression; Hypertension; Kidney; Mice; Rats; Renin-Angiotensin System; Steroids; Telmisartan | 1995 |
Effects of AT1 receptor blockade on blood pressure and the renin-angiotensin system in spontaneously hypertensive rats of the stroke prone strain.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Captopril; Cerebrovascular Disorders; Gene Expression; Hypertension; Kidney; Losartan; Male; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin; Renin-Angiotensin System; RNA, Messenger; Telmisartan | 1998 |
A new ACE inhibitor and two new angiotensin receptor blockers for hypertension.
Topics: Acrylates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Clinical Trials as Topic; Contraindications; Double-Blind Method; Half-Life; Humans; Hypertension; Imidazoles; Perindopril; Telmisartan; Thiophenes | 1999 |
[Pharma-clinics. Medication of the month. Telmisartan (Micardis)].
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Dose-Response Relationship, Drug; Half-Life; Humans; Hypertension; Receptors, Angiotensin; Telmisartan | 2000 |
[Blood pressure regulation. Also before waking, no treatment failures].
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Circadian Rhythm; Humans; Hypertension; Telmisartan | 2000 |
[Angiotensin II antagonism. Critical morning hours are covered].
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Circadian Rhythm; Humans; Hypertension; Myocardial Infarction; Stroke; Telmisartan | 2001 |
Angiotensin II receptor antagonists: new paradigms in the treatment of hypertension. Introduction.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Humans; Hypertension; Telmisartan | 2001 |
Mild-to-moderate uncomplicated hypertension: further analysis of a cost-effectiveness study of five drugs.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Benzothiadiazines; Calcium Channel Blockers; Cost of Illness; Cost-Benefit Analysis; Decision Trees; Diuretics; Drug Costs; Formularies as Topic; Humans; Hypertension; Managed Care Programs; Sodium Chloride Symporter Inhibitors; Telmisartan | 2001 |
[Coronary heart disease patient with hypertension. Dangerously increased blood pressure despite gigantic therapy arsenal].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Coronary Disease; Drug Therapy, Combination; Humans; Hypertension; Male; Telmisartan; Treatment Outcome | 2002 |
Comparative antihypertensive and renoprotective effects of telmisartan and lisinopril after long-term treatment in hypertensive diabetic rats.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Hyperglycemia; Hypertension; Kidney; Kidney Glomerulus; Lisinopril; Male; Organ Size; Proteinuria; Rats; Rats, Inbred SHR; Reference Values; Telmisartan | 2001 |
Effects of telmisartan, hydrochlorothiazide and their combination on blood pressure and renal excretory parameters in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Pressure; Diuretics; Drug Therapy, Combination; Heart Rate; Hydrochlorothiazide; Hypertension; Kidney; Male; Rats; Rats, Inbred SHR; Sodium Chloride Symporter Inhibitors; Telmisartan; Urine | 2001 |
[Regardless of therapy only every fifth person has normal blood pressure values. Morning hours are deadly].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Circadian Rhythm; Dizziness; Headache; Humans; Hypertension; Risk Factors; Telmisartan; Time Factors | 2002 |